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ABSTRACT 
 
 Halogenated natural products are common and serve roles as hormones, 
pesticides, antibiotics, and anti-tumor agents.  The incorporation of a halogen atom into 
an organic scaffold can tune the molecule’s potency and selectivity, making halogenation 
an important tailoring reaction.  To understand the mechanisms of enzymatic 
halogenation of natural products, X-ray crystallography was used to solve structures of 
enzymes from two classes of halogenases, the flavin-dependent halogenases and the non-
heme iron dependent halogenases.  Structures of the flavin-dependent tryptophan 7-
halogenase RebH from Lechevalieria aerocolonigenes, involved in rebeccamycin 
biosynthesis, were solved by molecular replacement.  These structures show distant 
flavin and L-Trp binding sites and identify the conserved residue Lys79 as a likely 
candidate for covalent modification to produce an enzyme–bound lysine chloramine 
intermediate.  A lysine chloramine at this position would direct the chlorination reaction 
to the correct site on the substrate, which could account for the halogenase’s observed 
regioselectivity.  Crystal structures of the non-heme iron-dependent threonine 4-
halogenase SyrB2 from Pseudomonas syringae, involved in syringomycin biosynthesis, 
were solved using selenomethionine labeling and single wavelength anomalous 
dispersion (SAD) techniques.  These structures show an overall cupin or β-sandwich fold 
and a novel iron binding motif containing a naturally occurring iron-chloride bond.  The 
carboxylate ligand typically found in non-heme iron dependent hydroxylases is replaced 
by an alanine residue in the halogenases, opening a coordination site for the halide and 
suggesting a mechanism by which these enzymes accomplish halogenation instead of 
hydroxylation.  The final chapter of this thesis reviews the known classes of halogenating 
enzymes and examines questions of halide binding and selectivity from the perspective of 
protein structure.   
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Chapter I: Halogenated Natural Products 
 
 
I.A Introduction  
 The term “natural product” generally refers to any secondary metabolite generated by a 
living organism, and thus encompasses a huge variety of biologically produced small molecules.  
Natural products have proven invaluable to humans in numerous roles, as spices, perfumes, dyes, 
pesticides, and especially as pharmaceuticals.  Even today, natural products are an essential 
resource for drug discovery.  A remarkable 70% of small molecule antiinfectives approved from 
1981-2006 were either natural products or “natural product mimics,” meaning that they were 
derived from known natural product scaffolds1.  That natural products are a potent source of 
pharmaceuticals is unsurprising, since they have evolved to possess powerful biological 
activities.   Natural products often play physiological roles in signaling or defense, and their 
activity must benefit the producing organism in order to outweigh the energetic cost of their 
biosynthesis.   
Many natural products are produced through “assembly-line” type non-ribosomal 
polypeptide synthetase (NRPS) or polyketide synthetase (PKS) strategies, in which a basic 
chemical scaffold is assembled from simple biological molecules2.  This basic scaffold can be 
modified or decorated by racemization, dehydration, methylation, cyclization or a variety of 
other chemistries to produce unique small molecules.  One such natural product modification is 
halogenation, or the addition of a halogen atom to an organic scaffold.  As will be demonstrated, 
halogenation can modulate the activity of a natural product in numerous ways, producing new 
functions and improving specificity.  Further, halogenases have been demonstrated to catalyze 
halogenation reactions with remarkable selectivity on a variety of substrates, including the 
difficult addition of a halogen to an unactivated, aliphatic carbon3, 4.  Since halogenation in 
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organic synthesis often presents challenges of specificity and control, understanding biological 
halogenation reactions could lead to development of improved catalysts.  Additionally, re-
engineering NRPS and PKS natural product producing systems to accept new building blocks 
and to interact with different decorating enzymes has become an active area of research with 
exciting promise for accessing new biologically active molecules2.  Thus, a better understanding 
of biological halogenation could allow the halogenase enzymes themselves to be exploited for 
combinatorial biosynthesis of compound libraries.    
 
I.B Halogenated Natural Products, Their Prevalence and Importance 
Halogenated natural products are remarkably abundant, with more than 4,500 unique, naturally 
occurring compounds known as of 20045, 6.  These can be divided into 2,320 chlorinated 
compounds, 2050 brominated compounds, 115 iodinated compounds, and 34 fluorinated 
compounds6.  The distribution of halogenated compounds does not exactly parallel the relative 
natural abundance of the halides, with chloride being by far the most abundant halide, followed 
by fluoride and bromide and finally iodide (Table I.1).  Thus far, only one enzymatic mechanism 
for incorporation of fluorine into organic compounds is known, while four classes of enzymes 
catalyze chlorinations and brominations, and at least two can perform iodination.  In order to 
demonstrate the amazing diversity and importance of halogenated natural products, in the 
following sections an illustrative set of example compounds will be discussed (Figures I.1-4).  In 
each case, an associated “producing” organism is noted, which is generally the organism in 
which a given natural compound was first discovered.  Often, a particular compound may be 
synthesized by a variety of species.  In the case of natural products isolated from higher 
organisms, such as marine sponges and insects, many compounds have now been shown to be 
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produced by a symbiotic associated bacterial or algal species.  Thus, the actual producing 
organisms for many compounds are unknown. 
Figure I.1 shows a small sample of known chlorinated natural products that illustrate their 
diversity of structure, activity, and origin.  Vancomycin7 and chloramphenicol8 are clinically 
important antibiotics that were isolated from Streptomyces bacteria.  The compounds 
syringomycin E9 from Psuedomonas syringae and griseofulvin10 from Penicillin griseofulvun 
have potent anti-fungal activity.  Other useful properties of some chlorinated natural products 
include anti-tumor activity (rebeccamycin11 from the soil bacterium Lechevalieria 
aerocolonigenes) and activity against mycobacterium, the causative agent of tuberculosis 
(maracen A5, produced by Sorangium cellulosum).  Chlorinated natural products are also found 
in plants (the alkaloid romucosine B12 from Rollinia mucosa, which has anti-platelet aggregation 
activity), insects (the sex pheromone 2,6-dichlorophenol13 from lone star ticks), and even 
vertebrates (the analgesic compound epibatidine5 from the poisonous tree frog Epipedobates 
tricolor).   
Many brominated compounds are isolated from marine environments because of the 
relatively large concentration of Br- in seawater (Table I.1).  An illustrative sample of known 
brominated compounds is shown in Figure I.2.  The anti-tumor compound plakortamine C5 is 
found associated with the marine sponge Plakortis nigra.  Another marine sponge, Dysidea 
dendyi, is thought to produce some of the only biologically synthesized dioxins, including 
spongiadioxin A6.  Marine red algae are another prolific source of brominated compounds, such 
as the potent insecticide telfairine5 from Plocamium telfairiae.  Another red algae genus, 
Laurencia, produces an amazing variety of unique brominated scaffolds, including the molecules 
neoirietetraol, japonenyne A, laurefucin, and laurallene5, 14.  Only a few brominated compounds 
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are produced by terrestrial organisms.  One such example of a brominated molecule, known only 
as CJ-19,7845, is isolated from the fungus Acanthostigmella.  A particularly interesting 
brominated compound is 2-octyl γ-bromoacetoacetate15, originally isolated from human cerebral 
spinal fluid.  Although little is known about its origin or biosynthesis, this molecule is thought to 
be involved in regulating rapid-eye-movement (REM) sleep.   
 A representative sample of iodinated natural products is given in Figure I.3.  Thyroxine5 
is a well-known mammalian thyroid hormone, and the compound iodolactone14 occurs in the 
thyroid glands of dogs. Although the iodinated hormones are probably the best known iodine-
containing natural compounds, there are also many other iodinated natural products with useful 
biological activities.  One example, Calicheamicin16, from the fungus Micromonospora 
echinospora ssp. calichensis, is a potent anti-tumor agent that binds to the minor groove of DNA 
and causes oxidative double-strand cleavage.  Despite the relatively low concentration of iodide 
in seawater compared to bromide and chloride, several iodinated natural products have been 
discovered in marine samples. Tasihalide A17, isolated from a mixture of the cyanobacterium 
genus Symploca and a red alga, is an iodinated diterpene.  Another red algal species, Hypnea 
valetiae, produces 5′-deoxy-5-iodotubercidin18, an adenosine kinase inhibitor which has been 
employed to study nucleotide metabolism.  Additionally, not all halogenated natural products 
contain only one type of halogen.  The iodoindole Plakohypaphorine A19 associated with the 
marine sponge Plakortis simplex and the iodinated sesquiterpene 10-bromo-7-hydroxy-11-
iodolaurene20 from the marine alga Laurenica nana contain both bromine and iodine 
substituents.   
 Fluorinated natural products are by far the most rare, with only 34 examples known as of 
20036 (Figure I.4).  The first fluorinated compound to be discovered was the toxin fluoroacetate 
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from the South African plant Dichapetalum cymosum6, 21, which has been used as a pest control 
agent.  Other fluorinated compounds detected in plants include fluorocitrate, fluoroacetone, and 
ω-fluoro-fatty acids21.  Many other plants are now known to produce fluorinated compounds, 
including Dichapetalum braunii, Dichapetalum toxicarium, Acacia georginae, and Glycine max 
(soybean).  Insight into the biosynthesis of fluorinated natural products has been gained through 
characterization of the enzyme that catalyzes fluorination of S-adensyl-L-methione to produce 5′-
fluoro-5′-deoxyadenosine in Streptomyces cattleya22.  This product is then thought to be 
metabolized into fluoroacetaldehyde, which likely serves as a precursor for most of the other 
known fluorinated compounds21.  Whether the fluorinated metabolites produced by plants are 
synthesized through a similar mechanism has not yet been conclusively shown.  This pathway 
also does not fully account for the biosynthesis of the bacterial fluorinated antibiotic nucleocidin. 
 
I.C Halogenation and Activity 
 The addition of a halogen substituent to an organic chemical scaffold can dramatically 
alter the compound’s chemical properties.  In biochemistry, we most often consider halogens as 
the halide salts (X—, where X is any halogen atom), which are negatively charged, polar, and 
very electronegative species.  However, when covalently bonded to carbons (as C-X), halogens 
can impart different properties. Halogen substituents may actually increase a compound’s 
lipophilicity when compared to hydroxyl substituents, as evidenced by more positive log P 
values (partition coefficients between hydrophobic octanol and water)23, 24.  For example, the 
activity of the plant toxin syringomycin E (Figure I.1), which depends on membrane insertion, is 
completely abrogated if the halogen is replaced by a hydroxyl group25.  The greater lipophilicity 
of the chlorine substituent may promote insertion into the lipid bilayer, while a hydrophilic group 
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at that position eliminates activity.  Even the most electronegative halogen, fluorine, has weak 
hydrogen bond accepting ability and is therefore very hydrophobic26.   
The electronegativity of halogen substituents and the polar covalent nature of a C-X bond 
can also tune a compound’s properties through electron withdrawing effects.  Fluorine in 
particular can have a strong inductive effect on neighboring amines, decreasing their basicity and 
therefore increasing the compound’s bioavailability26.  Of course, there are large variations in the 
properties of the different halogens and their respective effects on a given organic scaffold. 
Small, electronegative fluorine (in a C-F bond) is only weakly polarizable, and therefore 
although it is a weak hydrogen bond acceptor, it can form interactions with electropositive sites.  
In contrast, chlorine, bromine, and iodine are much more polarizable (with I > Br > Cl), and 
exhibit an “electropositive crown” directly opposite the attached carbon27.  These halogens can 
actually act similarly to hydrogen bond donors in electrostatic interactions termed “halogen 
bonds.”   Halogen bonding interactions have been shown to play a role in binding of some 
protein kinase inhibitors, as well as interactions of the thyroid hormone thyroxine with protein 
partners27, 28.  Halogenation can also limit the conformational flexibility of an organic scaffold, 
and therefore promote binding of an optimized ligand conformation26.  Thus, the incorporation of 
a halogen atom into a given a compound can have a surprising variety of effects on that 
molecule’s chemical properties, dependent on both the halogen choice and location. 
 The presence of the halogen substituent is often essential to the activity of halogenated 
natural products.  For example, vancomycin (Figure I.1) can lose up to 10-fold of its antibacterial 
activity and peptide binding affinity with the removal of both chlorine moieties29, 30.  Removal of 
the chlorine from the glycopeptide antibiotic balhyimycin decreases its activity between 8 and 16 
fold against Gram-positive organisms31.  Another antibiotic, clorobiocin, is almost 8-fold less 
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active without its chlorine substituent32.  Halogenation can influence the mode of action and 
specificity of a compound as well as its overall activity.  The anti-tumor agent rebeccamycin 
(Figure I.1)  shows varying cell-line specific activity depending on the presence or absence of 
two chlorine moieties33.    
 
I.D Halogenation as a Synthetic Strategy 
 Halogenation is commonly used in organic synthesis to activate carbons for further 
chemistry.  It has recently been shown that Nature also employs a similar halogenation strategy 
in order to access more complicated chemical scaffolds.  The most striking example of this use 
of halogenation is the biosynthesis of the cyclopropyl ring in the compound coronamic acid 34.  
The enzyme CmaB catalyzes chlorination of an unactivated methyl group on L-allo-Ile while the 
amino acid is covalently tethered to the thiolation domain CmaD (Figure I.5.A).  This 
chlorination then activates the carbon for nucleophilic attack catalyzed by the enzyme CmaC to 
form a cyclopropyl ring.  It is possible that other, similar roles for halogenation will be 
discovered based on natural product gene clusters, in which the halogen is required for 
biosynthesis but does not appear in the final compound. 
 Halogenation can also play a role in activating structures to produce unique scaffolds, as 
is hypothesized for bromination by vanadium-dependent haloperoxidases in terpene 
biosynthesis35, 36. The addition of bromine (as Br+) to a double bond leads to bromonium-ion 
induced cyclization to give a carbocation (Figure I.5.B). This cyclization is followed by either 
elimination or nucleophilic attack by the allylic alcohol to produce a variety of products from a 
single initial structure36.   Thus, Nature employs halogenation chemistry to increase the scope of 
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available carbon structures, using reactions that encompass much more than the simple addition 
of a halogen to an organic scaffold.   
 
I.E A Brief History of Halogenating Enzymes 
There are many excellent reviews on enzymatic halogenation3, 4, 37, so here only a brief 
timeline of relevant discoveries will be given.  Additionally, a more comprehensive review of the 
different classes of halogenating enzymes is provided in Chapter V of this thesis.  The first 
characterized halogenated natural product, 3,5-diiodotyrosine, was identified over 200 years 
ago38.  However, the characterization of the first known halogenating enzymes, the heme iron 
haloperoxidases, did not occur until the 1950s.  Heme iron haloperoxidases include human 
myeloperoxidase and lactoperoxidase, involved in the oxidative immune response, and human 
thyroid peroxidase, involved in biosynthesis of the human thyroid hormone thyroxine39.  In 1984, 
the first vanadium-dependent halogenation activity was demonstrated with the bromoperoxidase 
from the marine organism Ascophyllum nodosum40.  Both vanadium-dependent and heme-
dependent haloperoxidases require hydrogen peroxide and catalyze halogenation of electron-rich 
substrates.  Basic proposed mechanisms for these enzymes are given in Figure I.6-7.   
Because none of the haloperoxidases have the oxidative power to catalyze fluorination 
reactions, the existence of other halogenating enzymes was postulated as early as 198638.  
Additionally, the haloperoxidase requirement for electron-rich substrates, as well as their 
observed lack of regioselectivity, implied that other halogenation mechanisms might exist38.   
These predictions were borne out in 1995, with the cloning of the first flavin-dependent 
halogenase, which was shown to be involved in the biosynthesis of the natural product 
tetracycline41.  Flavin-dependent halogenases require reduced flavin (FADH2) and O2, and 
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catalyze halogenation of electron-rich substrates with exceptional specificity and 
regioselectivity4, 37.  The current mechanistic hypothesis for the flavin-dependent halogenation 
reaction is shown in Figure I.8, and is partially based on structural characterization of the 
rebeccamycin biosynthetic enzyme RebH, which is presented in Chapter II of this thesis.  In 
2002, the first fluorinating enzyme, 5′-fluoro-5′-deoxyadenosine synthase (5′-FDAS), was 
discovered and subsequently structurally characterized22, 42.  5′-FDAS employs a nucleophilic 
mechanism of halogenation and requires the substrate S-adenosyl-L-methionine (SAM) (Figure 
I.9).  Still, these enzymatic activities could not explain all the observed halogenated natural 
products, including the tri-chlorinated leucine residue in the molluscicidal compound barbamide 
(Figure I.11).  As early as 1999, this compound was postulated to require a radical halogenation 
mechanism43.  In 2005, activity was demonstrated for non-heme iron and O2-dependent 
halogenases, the first enzymes capable of halogenation at unactivated carbon centers (Figure 
I.10)34, 44.  The structural characterization of syringomycin biosynthetic enzyme SyrB2, a non-
heme iron-dependent halogenase, is the subject of Chapter III of this thesis45.   
The two classes of O2-dependent halogenases, flavin-dependent and non-heme iron-
dependent, are now known to be responsible for a wide variety of halogenation reactions.  The 
flavin-dependent halogenases in particular are quite common, with a BLAST46 search for the 
RebH protein sequence using a stringent expect value of 1 resulting in greater than 224 hits.  A 
similar search for SyrB2 gave 185 hits, although many of these may be hydroxylating enzymes 
related to phytanoyl-CoA dioxygenase rather than halogenases.  SyrB2 and the currently known 
non-heme iron halogenases all act on substrates tethered to a phosphopantetheine arm, and so 
there may be other non-heme iron halogenases with more distant primary sequences that act on 
free substrates.  The discovery of the O2-dependent halogenases has also opened a new pathway 
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for discovery and cloning of natural product gene clusters, through design of halogenase specific 
DNA primers.   Several natural product gene clusters and new halogenating enzymes have now 
been discovered in this manner47, 48.  There still remain several halogenated features in natural 
products for which the halogenation mechanism remains unclear.  One example is the alkynyl 
bromide group of the natural product jamaicamide A49, from Lyngbya majuscule (Figure I.11).  
Both flavin-dependent and non-heme iron-dependent halogenation mechanisms could be 
envisioned for the biosynthesis of this unusual functional group, and the gene cluster has been 
shown to contain both types of enzymes4, 49.  A second example is the fluorinated compound 
nucleocidin21, for which the relevant biosynthetic genes are still unknown (Figure I.11).  It 
remains to be seen whether new methods of halogenation and halogenating enzymes will be 
discovered, but the recent characterization of a SAM-dependent chlorinase that employs a 
nucleophilic mechanism indicates that there is still a great deal to be learned about enzymatic 
halogenation50.   
 
I.F Goals of the Thesis 
In addition to discovery of novel halogenated metabolites and the cataloging of new 
halogenating activities, much remains to be learned about the basic enzymatic mechanisms of 
halogenation.  In this thesis, we focus on enzymes from the two recently discovered classes of 
O2-dependent halogenases, the flavin dependent halogenase RebH, and the non-heme iron-
dependent halogenase SyrB2.  In each case, crystallographic structure determination has led to 
new insight into the mechanism of halogenation.  Chapters II and III of the thesis describe the 
structure determination and analysis of RebH and SyrB2 respectively, and describe how structure 
has contributed to our understanding of halogenation chemistry.  Intriguingly, both flavin-
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dependent and non-heme iron-dependent halogenases bear strong resemblances to enzymes that 
catalyze hydroxylation chemistry, specifically the flavin-dependent monooxygenases and the 
non-heme iron-dependent dioxygenases.  In both cases, the halogenating and hydroxylating 
enzymes have very similar overall structures, common cofactor requirements, and even similar 
mechanistic strategies.  Therefore, comparison of the halogenases with their hydroxylating 
counterparts has allowed us to gain a new understanding of the chemistry of both classes.  
Specifically, we have been interested in what distinguishes the two chemistries:  What modulates 
the ability of an enzyme to catalyze halogenation versus hydroxylation?  While we have some 
hypotheses about the basis for partitioning between halogenation and hydroxylation, many 
questions remain, including whether halogenating enzymes can be engineered to perform 
hydroxylation and vice versa.  In Chapter IV, we extend our discussion to review current 
structural information on the non-heme iron dioxygenases and examine remaining structural 
questions for these related enzymes.  Finally, in Chapter V, we return to halogenation and 
expand our focus to compare structures of the currently known five classes of halogenases and 
examine issues of halide binding and selectivity.   
 
 19
I.G References 
1 Newman, D. J., and Cragg, G. M. (2007) Natural products as sources of new drugs over 
the last 25 years. J Nat Prod 70, 461-77. 
 
2 Walsh, C. T. (2008) The chemical versatility of natural-product assembly lines. Acc 
Chem Res 41, 4-10. 
 
3 Fujimori, D. G., and Walsh, C. T. (2007) What's new in enzymatic halogenations. Curr 
Opin Chem Biol 11, 553-60. 
 
4 Vaillancourt, F. H., Yeh, E., Vosburg, D. A., Garneau-Tsodikova, S., and Walsh, C. T. 
(2006) Nature's inventory of halogenation catalysts: oxidative strategies predominate. 
Chem Rev 106, 3364-78. 
 
5 Gribble, G. W. (2004) Natural organohalogens: A new frontier for medicinal agents? J 
Chem Ed 81, 1441-9. 
 
6 Gribble, G. W. (2004) Amazing organohalogens. American Scientist 92, 342-9. 
 
7 Moellering, R. C. (2006) Vancomycin: A 50-year reassessment. Clinical Infectious 
Diseases 42, S3-4. 
 
8 Murphy, C. D. (2003) New frontiers in biological halogenation. J Appl Microbiol 94, 
539-48. 
 
9 Guenzi, E., Galli, G., Grgurina, I., Gross, D. C., and Grandi, G. (1998) Characterization 
of the syringomycin synthetase gene cluster. A link between prokaryotic and eukaryotic 
peptide synthetases. J Biol Chem 273, 32857-63. 
 
10 Harris, C. M., Roberson, J. S., and Harris, T. M. (1976) Biosynthesis of griseofulvin. J 
Am Chem Soc 98, 5380-6. 
 
11 Yeh, E., Garneau, S., and Walsh, C. T. (2005) Robust in vitro activity of RebF and RebH, 
a two-component reductase/halogenase, generating 7-chlorotryptophan during 
rebeccamycin biosynthesis. Proc Natl Acad Sci U S A 102, 3960-5. 
 
12 Kuo, R. Y., Chang, F. R., Chen, C. Y., Teng, C. M., Yen, H. F., and Wu, Y. C. (2001) 
Antiplatelet activity of N-methoxycarbonyl aporphines from Rollinia mucosa. 
Phytochemistry 57, 421-5. 
 
13 Berger, R. S. (1972) 2,6-dichlorophenol, sex pheromone of the lone star tick. Science 
177, 704-5. 
 
14 Gribble, G. W. (2003) The diversity of naturally produced organohalogens. Chemosphere 
52, 289-97. 
 20
 
15 Patricelli, M. P., Patterson, J. E., Boger, D. L., and Cravatt, B. F. (1998) An endogenous 
sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase. 
Bioorg Med Chem Lett 8, 613-8. 
 
16 Ahlert, J., Shepard, E., Lomovskaya, N., Zazopoulos, E., Staffa, A., Bachmann, B. O., 
Huang, K., Fonstein, L., Czisny, A., Whitwam, R. E., Farnet, C. M., and Thorson, J. S. 
(2002) The calicheamicin gene cluster and its iterative type I enediyne PKS. Science 297, 
1173-6. 
 
17 Williams, P. G., Yoshida, W. Y., Moore, R. E., and Paul, V. J. (2003) Novel iodinated 
diterpenes from a marine cyanobacterium and red alga assemblage. Org Lett 5, 4167-70. 
 
18 Carté, B. K. (1996) Biomedical potential of marine natural products. Bioscience 46, 271-
86. 
 
19 Campagnuolo, C., Fattorusso, E., and Taglialatela-Scafati, O. (2003) Plakohypaphorines 
A-C, iodine-containing alkaloids from the caribbean sponge Plakortis simplex. Eur J Org 
Chem, 284-7. 
 
20 Izac, R., and Sims, J. J. (1979) Marine natural products. 18. Iodinated sesquiterpenes 
from the red algal genus Laurencia. J Am Chem Soc 101, 6136-7. 
 
21 Murphy, C. D., Schaffrath, C., and O'Hagan, D. (2003) Fluorinated natural products: the 
biosynthesis of fluoroacetate and 4-fluorothreonine in Streptomyces cattleya. 
Chemosphere 52, 455-61. 
 
22 Dong, C., Huang, F., Deng, H., Schaffrath, C., Spencer, J. B., O'Hagan, D., and Naismith, 
J. H. (2004) Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 
427, 561-5. 
 
23 Hansch, C., and Albert, L. (1979) Substituent constants for correlation analysis in 
chemistry and biology, Wiley, New York. 
 
24 Lide, D. R. (2007) CRC Handbook of Chemistry and Physics, CRC Press, New York. 
 
25 Grgurina, I., Barca, A., Cervigni, S., Gallo, M., Scaloni, A., and Pucci, P. (1994) 
Relevance of chlorine-substituent for the antifungal activity of syringomycin and 
syringotoxin, metabolites of the phytopathogenic bacterium Pseudomonas syringae pv. 
syringae. Experientia 50, 130-3. 
 
26 Muller, K., Faeh, C., and Diederich, F. (2007) Fluorine in pharmaceuticals: looking 
beyond intuition. Science 317, 1881-6. 
 
27 Auffinger, P., Hays, F. A., Westhof, E., and Ho, P. S. (2004) Halogen bonds in biological 
molecules. Proc Natl Acad Sci U S A 101, 16789-94. 
 21
 
28 Voth, A. R., and Ho, P. S. (2007) The role of halogen bonding in inhibitor recognition 
and binding by protein kinases. Curr Top Med Chem 7, 1336-48. 
 
29 Harris, C. M., Kannan, R., Kopecka, H., and Harris, T. M. (1985) The role of the chlorine 
substituents in the antibiotic vancomycin: preparation and characterization of mono- and 
didechlorovancomycin. J Am Chem Soc 107, 6652-8. 
 
30 Nagarajan, R. (1991) Antibacterial activities and modes of action of vancomycin and 
related glycopeptides. Antimicrob Agents Chemother 35, 605-9. 
 
31 Bister, B., Bischoff, D., Nicholson, G. J., Stockert, S., Wink, J., Brunati, C., Donadio, S., 
Pelzer, S., Wohlleben, W., and Sussmuth, R. D. (2003) Bromobalhimycin and 
chlorobromobalhimycins--illuminating the potential of halogenases in glycopeptide 
antibiotic biosyntheses. Chembiochem 4, 658-62. 
 
32 Eustáquio, A. S., Gust, B., Luft, T., Li, S. M., Chater, K. F., and Heide, L. (2003) 
Clorobiocin biosynthesis in Streptomyces: identification of the halogenase and generation 
of structural analogs. Chem Biol 10, 279-88. 
 
33 Prudhomme, M. (2003) Rebeccamycin analogues as anti-cancer agents. Eur J Med Chem 
38, 123-40. 
 
34 Vaillancourt, F. H., Yeh, E., Vosburg, D. A., O'Connor, S. E., and Walsh, C. T. (2005) 
Cryptic chlorination by a non-haem iron enzyme during cyclopropyl amino acid 
biosynthesis. Nature 436, 1191-4. 
 
35 Moore, B. S. (2006) Biosynthesis of marine natural products: macroorganisms (Part B). 
Nat Prod Rep 23, 615-29. 
 
36 Butler, A., and Carter-Franklin, J. N. (2004) The role of vanadium bromoperoxidase in 
the biosynthesis of halogenated marine natural products. Nat Prod Rep 21, 180-8. 
 
37 van Pée, K. H., Dong, C., Flecks, S., Naismith, J., Patallo, E. P., and Wage, T. (2006) 
Biological halogenation has moved far beyond haloperoxidases. Adv Appl Microbiol 59, 
127-57. 
 
38 Neidleman, S. L., and Geigert, J. (1986) Biohalogenation: Principles, basic roles and 
applications, Halsted Press, New York. 
 
39 Dunford, B. H. (1999) Heme peroxidases, Wiley-VCH, New York. 
 
40 Vilter, H. (1984) Peroxidases from Phaeophyceae: A vanadium (V)-dependent 
peroxidase from Ascophyllum nodosum. Phytochemistry 23, 1387-90. 
 
 22
41 Dairi, T., Nakano, T., Aisaka, K., Katsumata, R., and Hasegawa, M. (1995) Cloning and 
nucleotide sequence of the gene responsible for chlorination of tetracycline. Biosci 
Biotechnol Biochem 59, 1099-106. 
 
42 O'Hagan, D., Schaffrath, C., Cobb, S. L., Hamilton, J. T., and Murphy, C. D. (2002) 
Biochemistry: biosynthesis of an organofluorine molecule. Nature 416, 279. 
 
43 Hartung, J. (1999) The biosynthesis of barbamide- A radical pathway for 
"biohalogenation"? Angew Chem Int Ed 38, 1209-11. 
 
44 Vaillancourt, F. H., Yin, J., and Walsh, C. T. (2005) SyrB2 in syringomycin E 
biosynthesis is a nonheme FeII alpha-ketoglutarate- and O2-dependent halogenase. Proc 
Natl Acad Sci U S A 102, 10111-6. 
 
45 Blasiak, L. C., Vaillancourt, F. H., Walsh, C. T., and Drennan, C. L. (2006) Crystal 
structure of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis. Nature 
440, 368-71. 
 
46 Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) Basic local 
alignment search tool. J Mol Biol 215, 403-10. 
 
47 Fujimori, D. G., Hrvatin, S., Neumann, C. S., Strieker, M., Marahiel, M. A., and Walsh, 
C. T. (2007) Cloning and characterization of the biosynthetic gene cluster for 
kutznerides. Proc Natl Acad Sci U S A 104, 16498-503. 
 
48 Galonic, D. P., Vaillancourt, F. H., and Walsh, C. T. (2006) Halogenation of unactivated 
carbon centers in natural product biosynthesis: trichlorination of leucine during 
barbamide biosynthesis. J Am Chem Soc 128, 3900-1. 
 
49 Edwards, D. J., Marquez, B. L., Nogle, L. M., McPhail, K., Goeger, D. E., Roberts, M. 
A., and Gerwick, W. H. (2004) Structure and biosynthesis of the jamaicamides, new 
mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya 
majuscula. Chem Biol 11, 817-33. 
 
50 Eustáquio, A. S., Pojer, F., Noel, J. P., and Moore, B. S. (2007) Discovery and 
characterization of a marine bacterial SAM-dependent chlorinase. Nat Chem Biol 4, 69-
74. 
 
51 Emsley, J. (2001) Nature's building blocks, Oxford University Press Inc., New York. 
 
52 Furtmuller, P. G., Obinger, C., Hsuanyu, Y., and Dunford, H. B. (2000) Mechanism of 
reaction of myeloperoxidase with hydrogen peroxide and chloride ion. Eur J Biochem 
267, 5858-64. 
 
53 Marquez, L. A., and Dunford, H. B. (1994) Chlorination of taurine by myeloperoxidase. 
Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 269, 7950-6. 
 23
 
54 Wagenknecht, H. A., and Woggon, W. D. (1997) Identification of intermediates in the 
catalytic cycle of chloroperoxidase. Chem Biol 4, 367-72. 
 
55 Yeh, E., Blasiak, L. C., Koglin, A., Drennan, C. L., and Walsh, C. T. (2007) Chlorination 
by a long-lived intermediate in the mechanism of flavin-dependent halogenases. 
Biochemistry 46, 1284-92. 
 
56 Galonic, D. P., Barr, E. W., Walsh, C. T., Bollinger, J. M., Jr., and Krebs, C. (2007) Two 
interconverting Fe(IV) intermediates in aliphatic chlorination by the halogenase CytC3. 
Nat Chem Biol 3, 113-6. 
 
 24
Table I.1  Relative halogen abundances51. 
 Elemental abundance in the Earth’s crust (p.p.m) 
Abundance of halide in 
average topsoils (p.p.m.) 
Abundance of halide in 
seawater (p.p.m.) 
Fluorine 950 150-400 1.3 
Chlorine 130 50-2000 (avg. 100) 19,000 
Bromine 0.4 5-40 65 
Iodine 0.14 0.1-10 0.06 
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Figure I.1 Examples of chlorinated natural products. 
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Figure I.2 Examples of brominated natural products. 
 
ClCl
Cl
Br
telfairine
Plocamium telfairiae
N
H
N N N
H
Br Br
N
plakortamine C
Plakortis nigra
O
O
OH
Br
Br
Br
spongiadioxin A
Dysidea dendyi
Br
O
O
OOH
O
O
HO
Br
CJ-19,784
Acanthostigmella sp.
O
O O
Br
2-octyl -γ -bromoacetoacetate
Homo sapiens
OBr
O
HO
laurefucin
Laurencia
O
O
C BrBr
laurallene
Laurencia
O
OBr Br
japonenyne
Laurencia
Br
HO OH OH
HO
Br
neoirietetraol
Laurencia
 
 
 27
Figure I.3 Examples of iodinated natural products. 
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Figure I.4 Examples of fluorinated natural products. 
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Figure I.5 Halogenation as a synthetic strategy.  A. Halogenation of L-allo-Ile by the non-
heme iron and α-ketoglutarate (αKG)-dependent halogenase CmaB occurs while the amino acid 
is tethered to an NRPS thiolation (T) domain34.  The enzyme CmaC then uses the chlorine 
substituent as a leaving group to facilitate formation of the cyclopropyl group of coronamic acid. 
B. Reaction of (E)-(+)-nerolidol with a vanadium bromoperoxidase generated Br+-equivalent 
results in cyclization to produce several possible products36. 
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Figure I.6  Proposed mechanisms of heme-dependent haloperoxidases52-54.  Reaction of 
heme-dependent haloperoxidase MPO showing either direct halogenation by an enzymatic 
intermediate or by free hypohalous acid.  
 
 
His
Fe(III)
N
N N
N
His
Fe(IV)
N
N N
N
H2O2
O
H2O
His
Fe(III)
N
N N
NOX-
X
Substrate:
His
Fe(III)
N
N N
N
Substrate-X
H+
XOH
Substrate:
Substrate-X
H+
H2O
2H+
His
Fe(III)
N
N N
N
H2O
Compound I
 
 31
Figure I.7  Proposed mechanisms of vanadium-dependent haloperoxidases36.  Formation of 
the vanadium-peroxo intermediate followed by either direct halogenation with an enzymatic 
intermediate or by free hypohalous acid. 
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Figure I.8  Proposed mechanisms of flavin-dependent halogenases55.  Reaction of FADH2 
with O2 to give a peroxo intermediate and formation of hypohalous acid.  Chlorination of a 
protein Lys residue produces a lysine chloramine that then reacts with an electron rich substrate.   
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Figure I.9  Proposed mechanism of SAM-dependent halogenases22, 50.  Halide ion attack on 
C5 of SAM in SN2-type nucleophilic mechanism. 
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Figure I.10  Proposed mechanism of non-heme iron-dependent halogenases45, 56.  Formation 
of iron(IV)-oxo intermediate followed by hydrogen atom abstraction and radical recombination 
with the halogen. 
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Figure I.11 Some halogenated natural products with interesting functional groups.   
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Chapter II: Structural Characterization of the Flavin-dependent 
Halogenase RebH 
 
 
II.A Summary 
 The FADH2 and O2-dependent halogenase RebH from Lechevalieria 
aerocolonigenes catalyzes the chlorination of tryptophan during biosynthesis of the anti-
cancer compound rebeccamycin.  Biochemical studies have shown that the chlorination 
reaction proceeds in two steps, formation of a stable chlorine-protein intermediate, 
followed by transfer of the chlorine to the substrate.  Here we describe the 2.1 Å 
resolution crystal structure of the halogenase RebH, which was solved by molecular 
replacement using the structure of the homologous enzyme PrnA, from Pseudomonas 
fluorescens.    The RebH structure implicates a lysine residue (Lys79) in the active site as 
the likely location for storage of the chlorine as a lysine chloramine intermediate.  The 
combination of this structural data and biochemical results led to the proposal of a novel 
halogenation mechanism and provided detailed insight into the chemistry of formation of 
the medically important compound rebeccamycin.   
 
 
Note: Reproduced in part with permission from Yeh, E., Blasiak, L. C., Koglin, A., 
Drennan, C. L., and Walsh, C. T. (2007) Chlorination by a long-lived 
intermediate in the mechanism of flavin-dependent halogenases Biochemistry 46, 
1284-921. Copyright 2007 American Chemical Society.  The paper has been 
edited to emphasize the structural work as the focus of the chapter. 
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II.B. Introduction 
Halogenated natural products are medically valuable and include antibiotics (e.g. 
vancomycin), chemotherapeutics (e.g. rebeccamycin), and hormones (e.g. thyroxine)2.  
The addition of a halogen substituent to an organic scaffold can modulate the biological 
activity, chemical reactivity, and specificity of the compound3.  Flavin-dependent 
halogenases are a recently discovered class of enzymes that have been implicated in the 
biosynthesis of numerous halogenated natural products, including the antibiotics 
vancomycin and chloramphenicol as well as the anti-tumor agent rebeccamycin.  These 
enzymes require reduced flavin adenine dinucleotide (FADH2) which is provided by a 
partner flavin reductase, a halide ion (usually Cl−), and O24, 5.  Flavin-dependent 
halogenases catalyze the formation of carbon-halogen bonds on electron-rich substrates 
by activating the halogen as an electrophilic species (X+, where X represents the 
halogen)3.  
Insight into the chemical mechanism of flavin-dependent halogenases has 
emerged both from the structure of the halogenase PrnA in the pyrrolnitrin biosynthetic 
pathway and from kinetic characterization of RebH involved in rebeccamycin 
biosynthesis6, 7.  PrnA and RebH share 55% sequence identity and, within their respective 
pathways, catalyze the identical overall reaction to chlorinate tryptophan at its C7 
position.  The reaction of FADH2 and O2 in the active site generates a FAD(C4a)-OOH 
intermediate, which has been detected during the RebH reaction7.  Both structural and 
kinetic evidence support the subsequent formation of hypochlorous acid (HOCl) in the 
active site when FAD(C4a)-OOH is captured by Cl−6, 7.  It has been presumed that HOCl 
 36
would then act as the proximal chlorinating agent, providing an electrophilic Cl+ 
equivalent to directly chlorinate the indole ring of tryptophan6. 
A potent oxidant, HOCl reacts indiscriminately with many biological molecules, 
including the exposed side chains of several different amino acids.  To fulfill its proposed 
function as the chlorinating agent in the active site of flavin halogenases, it is assumed 
that it would need to be protected from other reactive functionalities in these enzymes 
and that it be quickly and specifically consumed in the substrate chlorination reaction.  
However, two observations from the RebH reaction kinetics and the PrnA structure seem 
to challenge these assumptions.  First, during stopped-flow studies to monitor formation 
of flavin intermediates in RebH, flavin reactions leading to HOCl production were 
observed with or without L-Trp present, suggesting that this potent oxidant is formed in 
the active site without available substrate for reaction7.  Second, in the PrnA structure, an 
active-site Lys79 residue is located adjacent to the bound tryptophan6.  Studies of protein 
oxidation by HOCl show that the εNH2 of lysine reacts rapidly with HOCl to form a 
long-lived chloramine Lys-εNH-Cl (t½> 25 h)8, 9.  Chloramines can also carry out 
chlorination reactions, albeit with reduced reactivity compared to HOCl10-12, and may 
play a role in the flavin halogenase mechanism.  These observations led us to ask whether 
a stable product of an enzyme reaction with HOCl, rather than HOCl itself, might be 
responsible for the observed regioselective chlorination reaction.  If so, a stable 
intermediate should persist in the active site when the flavin reactions are carried out in 
the absence of substrate, and this intermediate should then be competent for reaction once 
substrate is added. Biochemical studies to test this hypothesis were performed by our 
collaborator Ellen Yeh in Christopher T. Walsh’s lab at Harvard Medical School.  The 
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results of her excellent experiments, which were published with our structure, will be 
briefly summarized in the following section.  
Biochemical characterization of a stable chlorinating intermediate 
Addition of FADH2, Cl−, and O2 to RebH, in the absence of L-Trp, was shown to result in 
the formation of a stable chlorinating intermediate.  When L-Trp was added to this 
intermediate in a second reaction, the intermediate was then capable of performing the 
chlorination reaction. The chlorinating intermediate was further characterized through the 
use of radioactive 36Cl.   The reaction to generate the intermediate was carried out with 
36Cl-, and the products were then separated by size-exclusion chromatography.  The 
radioactive 36Cl migrated with the RebH protein, indicating that the intermediate species 
had incorporated some form of bound chlorine.  Incorporation of 0.6 equivalents of 36Cl 
per RebH enzyme was observed.  Subsequent addition of L-Trp resulted in formation of  
7-[36Cl]chlorotryptophan product, and corresponding loss of the 36Cl label from the 
protein.  The mutants Lys79Ala and Lys79Met were inactive, and no incorporation of the 
36Cl label on these proteins was observed.   
The stability of the chlorinating intermediate was measured by assessing the 
ability of the intermediate to catalyze the chlorination reaction over time.  Thus, the loss 
of chlorinating activity was equated with decay of the intermediate species.  The half-life 
for decay of the intermediate was determined to be 63 h at 4 °C and 28 h at 25 °C, which 
is comparable to the half-life of free lysine chloramine in solution.  The addition of I- to 
the intermediate resulted in much faster decay (complete loss of activity in 20 min), 
indicating that I- is able to access the intermediate and cause its degradation.   
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The description of the intermediate as “stable” or “long-lived” applies to the stability of 
the intermediate in the active site before addition of L-Trp, rather than to its rate of 
reaction with L-Trp to give chlorinated product.  The chlorinating intermediate was 
shown to catalyze the chlorination reaction with kinetically competent rates (0.29 s-1 for 
chlorination by the intermediate, compared to 0.05 s-1 for the overall reaction).  This 
result suggests that the intermediate is on-pathway, and part of the normal enzymatic 
mechanism.   Further, the rate determining step was shown to likely be the formation of 
the chlorinating species itself. 
The biochemical and kinetic characterization of RebH demonstrated that a key 
reaction intermediate is a stable chlorinating species on the protein.  Based on the 
intermediate’s stability and yet apparent solvent accessibility (as inferred by the ability of 
I- to access and eliminate the intermediate), the chlorinating species was hypothesized to 
represent some form of covalently enzyme-bound chlorine, rather than a sequestered 
molecule of HOCl.  HOCl generated by the flavin reactions could covalently modify a 
protein residue, which would then act as the proximal chlorinating agent.  The structural 
characterization of RebH was therefore carried out in order to determine the likely site of 
covalent chlorine modification.  In the rest of this chapter, we will discuss the structures 
of apo, flavin-bound, and L-Trp-bound RebH, and their implications for this new 
proposed mechanism of chlorination. 
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II.C. Structural Analysis 
Overall structure of RebH  
The structure of RebH was initially solved in the apo form, and later structures with 
bound FAD or L-Trp were obtained. The overall structure of apo-RebH form is shown in 
Figure II.1.  RebH crystallizes as a dimer in the asymmetric unit, and the biological 
oligomeric state is also thought to be dimeric (Figure II.1B).  The structure of PrnA, 
which shares 55% sequence identity with RebH, was previously determined (Figure 
II.2)6, 13.  As expected, in the overall fold and binding of flavin and tryptophan, RebH 
closely resembles PrnA with an RMSD of 0.99 Å for superimposition of the alpha 
carbons of 483 residues.  The structure contains a flavin-binding domain similar to the 
flavin monooxygenase phenol hydroxylase, which is composed of a long 7-stranded β-
sheet positioned under a bundle of 6 α-helices and a second smaller sheet. The L-Trp 
binding site is located above the large β-sheet in a largely α-helical domain.  Although we 
were unable to obtain a structure of the enzyme containing the actual chlorinating 
intermediate, the apo, tryptophan-bound, and flavin-bound RebH structures were 
evaluated in light of the new evidence for formation of a stable chlorinating intermediate 
in the active site.   
Central position of an active site lysine.   
A key finding from the structure of halogenase PrnA was that flavin and tryptophan are 
separated by over 10 Å in the active site6.  It was concluded that HOCl generated in the 
flavin binding site would have to traverse this distance in order to catalyze the 
chlorination of tryptophan.  The residue Lys79 in PrnA was highlighted as having a 
potential role in orientation of HOCl within the active site.  We were also intrigued by the 
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key position of Lys79 in the RebH structure (corresponding to same residue in PrnA).  In 
both PrnA and RebH, Lys79 is located directly between the flavin and tryptophan binding 
sites (Figure II.2).  Using the program CASTp14 and a standard probe size of 1.4 Å, we 
searched for cavities in the tryptophan-bound RebH structure.  This analysis showed that 
flavin and tryptophan bind in two separate cavities and that there is no open pathway 
between the two binding sites (Figure II.3).  In fact, it would appear that HOCl generated 
in the flavin binding site would first encounter Lys79 before it could access the Trp 
binding pocket.  In studies of protein oxidation, HOCl reacts readily with the εNH2 of 
lysine (k= 7900 M-1 s-1) to form a stable chloramine, Lys-εNH-Cl8, 9.  Notably, the side-
chain of Lys79 is ordered and its position and interactions are conserved in all the 
structures solved thus far of RebH and PrnA (Figure II.2). 
L-Tryptophan binding site 
The L-Trp binds in a small pocket with its side chain ring positioned above Phe111 and 
below His109 (Figure II.4).  The free amine and carboxylic acid groups of the amino acid 
are coordinated by residues Tyr454, Tyr455, Glu461, and the backbone carbonyl of 
Phe465.  The indole nitrogen of the L-Trp makes an interaction with the backbone 
carbonyl of Glu357.  In both PrnA and RebH, Lys79 sits just 4.1 Å from C7 of 
tryptophan and forms a hydrogen bonding interaction with the hydroxyl of Ser347 
(Figure II.3 and Figure II.4).  This interaction may be critical to the overall structure of 
the enzyme, as RebH Lys79Ala and Lys79Met variants exhibit slowed flavin oxidation 
reactions as well as eliminated overall halogenation activity.  The remainder of the 
tryptophan binding site is well-conserved with the PrnA structure, including the position 
of Glu357, which is proposed to be involved in deprotonation of the Cl-Trp intermediate.  
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In both the RebH and PrnA structures, the side chain of Glu357 forms hydrogen bonds to 
two histidine residues, including one very short interaction with His406.  The position of 
Lys79 closest to the C7 position of L-Trp, the position which is selectively chlorinated, 
implies a mechanism for the observed regioselectivity of RebH.  Lys79 occupies a key 
position in the RebH (and PrnA) active site and is a likely potential site for covalent 
modification by HOCl.   
Implications of the apo-RebH structure 
An alternative to the formation of a lysine chloramine as the chlorinating intermediate is 
the sequestration of the small molecule HOCl in the active site to carry out the 
chlorination reaction.  Since the form of the enzyme that contains the chlorinating 
intermediate does not require either bound FAD or L-Trp, we compared the structure of 
apo-RebH to that of PrnA containing both FAD and tryptophan to assess the potential for 
a small-molecule binding pocket in the apo-enzyme.  Notably, when flavin and 
tryptophan binding sites are unoccupied, the active site becomes exposed to solvent.  A 
loop comprised of residues 40-49 is shifted 6 Å away from the opening of the flavin 
binding site, allowing solvent access to the entire flavin binding pocket (Figure II.2 and 
Figure II.5).  Residues 468-475 also become disordered allowing both substrate and 
solvent access to the tryptophan binding site (Figure II.2 and Figure II.6).  Thus, in the 
active site of the apo-RebH structure, we were unable to identify a binding pocket that 
could protect a small-molecule intermediate, particularly one as reactive as HOCl.  
Moreover, addition of tryptophan to the FAD-bound enzyme also causes FAD to become 
disordered, so that the flavin binding site becomes exposed when substrate is in position 
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to react.  The available structures suggest that it would be exceedingly difficult to retain a 
chlorinating agent in the active site without some form of covalent attachment. 
 
II.D. Discussion 
HOCl generated from capture of FAD(C4a)-OOH by Cl− during flavin redox reactions6, 7 
was previously proposed to function as the chlorinating agent that reacts directly with 
bound substrate during the halogenase reaction.  This mechanism now appears unlikely 
given the remarkable stability of the enzyme-bound chlorinating intermediate detected in 
RebH (t½= 63 h or 2.6 days at 4 ˚C).  It seems highly improbable that HOCl could be 
sequestered within the active site for such an extended time (up to 2 days) to prevent its 
diffusion away from the enzyme and reaction with other biological molecules.  In the 
RebH structure and previously reported PrnA structure6, no binding site for protection of 
such a reactive intermediate could be identified.  In fact, the RebH active site becomes 
relatively exposed to solvent when flavin and tryptophan are absent.  The ability of I− to 
access the chlorinating intermediate in RebH and accelerate its decomposition also 
suggests that the active site which contains this intermediate is solvent-accessible and 
unlikely to harbor a noncovalently associated, reactive small molecule. 
Rather, the RebH structure and closely-related PrnA structure6 show Lys79 
located between the binding pockets for FAD and tryptophan in the active site.  In this 
arrangement, HOCl generated from flavin redox reactions would encounter this lysine 
residue before reaching the substrate tryptophan.  We propose that HOCl reacts with the 
active-site lysine to form a stable chloramine.  Indeed, the stability of the detected active-
site chlorinating species (t½= 28 h at 25 ˚C and 63 h at 4 ˚C) is consistent with that of 
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Lys-εNH-Cl, which has t½> 25 h at 37 ˚C8, 15.  As a covalently-bound lysine chloramine, 
the chlorinating intermediate can be tethered via the N-Cl bond in the active site for 
prolonged periods.  Neither HOCl nor an enzyme chloramine is expected to be stable in 
the unfolded enzyme as both react readily with Met and Cys residues that become 
exposed upon protein denaturation.  Similarly, both are decomposed upon reaction with 
I−.   
Unfortunately, attempts to characterize this intermediate by X-ray 
crystallography, NMR spectroscopy, and mass spectrometry were unsuccessful.  
Although the apo-enzyme crystallized in 2 days at 4 °C, crystallization of the 
intermediate form of the enzyme required 2 weeks, by which time all of the intermediate 
had decayed.  Conformational dynamics which occur during the flavin reactions may also 
prevent in situ generation of the chlorinating intermediate, as it could not be detected in 
the crystal of the apo-enzyme following soaking with FADH2.  A variety of reaction 
conditions were employed to attempt to generate the intermediate in RebH crystals, and 
more details of these experiments can be found in section II.F. Materials and Methods.  
In NMR experiments, a distinct chemical shift change of the εC of lysine is associated 
with formation of free lysine chloramine, but the same change could not be observed by 
13C-HSQC or direct 13C detection of enzyme containing lysine-specific labeling.  The 
sensitivity by NMR may be limited by the large size of the enzyme, which likely exists as 
the dimer (120 kDa).  Finally, the decay of the intermediate upon protein denaturation 
precluded proteolytic digestion and detection of modified protein fragments by mass 
spectrometry.  Further discussion of other possible methods for directly observing this 
intermediate will follow in section II.E Future Directions.   
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Despite the lack of direct detection of the proposed enzyme chloramine 
intermediate, the biochemical and structural evidence presented herein provides a basis 
for proposal of the following mechanism with Lys-εNH-Cl as the proximal chlorinating 
agent.  As shown in Figure II.7, HOCl is formed as a product of flavin-based redox 
reactions and reacts with the active-site lysine to form Lys-εNH-Cl.  In the RebH 
structure, the εN of Lys79 sits 4.1 Å away from C7 of tryptophan.  Thus, a Lys79-εNH-
Cl may be ideally oriented for delivering a Cl+ equivalent for electrophilic aromatic 
substitution of the indole ring at C7.  A candidate lysine corresponding to Lys79 can be 
identified in other known flavin-dependent halogenases (Figure II.8).  Furthermore, a 
similar chlorinating species has also been detected in the halogenase PltA and PltM from 
pyoluteorin biosynthesis.  Hence, we anticipate that formation of an enzyme chloramine 
intermediate will be a common feature in the mechanism of flavin-dependent halogenases 
The available kinetic data for RebH suggests that formation of this chlorinating 
intermediate is the rate-limiting step.  Because the chemical reaction between HOCl and 
lysine to form Lys-εNH-Cl is fast12, the slow rate could be attributed to protein 
conformational changes that occur upon formation of this covalent enzyme intermediate.  
Protein dynamics were already shown to be critical for formation of flavin intermediates 
in RebH7, and structural changes in the enzyme following formation of the chlorinating 
intermediate are indicated by NMR studies.  The apparent KD for tryptophan in the 
unreacted enzyme was >100 µM as determined by equilibrium dialysis and 
ultrafiltration16 despite a steady-state Km value of 2.0 µM4.  Structural changes following 
intermediate formation could increase the affinity of the enzyme (now in the reactive 
form) for the substrate.  In this way, substrate tryptophan only binds to the enzyme once 
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the chlorinating intermediate is formed and the active site is set up for the chlorination 
reaction, possibly to prevent inappropriate reaction of substrate with HOCl that is also 
generated in the active site.    
The sequence of reactions proposed in the halogenase active site has precedent in 
protein oxidation carried out by HOCl and its chloramine products during the 
inflammatory response.   Myeloperoxidase-generated HOCl is released by neutrophils 
and macrophages as a chemical weapon against invading microbes, where oxidative 
damage to cellular proteins leads to cell death.  In addition to direct rapid oxidation by 
HOCl, chloramine products formed from the reaction of HOCl with biological amines 
have been shown to be important secondary mediators of further oxidative reactions10, 16.  
The relatively stable chloramines remain active long after the initial immune response 
and can also diffuse away from the local site to inflict oxidative damage.  As oxidizing 
agents, chloramines are milder and more selective for their target16, 17, since their 
reactivity can be influenced by local structure and environment.  Following HOCl 
treatment of high-density lipoprotein (HDL), formation of a chloramine on an adjacent 
lysine directs chlorination of a specific Tyr192 residue in HDL18-20.  Chlorination of a 
catalytic Tyr in D-amino acid oxidase also requires specific binding of D-amino acid 
chloramine but does not occur with L-amino acid derivatives21, 22.  In this biological 
setting, the stability and selectivity of chloramines distinguishes them from more potent 
and indiscriminate HOCl. 
The conversion of HOCl to a covalent chloramine in the active site of flavin-
dependent halogenases offers distinct advantages for carrying out the regiospecific 
halogenation of small molecules for natural product construction.  First, the oxidative 
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potential of reactive HOCl is stored in a long-lived chloramine intermediate that is 
primed to react upon availability of the substrate.  Though reactions with chloramines are 
slower by 105 compared with HOCl11, 12, 17, their reactivity is more easily tuned by the 
protein environment such that a Cl+ equivalent may be efficiently delivered to a substrate 
presented  in optimal orientation and van der Waals distance from the N-Cl bond.  
Second, covalent catalysis by a reactive modification on a protein side-chain provides for 
substrate and regiospecificity essential to the reaction by facilitating the orientation of 
substrate to the chloramine.  This precise arrangement may be especially important since 
C7 is not the most activated position for nucleophilic substitution on the indole ring.  
Orientation effects may also explain the regiospecificity of halogenases that chlorinate at 
C5 or C6, rather than C723, 24.  In contrast, perhydrolases and haloperoxidases that 
generate free HOCl lack the specificity required for utility in biosynthetic reactions25-27.  
Detection of the long-lived chlorinating intermediate in the flavin-dependent halogenase 
mechanism suggests Nature’s ingenious solution to the chemical problem of controlling a 
reactive and potentially destructive oxidant, HOCl, for C-Cl bond construction. 
 
II.E. Future Directions 
Although the current biochemical and structural evidence all points to the involvement of 
a Lys79 chloramine intermediate in the RebH mechanism, we would ideally prefer a 
more direct method of observation to further support this argument.  The chosen method 
must be able to distinguish between a covalent chloramine and free hypochlorous acid, as 
well as pinpoint the covalently-modified residue.  The close similarities between 
chloramine and hypochlorous acid chemistry, along with the large size of RebH and the 
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instability of the intermediate, have made this task quite challenging.  Thus far, we have 
attempted to observe the intermediate using crystallography, NMR, and mass 
spectrometry.  Here we describe the obstacles that may have prevented direct observation 
by crystallography, and propose new chemical and spectroscopic methods that could 
allow further characterization of the intermediate.   
Discussion of attempts at detection by x-ray crystallography  
 The obvious and perhaps most convincing method to detect the chlorinating 
intermediate would be direct observation by x-ray crystallography.  We have attempted to 
both directly crystallize protein in the intermediate state and to generate the intermediate 
in apo-RebH crystals.  Direct crystallization of RebH in the intermediate form was 
unsuccessful, although crystals did form after several weeks. The intermediate is stable 
for only a few days even at 4°C, so the intermediate had completely decayed before the 
crystals would grow.  Thus, it appeared that the protein would only crystallize after the 
intermediate had decayed to the apo-RebH state.  This observation could indicate that the 
chlorinating intermediate-RebH is in a different conformation, or simply that the 
intermediate-containing protein was more heterogeneous and therefore slower to 
crystallize.   
We also tried to generate the intermediate within apo-RebH crystals, as described 
in section II.F.  In no case did we observe any structural changes at Lys79 or any likely 
density for HOCl, even though our data quality and resolution should have permitted 
their detection. It seems that RebH is unable to catalyze the reaction that would generate 
the intermediate within the confines of the crystal.  One could imagine several 
explanations for this lack of reactivity.  First, the reaction could require a conformational 
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change that would be slowed or not allowed within the constraints of the crystal lattice.  
For example, crystallographic symmetry contacts between the flavin binding loops of 
adjacent protein molecules could slow FADH2 binding (Figure II.9).  Another possible 
explanation is that the timing and order of addition of substrates could prevent reaction 
within the crystal lattice.  The RebH reaction requires that FADH2 reach and bind the 
enzyme active site before being oxidized7, and diffusion of the flavin through the crystal 
lattice might be slowed.  Additionally, the enzyme will not turn over productively if 
reduced flavin is first mixed with anaerobic protein solution, meaning that the oxygen 
cannot be added in a second step to initiate the reaction after FADH2 is bound.  Given the 
variety of reaction conditions we have tried, we estimate that crystallographic detection 
of the intermediate would require finding new crystallization conditions for either a less 
conformationally restricted crystal form or for fast crystallization of the intermediate 
itself.  
Discussion of new possibilities for detection of the chlorinating intermediate 
Hofmann-Löffler-Freytag reaction 
One well known reaction of chloramines in organic chemistry is the Hofmann-Löffler-
Freytag reaction (Figure II.10)28, 29.  This reaction depends on the presence of a 
protonated chloramine, the N-chloroammonium ion, which can be readily photolyzed 
with UV light to give a nitrogen radical species.  The nitrogen radical can then abstract a 
hydrogen atom to produce the 4-chloroalkylammonium ion.  Upon treatment with base, 
the chlorine acts as a leaving group for intramolecular SN2 attack of the deprotonated 
nitrogen to form a pyrrolidine.  Although we have considered the possibility that the 
RebH reaction itself could occur through a similar radical mechanism, we have 
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concluded that the non-radical mechanism is much more likely.  Several factors disfavor 
the radical mechanism, including the stability and lack of light sensitivity of the 
chloramine intermediate and the position of Glu357 where it could stabilize the 
protonated Cl-Trp intermediate.   Although the radical chlorination mechanism seems 
unlikely, we have also considered whether this chemistry could be exploited in order to 
chemically detect the presence of a lysine chloramine by using the chloramine itself as a 
radical crosslinking agent.  If the intermediate could be protonated and photolyzed, 
perhaps the chlorine would label a nearby carbon.  The closest carbon atom to Lys79 in 
the RebH structure is the CZ of Phe111 at 3.8 Å, and the side chain oxygen of Ser358 is 
much closer at 2.9 Å.  Of course, the Hofmann reaction occurs in an organic chloramine 
solution rather than the aqueous environment of a protein.  It seems highly unlikely that a 
Lys79 nitrogen radical would specifically abstract a hydrogen from a carbon atom on the 
protein, that the resulting radical would be quenched by the single chlorine radical, and 
that all of this would occur with enough efficiency and specificity for observation.  
Further, the UV photolysis of the N-Cl bond could potentially cause unrelated oxidative 
protein damage that might be confused with a positive result.   
Chloramine-specific labeling 
Another possible chemical method for detection of a lysine chloramine would be a 
derivatization method that could label the nitrogen atom in a chloramine, but not the free 
side chain of lysine.  In this scenario, the chlorine itself would be lost, but the observation 
of a stable derivative on the lysine would demonstrate the former location of the 
chloramine.  Derivatization is a commonly used technique to detect organic 
chloramines30.  Unfortunately, substitution reactions of nitrogen, even of a nitrogen 
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bonded to chlorine, would never occur through a concerted mechanism; the nitrogen will 
always act as the nucleophile.  Therefore, any nucleophile added to the RebH 
intermediate would first react with the chlorine, and then specific labeling of the nitrogen 
would be highly unlikely.  Non-specific reactions of the nucleophile with other protein 
residues could also complicate this method.   
Spectroscopic methods 
The most promising methods for confirmation of the chloramine intermediate at Lys79 
are spectroscopic techniques, as these would allow direct observation of the intermediate 
in situ within the protein environment.  In particular, infrared (IR) spectroscopy, or the 
related technique resonance Raman spectroscopy, should allow clear detection of the N-
Cl bond.  In IR spectroscopy, the chloramine N-Cl bond is expected to absorb at around 
975 cm-1, compared to most protein resonances at 1100 cm-1 and above31, 32.  Difference 
spectra, obtained through both elimination of the chloramine through addition of I- and 
isotopic labeling of either lysines or chlorine should allow confirmation that the observed 
signal corresponds to a lysine chloramine32, 33.  Another spectroscopic option is bromine 
K-edge extended X-ray absorption fine structure (EXAFS) of the lysine bromamine 
intermediate.  In EXAFS, an element is selectively excited at its K or L-edge, and back-
scattering from nearby atoms can allow determination of the element’s local 
environment34.  Although the bromamine intermediate is less stable than the chloramine, 
it still has a half-life of 60 min at 4°C, which should permit detection by EXAFS.  
EXAFS has been used successfully to observe covalent bromine compounds of a 
vanadium bromoperoxidase35.  Finally, the use of magic angle spinning (MAS) solid state 
NMR would eliminate the problem of the large protein size that was encountered with 
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standard solution state NMR36.  Incorporation of 15N labeled lysines and development of 
a 15N-35Cl recoupling protocol could allow measurement of the 15N-35Cl distance.   
 
II.F. Materials and Methods 
Crystallization and data collection.   
Crystals of apo-RebH appeared within 48 hours using the hanging-drop vapor diffusion 
method at 4°C (Figure II.11). Apo-RebH (2 μl of 8 mg/mL in 20mM HEPES pH 7.5) was 
mixed with an equal volume of reservoir solution (1.2 M Na/K phosphate pH 7.0).  
Crystals were cryoprotected by transferring to reservoir solution augmented with 10%, 
20%, and then 30% glycerol and flash frozen in liquid nitrogen.  To obtain the Trp-bound 
RebH structure, crystals were soaked in reservoir solution containing 5 mM FAD, 5 mM 
NaCl, and saturating L-tryptophan.  They were cryoprotected in this soaking solution 
augmented with 10%, 20%, and 30% glycerol.  FAD was clearly present in this structure 
but was too disordered to model.  To attempt to generate the chlorinating intermediate in 
the crystal, crystals of apo-RebH were soaked in anaerobic reservoir solution with 10 mM 
FADH2 and 3 mM NaCl, and the FADH2 was allowed to oxidize to FAD.  This soak was 
repeated with 10%, 20%, and 30% glycerol, and then the crystals were flash frozen in 
liquid nitrogen.  The resulting structure is referred to here as FAD-RebH. 
Native datasets for apo-RebH and Trp-RebH were collected at the Stanford Synchrotron 
Radiation Light Source (SSRL) beamline 9-1, and the FAD-RebH dataset was collected 
at SSRL beamline 9-2.  All data were collected at a wavelength of 0.98 Å and at a 
temperature of 100K.  Data were processed and scaled in HKL200037.  The crystals 
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belonged to the spacegroup P62 with two RebH molecules per asymmetric unit.  Data 
collection statistics are summarized in Table II.1.   
Structure determination and refinement.   
The structure of apo-RebH was solved by molecular replacement with data to 3.0 Å 
resolution using the CCP438 program PHASER39 and the structure of PrnA(2AQJ) as a 
search model.  PrnA has 54% identity and 82% homology with RebH.  The top solution 
gave a Z-score of 57.0.  The model was built using XFIT40 and COOT41, and refined in 
CNS42.  The Trp-RebH and FAD-RebH structures were solved by rigid body refinement 
using the apo-RebH model.  The same set of test reflections (extended for higher 
resolution structures) was used to calculate Rfree for all models.  Simulated annealing 
composite omit maps calculated in CNS were used to verify structures throughout 
refinement (Figure II.11).  The final model of apo-RebH contains residues 2-528 out of 
530 with one chain break per molecule (from residue 451 to 454).  In the Trp-RebH 
structure, residues 2-528 were observed in the electron density.  The FAD-RebH structure 
contains residues 2-528 with one chain break (residues 451 to 452 in chain B).  The B-
factors for the FAD in this structure are higher than those of the surrounding protein, 
indicating that the FAD is not present at full occupancy.  This is unsurprising given that 
the natural substrate of RebH is FADH2.  The topology and parameter files for FAD were 
obtained from the HIC-Up server43.   A summary of the final refinement statistics is 
available in Table II.1.  Assessment of the models in PROCHECK44 revealed no 
unfavorable geometries, with 90.3, 90.8, and 89.7 % of residues in the “most favored” 
conformation for the apo-RebH, Trp-RebH, and Fad-RebH structures respectively.  
Figures were generated in PyMOL45. 
 53
  
Attempts to crystallize the chlorinating intermediate 
Trays containing RebH protein in the intermediate form were set up from the following 
protein solutions: Batch 051121 at 30 mg/mL in 25 mM HEPES pH 7.5 and Batch 
051128 at 30 mg/mL in 20 mM HEPES pH 7.5 + 10 mM NaCl.  Both sparse matrix 
screens and screens around the apo-RebH condition were attempted with both batches at 
30, 15 and 8 mg/mL protein solution in the cold room.  Crystals appeared near the apo-
RebH conditions, but only after several weeks when all of the intermediate had decayed.   
Attempts to generate the chlorinating intermediate in apo-RebH crystals 
Table II.2 details the conditions used for each apo-RebH soaking experiment.  For each 
dataset collected, several crystals were subjected to an identical soaking procedure and 
the best diffracting crystal was selected for data collection.  Crystals from home datasets 
6 and 8 were taken to the synchrotron and collected as datasets 7rebh (FAD-RebH, 
PDBID 2OAL) and fadrebh (L-Trp-RebH, PDBID 2E4G) respectively.   
 In no case were we able to observe any change in the position or appearance of 
Lys79 density or any indication of HOCl binding.  Other lysines in the structure were 
also checked for possible modifications.  Dataset 3 shows clear binding of some form of 
FAD as well as motion of the FAD binding loop with better electron density for chain B.  
We suspect that this structure actually contains mainly bound FADH2.  In both datasets 
with L-Trp bound, the FAD density was poor.  In the datasets where FADH2 was given 
sufficient time to convert to FAD, density for FAD was observed, but the FAD binding 
loop remains in the open position. 
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Table II.1.  Data collection and refinement statistics  
 apo-RebH Trp-RebH FAD-RebH 
Data collection    
Space group P62 P62 P62 
Cell dimensions      
    a, b, c (Å) 114.81, 114.81, 
230.63 
114.75, 114.75, 
231.23 
114.72, 114.72, 
230.88 
    α, β, γ  (°)  90.00, 90.00,  
120.00 
90.00, 90.00, 
120.00 
90.00, 90.00, 
120.00 
Resolution (Å) 2.30 (2.38-2.30)* 2.08 (2.15-2.08) 2.10 (2.18-2.10) 
Rsym 7.9 (49.5) 8.2 (49.7) 4.2 (17.6) 
I / σI 18.2 (2.4) 19.6 (2.6) 36.3 (6.6) 
Completeness 
(%) 
99.7 (99.6) 99.7 (99.5) 99.6 (97.2) 
Redundancy 4.5 (4.5) 4.5 (4.5) 3.9 (3.8) 
    
Refinement    
Resolution (Å) 2.30 2.08 2.10 
No. reflections 75897 96465 75285 
Rwork / Rfree 19.9 / 22.6 19.2 / 21.7 20.1 / 23.1 
No. atoms 8964 9268 9040 
    Protein 8386 8452 8432 
    Ligand/ion - 30 106 
    Water 578 786 502 
B-factors    
    Protein 38.9 30.8 36.7 
    Ligand - 28.7 57.5 
    Water 43.5 41.0 41.8 
R.m.s deviations    
  Bond lengths 
(Å) 
0.0064 0.011 0.011 
  Bond angles (°) 1.31 1.75 1.63 
*Highest resolution shell is shown in parenthesis.  
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Table II.2.  RebH soaking experiments 
Dataset 
Crystal and 
collection 
names 
Soaking conditions Result Resolution (Å) 
Rsym 
(%) 
Exposure 
time 
(min) 
1 Home4deg, home 10,20,30% glycerol Apo 3.05 
11.0 
(37.3) 10 
2 5906reb4, home2 
10,20% glycerol, 30% 
glycerol with .3mM FAD, 
.6mM dithionite, 2mM NaCl 
No clear  
FAD 
density 
2.75 7.3 (33.5) 10 
3 51806reb, home3 
0, 10, 20, 30% glycerol, 2x 
each, with in each 
1mM FAD, >3mM dithionite, 
5mM NaCl 
Filled syringes in anaerobic 
tent 
Density 
for some 
form of 
FAD  
3.10 12.3 (52.5) 10 
4 52606reb, home4 
0, 10, 20, 30% glycerol, 2x 
each, with in each 
.8 mM FAD, 2.4 M dithionite, 
5 mM NaCl. 
Confirmed reduced by UV-Vis 
Density 
for some 
form of 
FAD 
2.90 9.5 (38.5) 10 
5 52707reb, home5 
10, 20% glycerol, 30% 
glycerol with 1 mM FAD, 5 
mM NaCl, and saturating L-
Trp 
Trp 
density, 
poor  
FAD 
density 
3.05 9.8 (31.4) 6 
6 6906reb7, home6 
0, 10, 20, 30% glycerol, 2x 
each, with in each: 
1 mM FAD titrated to color 
change FADH2 with dithionite, 
5mM NaCl 
Density 
for some 
form of 
FAD 
2.55 7.0 8 
7 62306, home7 
1 mM FAD,  30 mM NADPH, 
5 mM NaCl, 33 uM SsuE 
followed by 10, 20, 30% 
glycerol 
Density 
for some 
form of 
FAD 
3.0 11.7 5 
8 62406, home8 
0,10,20,30% glycerol, 2x 
each, with in each: 
1mM FAD + 5mM NaCl + sat. 
Trp 
Density 
for some 
form of 
FAD 
2.85 10.3 5 
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Figure II.1 Structure of RebH.  RebH is shown in cartoon representation with β-strands 
in orange and α-helices in blue.  A.  Stereoview of the apo RebH monomer.  Lys79 is 
shown as magenta sticks.  Disordered region of the structure is shown as a black line.  B.  
Stereoview of apo-RebH dimer. 
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Figure II.2 Comparison of RebH and PrnA.  Stereoview of the superposition of apo-
RebH(cyan) with FAD- and L-Trp-bound PrnA(green) (PDBID 2AQJ).  The disordered 
region of the apo-RebH structure is shown as a black line.  Lys79 from both proteins is 
shown as sticks.  Flavin is shown as orange sticks and L-Trp as magenta sticks.  An arrow 
indicates the closed conformation of the flavin binding loop.   
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Figure II.3 Cavity analysis of L-Trp-bound RebH.  The ribbon structure of RebH with 
bound L-Trp (green sticks) shows the central position of Lys79 (pink sticks) between the 
flavin and tryptophan binding sites.  FAD (orange sticks) is superimposed from the 
flavin-bound structure.  Lys79 forms a hydrogen bond with Ser347 (blue sticks).  The 
interior contact surface of the flavin (orange) and tryptophan (green) binding pockets 
were mapped using a standard probe size of 1.4 Å.  No open pathway exists between 
these two cavities.   
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Figure II.4 RebH tryptophan binding site.  A. An unbiased Fo-Fc map for tryptophan 
bound in RebH is shown contoured to 3σ.  Interactions between the protein and L-Trp 
substrate are shown, and distances are labeled in angstroms.  Lys79 sits 4.1 Å from the 
C7 of L-Trp where chlorination occurs.  B.  Stereoview of the L-Trp binding site.  The C7 
position of the L-Trp substrate is marked with an asterisk.   
 
A. 
 
 
B. 
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Figure II.5 Comparison of apo and flavin-bound structures.  A. Stereoview of a 
surface representation of PrnA (green) with bound FAD (orange) showing closure of the 
flavin binding pocket.  B.  Stereoview of a surface representation of apo-RebH (cyan) 
superimposed on FAD (orange) from PrnA showing opening of the flavin binding pocket.  
The RebH structure is shown in the same orientation as PrnA in A.   
 
A. 
 
 
B. 
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Figure II.6 Solvent accessibility of apo-RebH structure.  A. Solvent accessible contact 
surfaces for the flavin (orange) and tryptophan (green) binding pockets are shown.  Lys79 
is shown as blue sticks.  
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Figure II.7  Proposed mechanism for halogenation by RebH.   
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Figure II.8 Lys79 is conserved in flavin-dependent halogenases.  Section from a 
sequence alignment of some known flavin-dependent halogenases highlighting the region 
of conserved Lys79 (red box).  For each sequence, the source organism and accession 
number are as follows: AdpC (Anabaena circinalis 90), CAC01605; Asm12 
(Actinosynnema pretiosum subsp. Auranticum), AAM54090; BhaA (Amycolatopsis 
balhimycina), CAA76550; calO3 (Micromonospora echinospora), AAM70353; CepH 
(Amycolatopsis orientalis), CAA11780; clohal (Streptomyces roseochromogenes subsp. 
Oscitans), AAN65237; CmlS (Streptomyces venezuelae ISP5230), AAK08979; ComH 
(Streptomyces lavendulae), AAK81830; Cts4 (Streptomyces aureofaciens NRRL3203), 
BAA07389; HalA (Actinoplanes sp. ATCC 33002), AAQ04684; HalB (Actinoplanes sp. 
ATCC 33002), AAQ04685; Neocarzilin Orf3 (Streptomyces carzinostaticus), 
BAD38872; PltA (Pseudomonas fluorescens Pf-5), AAD24884, PltM (Pseudomonas 
fluorescens Pf-5), AAD24882; PrnA (Pseudomonas fluorescens BL915), AAB97504; 
PrnC (Pseudomonas fluorescens BL915), AAB97506; PyrH (Streptomyces rugosporus 
LL-42D005), AAU95674; RebH (Lechevalieria aerocolonigenes ATCC 39243), 
CAC93722; SgcC3 (Streptomyces globisporus), AAL06656. 
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Figure II.9 Crystallographic symmetry interactions between RebH flavin binding 
loops.  Cartoon diagram of RebH (orange) and one symmetry related molecule (cyan).  
The flavin binding loops and bound FAD are shown as sticks. 
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Figure II.10 Hofmann-Löffler-Freytag reaction. 
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 Figure II.11 Photograph of crystals of apo-RebH.   
 
 
 
 
 
 
 
 
 
 71
Figure II.12 Sample density for L-Trp-bound RebH structure.  Stereoview of the 
tryptophan binding site with simulated annealing composite omit map density contoured 
to 2 σ. 
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Chapter III: Crystal structure of SyrB2, a Non-heme Iron Halogenase in 
Syringomycin Biosynthesis 
 
III.A Summary 
The non-heme iron-dependent halogenase SyrB2, from Pseudomonas syringae, catalyzes the 
conversion of L-Thr to 4-chloro-Thr.  As with the related non-heme iron dioxygenases, the non-
heme iron halogenases require mononuclear Fe(II), O2, and the co-substrate α-ketoglutarate 
(αKG).  Here we describe the first crystal structures of a non-heme iron-dependent halogenase, 
SyrB2 with bound αKG, SyrB2 with αKG, Fe(II), and Cl-, and SyrB2 with αKG, Fe(II), and Br-.  
The overall structure of SyrB2 is highly homologous to non-heme iron dioxygenases, but the 
active site contains a novel iron binding site adapted for chlorination.  While in non-heme iron 
dioxygenases the iron is coordinated by two His ligands and one carboxylate ligand, in SyrB2 the 
carboxylate ligand is replaced by a halide ion.  The unique iron coordination motif revealed by 
the SyrB2 structures has provided new insight into the mechanism of halogenation by non-heme 
iron enzymes.   
 
 
Note: This chapter was previously published as “Blasiak, L.C., Vaillancourt, F.H., Walsh, C.T., 
Drennan, C.L. (2006) Crystal structure of SyrB2, a non-haem iron halogenase in 
syringomycin biosynthesis. Nature 440:1191-1194.” 
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III.B Introduction 
Non-heme Fe(II)/α-ketoglutarate (αKG)-dependent enzymes harness the reducing power 
of αKG to catalyze oxidative reactions, usually the hydroxylation of unactivated carbons, and are 
involved in processes such as natural product biosynthesis, the mammalian hypoxic response, 
and DNA repair1, 2.  These enzymes couple the decarboxylation of αKG with the formation of a 
high energy ferryl-oxo intermediate that acts as a hydrogen abstracting species1-4.  All previously 
structurally characterized mononuclear iron enzymes contain a 2-His-1-carboxylate motif that 
coordinates the iron1, 2.  The two histidines and one carboxylate, known as the “facial triad”, 
form one triangular side of an octahedral iron-coordination geometry.  Recently, a new sub-class 
of mononuclear iron enzymes was shown to catalyze halogenation reactions, rather than the more 
typical hydroxylation reaction5, 6.  SyrB2, a member of this sub-class, is a non-heme Fe(II)/αKG-
dependent halogenase that catalyzes the chlorination of threonine in syringomycin E 
biosynthesis5.  Here we report the structure of SyrB2 with both Cl- and αKG coordinated to the 
Fe(II) ion  at 1.6 Å resolution.  This structure reveals a novel iron coordination, in which the 
carboxylate ligand of the facial triad is replaced by a chloride ion.    
The SyrB2 gene is found in the non-ribosomal peptide synthetase (NRPS) gene cluster 
for production of the phytotoxin syringomycin E in Pseudomonas syringae pv. syringae B301D 
(Figure III.1.A)7.  SyrB2 catalyzes the Fe(II), αKG, Cl-, and O2-dependent conversion of L-Thr to 
4-Cl-L-Thr (Figure III.1.B)5, a modification essential for the natural product’s antifungal 
activity8.  SyrB2 is only active on L-Thr when the amino acid is tethered to the 
phosphopantetheine prosthetic arm of the holo-SyrB1 thiolation (T) domain5.  Another class of 
halogenases, the flavin-dependent enzymes, have been structurally characterized and shown to 
catalyze halogenation at aromatic or electron-rich carbons9.  Halogenation at aliphatic carbons, 
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as in the natural products syringomycin E7, a phytotoxin, barbamide10, a molluscicidal 
compound, and victorin11, a host-selective crop toxin, requires a more reactive catalyst.  It has 
been shown that Fe(II)/α-ketoglutarate (αKG)-dependent enzymes, such as SyrB2, catalyze these 
more challenging halogenation reactions5, 6.  Other recently discovered Fe(II)/αKG-dependent 
halogenases include BarB1/B2 and CmaB, which are involved in the biosynthesis of barbamide10 
and the phytotoxin coronatine6, respectively. 
 
III.C Results 
The core of SyrB2 is composed of an 8-stranded anti-parallel β-sandwich “jelly-roll” 
motif (β 2,12,5,10; 9,6,11,3) that defines the cupin superfamily (Figure III.2.A, Figure III.3).  A 
structural alignment search for SyrB2 using the DALI server12 produced five matches with Z-
scores greater than 4, all members of the cupin superfamily.  The closest structural relative, with 
a Z-score of 8.5, is human factor-inhibiting hypoxia-inducible factor-1 (FIH-1), an Fe(II)/αKG-
dependent asparaginyl hydroxylase involved in the mammalian hypoxic response13.   
SyrB2 is the first structurally-characterized mononuclear iron protein that does not 
contain the classic 2-His-1-carboxylate iron coordination motif.  The two histidine ligands 
(H116, H235) are present, but there is no carboxylate ligand to the iron (Figure III.2.B).  Instead, 
this site is occupied by a chloride ion in our structure, as evidenced by an 8σ peak in the Fo-Fc 
map.  To verify that this iron ligand is a halide ion, we took advantage of SyrB2’s ability to 
catalyze bromination14 as well as chlorination5.  Unlike chloride, which does not have a strong 
anomalous signal, bromide has an anomalous peak at 0.9195 Å, well separated from the iron 
anomalous peak at 1.7397 Å.  Bromide-soaked crystals were prepared, and a dispersive 
difference Fourier map was calculated between the iron and bromide edges, confirming the 
 75
location of the iron and halide ion (Figure III.2.D).  One other bromide is located on the surface 
of each SyrB2 molecule, but it is unlikely to have biological significance.   
In addition to the 2 His and 1 chloride ligands, the remaining iron coordination sites are 
occupied by the αKG and a water molecule.  The water molecule binds trans to His235 at the site 
where dioxygen would likely bind during catalysis (Figure III.2.B).   αKG coordinates iron in a 
bidentate fashion, with the C-1 carboxylate opposite to His116, and the C-2 ketone opposite to 
the chloride ligand. The αKG is anchored within the active site through hydrogen bonds between 
the C-5 carboxylate and Thr113, Arg248, and Trp145 (Figure III.2.C).  Bidentate binding of 
αKG and the arginine/threonine hydrogen bonding interactions are conserved across many 
members of the Fe(II)/αKG-dependent family2, while the Trp145 interaction is unique to SyrB2.  
Phe104 stacks above the planar αKG, while Arg254 is situated 2.9 Å above the αKG and may be 
important in positioning the C1-carboxylate.  A similar arginine or asparagine is observed in 
many other family members2.    
 The chloride ligand in SyrB2 sits in a largely hydrophobic pocket composed of residues 
Ala118, Phe121 and the β-carbon of Ser231.  However, it also forms interactions with two water 
molecules, which in turn form hydrogen bonds with Thr143 and Asn123 (Figure III.2.C).  The 
Fe(II)-Cl bond is 2.44 Å, which is slightly longer than the average six-coordinate Fe(II)-Cl bond 
length of 2.30 Å found in the Cambridge Structural Database15 and other model compounds16.  
All other iron-ligand bond lengths are typical for Fe(II)/αKG-dependent enzymes.   
 The position of Ala118 in SyrB2 appears to play a role in the protein’s halogenase 
activity by creating space in the active site for the chloride ligand to bind iron.  Ala118 is 
completely conserved among known members of the new class of mononuclear iron halogenases 
(Figure III.4.A).  A structure-based sequence alignment of SyrB2 with non-halogenase 
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Fe(II)/αKG-dependent enzymes demonstrates that the active site residues are located at 
structurally equivalent positions (Figure III.4.B).  Ala118 in SyrB2 replaces the conserved 
Asp/Glu that serves as an iron ligand in other mononuclear iron enzymes.  An alignment of 
SyrB2 with its most structurally similar relative, FIH-1, illustrates the replacement of the Asp by 
Ala, creating space for chloride to bind (Figure III.5).  If a Glu is modeled in place of Ala118 in 
the SyrB2 structure, it is ideally positioned for iron coordination.  To verify that substitution of 
Ala118 with Asp or Glu would abolish chlorination activity while retaining iron binding ability, 
A118D and A188E variants were expressed, purified, and reconstituted with Fe(II) and αKG.  
Both variants bind iron, but the mutations completely abrogate chlorination activity, and no 
hydroxylation activity was observed (Table III.1 and Figure III.6).  Thus, in SyrB2, it appears 
that Nature chooses Ala at this position instead of an Asp/Glu to create an iron coordination site 
for chloride binding. 
Despite the requirement for a “facial triad” of ligands in all other Fe(II)/αKG dependent 
hydroxylases, it seems unlikely that a carboxylate ligand could bind to iron in SyrB2 in any 
conformation or stage of catalysis.  The closest candidates (Asp114 and Asp119) are >10 Å from 
the iron, pointing in the opposite direction (Figure III.5).  Asp114 forms part of the β-sandwich 
core, and Asp119 is not conserved.  The iron coordination structure with only two direct protein 
ligands also helps explain the low affinity of apo-SyrB2 for Fe(II) during reconstitution, which 
yields only ~35% incorporation, while reconstitution with αKG followed by Fe(II) gives yields 
of ~90%5.   
Thus far, SyrB2 only crystallizes in the presence of αKG, indicating that this cofactor 
provides structural stability to the protein. The structure of SyrB2 with only αKG bound has two 
channels leading to the active site (Figure III.7.A).  The loops covering the active site in this 
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structure have higher B-factors (by 10-20 Å2) than the average for the rest of the structure, 
indicating they have some degree of mobility.  Once iron and chloride bind, the protein closes 
down around the active site (Figure III.7.B).  This closure involves motions of loop 122-128 
(between β3 and β4), the β-hairpin 271-275 (β14 and β15), and loop 56-61 (between α2 and α3) 
(Figure III.2.A, Figure III.7.C).  The substrate of SyrB2, L-Thr loaded on the phosphopantetheine 
arm of the 66 kDa SyrB1, probably enters the active site through the remaining narrow tunnel 
above the αKG (Figure III.7.B). The distance from the iron to the edge of the tunnel is ~17 Å, 
similar to the length of the extended phosphopantetheine arm (~20 Å). Access through this 
tunnel is limited by the side chain of Phe196 (Figure III.7.B, Figure III.8), which may be 
involved in gating the entrance to the active site. However, we cannot rule out that SyrB2 
undergoes a conformational change upon interaction with SyrB1 that opens a different 
passageway to the active site.   
 
III.D Discussion 
When predicting how the Fe(II)/αKG-dependent enzyme scaffold might be used to 
perform halogenation, one persistent question was the location of the chloride ion.  Without a 
structure, it was presumed that SyrB2 would contain the characteristic HX(D/E)XnH motif for 
iron binding.  The sequence of SyrB2 does contain a conserved HXD motif, but it is located 
greater than >15 Å from the active site in our structure.  If we assumed three protein ligands and 
bidentate αKG, there would remain only one coordination site for dioxygen, leaving none for 
chloride binding.  If this were true, chloride binding to iron would have to take place after 
decarboxylation of αKG (and subsequent release of succinate or CO2) and formation of the 
ferryl-oxo intermediate.  However, the high-energy ferryl-oxo species is expected to be very 
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reactive, so it would be unfavourable to form this intermediate before chloride were in position 
to react.  The missing carboxylate ligand in SyrB2 elegantly solves this mechanistic dilemma.  
Our crystallographic data confirm that halide ions bind directly to the iron, which could allow the 
chloride to be in position before decarboxylation of αKG and formation of a reactive iron-oxo 
species.   
Based on the structure of the resting state of SyrB2 and by analogy with the  Fe(II)/αKG-
dependent hydroxylation mechanism of TauD3, 4, 17, 18, we propose a working mechanism for 
halogenation by SyrB2 (Figure III.9).  As observed crystallographically, αKG, Cl-, and H2O 
coordinate the iron in the resting Fe(II) state (Figure III.9, intermediate A).  L-Thr-S-SyrB1 
binding would then exclude water from the active site and allow dioxygen to bind (Figure III.9, 
intermediates B,C).   Decarboxylation of αKG would lead to the formation of a high energy 
ferryl-oxo intermediate (Figure III.9, intermediate D), which would then abstract a hydrogen 
atom from the substrate. The substrate radical abstracts the chloride (Figure III.9, intermediate 
E), producing chlorinated L-Thr-S-SyrB1 and regenerating the reduced iron center.  After 
formation of the substrate carbon radical, however, some competition between transfer of Cl• 
and OH• would be expected.  No Thr-hydroxylation side-reaction has been detected by HPLC, 
indicating that chloride transfer is greatly favored5, 14.  There are several possible explanations 
for this selectivity, including the positioning of the substrate in the active site during the reaction, 
and the lower potential of Cl• vs. OH•, as is proposed to explain similar reactivity in model 
complexes5, 19. 
The crystal structure of SyrB2 reveals a surprising iron scaffold that was not predicted 
from the protein sequence, and provides insight into the function of Fe(II)/αKG-dependent 
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halogenases.  SyrB2 could serve as an excellent model system for studying the reactivity of iron 
halides and the detailed mechanism of halogenation by mononuclear iron enzymes. 
 
III.E Materials and Methods 
Protein preparation and crystallization  
Apo-SyrB2 was purified as previously described5, and reconstituted with 3mM αKG for 
crystallization (15mg mL-1 SyrB2 in 20mM HEPES pH 7.5, 3 mM αKG).  Crystals grew within 
48 hours using the hanging-drop vapor diffusion method at 4°C.  Protein samples (2 μl) were 
mixed with an equal volume of reservoir solution (15% PEG 3350, 250 mM Na formate, 20 mM 
HEPES pH 7.5) and 0.2 μl each of 10 mM spermine tetraHCl and n-decanoyl-sucrose.  To obtain 
seleno-methionine labeled protein, SyrB2 was overexpressed in E.coli strain B834 (DE3) (Met 
auxotroph) in minimal media with seleno-methionine.   Crystals of seleno-methionine labeled 
SyrB2 grew in identical conditions with microseeding.  Crystals were cryoprotected in reservoir 
solution with 25% glycerol and flash frozen in liquid nitrogen.  To obtain crystals with bound 
Fe(II), αKG-SyrB2 crystals were transferred to a Coy anaerobic chamber (90% argon/10% 
hydrogen atmosphere) at room temperature and washed several times in an anaerobic storage 
solution of 25% PEG 3350, 250 mM Na Formate, and 20 mM HEPES pH 7.5.  Crystals were 
then soaked for 30 minutes in the storage solution with 5 mM Fe(II) (NH4)2(SO4)2·6H2O and 
either 5 mM NaCl or 5 mM NaBr.  Soaked crystals were quickly cryoprotected as described 
above and cryocooled in the anaerobic chamber.   
Data collection and analysis 
The Se-SAD dataset (αKG) and a native dataset (Fe(II), Cl-, αKG) were collected by Jay Nix at 
the Berkeley Advanced Light Source beamline 4.2.2.  These data were processed using the 
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program D*TREK20.  A high resolution native dataset on αKG-SyrB2 and a MAD dataset on Br-
Fe(II)-αKG-SyrB2 were collected at the Stanford Synchrotron Radiation Lightsource beamline 
9-2 and processed with MOSFLM21.  For the Br-Fe(II)-αKG-SyrB2 crystals an X-ray 
fluorescence scan was used to confirm the presence of bromide and iron in the protein crystals 
and to determine their respective K-edges.  Data were collected at the bromide absorption 
maxima (13484 eV, 0.91949 Å), the bromide inflection point (13480 eV, 0.91976 Å), and the 
iron inflection point (7122 eV, 1.74086 Å). The crystals belonged to the spacegroup P212121 with 
2 molecules per asymmetric unit. These two molecules form a dimer with 840 Å2 buried surface 
area, but the protein is most likely a monomer in solution based on gel filtration experiments22.  
The crystallographic dimer forms only 6 hydrogen bonds and analysis of the interface with the 
program SURFNET23 gives a Gap Volume index of >5,  also in support of a biological 
monomer24.  Data collection statistics are summarized in Table III.2 and Table III.3. 
Structure determination and refinement 
Phases were determined from a SAD experiment on seleno-methionine labeled SyrB2 with αKG.  
Sixteen selenium sites (8 per molecule) were found in SOLVE25 and refined in SHARP26, with 
an acentric figure of merit of 0.431 to 2.3 Å resolution.  To improve the quality of the electron 
density map, non-crystallographic averaging (over the 2 molecules in the asymmetric unit) and 
solvent flattening were performed in DM27.  The initial model was built manually using XFIT28, 
and then refined in CNS29 with NCS restraints applied. Several rounds of iterative model 
building and refinement without NCS restraints followed.  When the R-factor dropped below 
25.5%/28.0%, the model was refined against the high resolution αKG-SyrB2 and Fe(II) datasets 
respectively.    The same set of test reflections (extended for higher resolution structures) was 
used to calculate Rfree for all models.  Final rounds of refinement for all structures were 
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performed using the program REFMAC530.  Simulated annealing composite omit maps 
calculated in CNS were used to verify structures throughout refinement.  The final model of 
αKG-SyrB2 contains residues 2-310 in molecule A and 3-55, 61-133, and 139-310 in molecule B 
out of 310 residues.  The final models of Cl/Br-Fe(II)-αKG-SyrB2 contain residues 3-56, and 61-
310 in molecule A and 4-53, and 62-310 in molecule B. All structures contain one detergent 
molecule from the crystallization condition (n-decanoyl sucrose, DSU), bound on the surface of 
molecule A. The topology and parameter files for αKG were obtained from the REFMAC530 
dictionary, and the DSU dictionary was generated in the program SKETCHER31.  Planar 
restraints on the sugar rings were removed for refinement.   A summary of the final refinement 
statistics is available in Tables III.2 and III.3.  Assessment of the models in PROCHECK32 
revealed no unfavorable geometries, with >90% of residues in the “most favored” conformation.  
A dispersive difference Fourier map was calculated in CNS29 by subtracting the bromide 
inflection data from the iron inflection data using phases calculated from a model that contained 
only protein atoms.  The observed negative dispersive difference electron density confirmed the 
presence of one iron site per asymmetric unit, and the positive dispersive difference electron 
density indicates the presence of two bromide sites (one bound to iron in the active site and one 
on the surface) per molecule. Secondary structure assignment was performed in DSSP33, and 
figures were generated in PyMOL34.  The coordinates and structure factors for αKG-SyrB2, Cl-
Fe(II)-αKG-SyrB2 and Br-Fe(II)-αKG-SyrB2 have been deposited in the Protein Data Bank with 
accession codes 2FCT, 2FCU, and 2FCV, respectively. 
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Construction of plasmids, overexpression, protein purification and assays of the SyrB2 A118D 
and A118E variants. 
The SyrB2 A118D and the SyrB2 A118E overexpressing plasmids were generated using the 
restriction site elimination technique35 and the GeneEditor in vitro site-directed mutagenesis 
system (Promega). The following oligos: oSyrB2-A118D  
5’-CCGACTGGCACCAGGACGACACCTTCGCCAATG-3’ and oSyrB2-A118E  
5’- CCGACTGGCACCAGGAGGACACCTTCGCCAATG -3’ that introduced the mutations 
(bold) and the oligo o28bSyrB2-EcoRI  
5’-TCGAAGCGGTCTGATGGATCCGAGCTCCGTCGACAAGC-3’ that removes the EcoRI 
site (underlined) of the SyrB2 overexpression plasmid were used. The SyrB2 variants were 
overexpressed, purified and assayed as previously described5.  The cloned DNA was sequenced 
to confirm that it contained no errors. 
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Table III.1 Activity and iron content of SyrB2 variants. 
 
 wt SyrB2 A118D SyrB2 A118E SyrB2 
Activity + - - 
Iron content 83.0% 65.3% 74.4% 
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Table III.2 Data collection, phasing and refinement statistics  
 
 αKG-SeMet 
SAD 
αKG 
Native 
Cl-Fe(II)-αKG 
Native 
Data collection    
Space group P212121 P212121 P212121 
Cell dimensions 
    a, b, c (Å) 
57.28, 89.88, 
129.16 
57.26, 90.04, 
128.77 
57.15, 89.60, 
124.89 
 Peak   
Wavelength 0.9788 1.0332 1.1271 
Resolution (Å) 2.00 1.60 1.60 
Rsym1 0.09 (0.40) 0.07 (0.40) 0.06 (0.39) 
<I/σI>1 13.9 (4.7) 14.2 (3.0) 14.2 (2.8) 
Completeness (%)1 95.8 (94.3) 98.7 (96.1) 96.0 (92.2) 
Anom Completeness (%)1    
Redundancy1  5.0 (4.7) 6.2 (5.07) 
Anom Redundancy1 6.4 (5.0)   
Refinement    
Resolution (Å)  1.60 1.60 
No. reflections(work/free)  81488/5784 73846/3967 
Rwork/ Rfree  17.4/20.1 17.0/20.2 
No. atoms  5354 5411 
    Protein  4864 4831 
    Ligand/ion  54 60 
    Water  436 520 
B-factors    
    Protein  21.5 17.6 
    Ligand/ion  25.6 21.3 
    Water  29.6 27.3 
R.m.s deviations    
    Bond lengths (Å)  0.016 0.017 
    Bond angles (º) 
 
1.64 1.64 
1Highest resolution shell is shown in parenthesis.  
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Table III.3 Bromide dispersive difference experiment: Data collection, phasing and 
refinement statistics. 
 Br-Fe(II)-αKG MAD 
Data collection  
Space group P212121 
Cell dimensions 
    a, b, c (Å) 57.12, 89.35, 125.06 
 Br-Inflection 
Fe-
Inflection Peak 
Wavelength 0.9197 1.7340 0.9195 
Resolution (Å) 2.20 2.20 1.80 
Rsym1 
0.09 
(0.35) 
0.08 
(0.25) 
0.07 
(0.37) 
<I/σI>1 20.4 (4.4) 20.2 (5.8) 20.0 (3.9) 
Completeness (%)1 99.3 (99.3) 
95.2 
(91.3) 
95.3 
(84.4) 
Anom Completeness 
(%)1 
99.2 
(99.0) 
94.2 
(89.3) 
93.1 
(78.8) 
Redundancy1 8.1 (7.3) 7.4 (7.1) 7.5 (5.9) 
Anom Redundancy1 4.3 (3.8) 3.9 (3.1) 4.0 (3.2) 
Refinement    
Resolution (Å)   1.8 
No. 
reflections(work/free)   
53157/33
41 
Rwork/ Rfree   16.5/20.8 
No. atoms   5357 
    Protein   4831 
    Ligand/ion   60 
    Water   466 
B-factors    
    Protein   19.3 
    Ligand/ion   23.0 
    Water   26.9 
R.m.s deviations    
    Bond lengths (Å)    0.022 
    Bond angles (º)   1.74 
    
 
1Highest resolution shell is shown in parenthesis.  
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Figure III.1 SyrB2 activity in syringomycin E biosynthesis.  A. SyrB2 catalyzes the 
conversion of L-Thr to 4-Cl-L-Thr, which is then incorporated into syringomycin E.  B. 
Schematic showing the adenylation of L-Thr by SyrB1, loading of L-Thr-AMP onto the SyrB1 
phosphopantetheine group, and subsequent chlorination by SyrB2.  The phosphopantetheine 
prosthetic group on SyrB1, indicated by a wavy line, is post-translationally attached through a 
Ser and functions as a “swinging arm” for transfer of the covalently attached amino acid between 
enzyme active sites.  A, adenylation domain; T, thiolation domain. 
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Figure III.2 Structure of SyrB2 with bound Fe(II) (brown), chloride (green), and αKG.  A. 
Stereoview of SyrB2 structure.  Two protein iron ligands (His116 and His235), αKG, and 
Arg248 are shown as sticks.  One disordered loop (residues 56-60) is indicated by a dashed line.  
A detergent molecule (n-decanoyl sucrose, DSU) from the crystallization condition packs along 
the bottom surface of the structure.  B. Stereoview of SyrB2 active site.  A 2Fo-Fc composite 
omit map contoured to 2σ is shown in blue mesh.  C. SyrB2 active site distances.  D. Dispersive 
difference Fourier map from bromide-containing crystals, calculated by subtracting data 
collected at 0.9197 Å (Br edge) from data collected at 1.7340Å (Fe edge). The purple mesh 
(+4σ) confirms the location of the halide ion, and the brown mesh (-4σ) confirms the location of 
the iron.   
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Figure III.3 SyrB2 Topology diagrams.  A. Topology diagram of entire SyrB2 sequence. B.  
Topology diagram showing only strands in the conserved "jelly-roll" motif. 
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Figure III.4 Comparison of SyrB2 with other Fe(II)/αKG-dependent enzymes.  A. Sequence 
alignment of SyrB2 with other known Fe(II)/αKG-dependent halogenases showing only the iron 
coordination motif.  Ala118 is strictly conserved.  DysB1 and DysB2 in the biosynthesis of 
chlorinated leucine precursors36, BarB1 and BarB2 in barbamide biosynthesis10, and CmaB in 
coronatine biosynthesis6.  b, Structure-based sequence alignment from DALI12 of Fe(II)/αKG-
dependent family members against FIH-1 showing only the iron coordination motif.  Ala118 in 
SyrB2 replaces the conserved Asp ligand.  Human factor inhibiting HIF-1 (FIH-1)13, 
deacetoxycephalosporin C synthase (DAOCS)37, clavaminate synthase (CAS)38, carbapenem 
synthase (CarC)39, alkylsulfatase (Atsk)40, taurine dioxygenase (TauD)41. 
 
A.  
  SyrB2    HQA(X116)H        
  DysB1    HQA(X116)H 
  DysB2    HQA(X116)H 
  BarB1    HQA(X116)H 
  BarB2    HQA(X116)H 
  CmaB     HQA(X116)H 
 
B.        
  SyrB2        HQA(X116)H        
  FIH-1(1mzf)  HYD(X 77)H     
  DAOCS(1unb)  HYD(X 57)H     
  CAS(1ds1)    HTD(X132)H     
  CarC(1nx8)   HAD(X147)H     
  AtsK(1oih)   HTD(X153)H     
  TauD(1os7)   HTD(X153)H   
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Figure III.5 Comparison with FIH-1.  View of the active site from a structural alignment of 
SyrB2 (grey) and FIH-1 (cyan).  Alignment was performed with LSQMAN42. Ninety-nine 
residues (33% of SyrB2) align with an rmsd of 1.95 Å. Iron from SyrB2 is shown in grey and 
chloride in green, iron from FIH-1 is shown in cyan.  Labels are for SyrB2.    
 
 
 
Figure III.6 A118E and A118D SyrB2 variants have no chlorination activity.  Fluorescence 
HPLC traces of hydrolyzed and derivatized amino acid obtained after incubation of L-Thr-S-
SyrB1 with A118E, A118D, or wt SyrB2.  Assays were performed as previously described5. 
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Figure III.7 SyrB2 conformational changes. A. Cut-away view of SyrB2 with bound αKG and 
no iron.  Two channels lead to the active site.  Phe196 is not visible due to clipping planes.  B. 
Cut-away view of Cl-Fe(II)-αKG-SyrB2 in similar orientation to A, but the molecular surface is 
clipped to clearly show Phe196 (red).  SyrB2 closes down around the bound iron (brown) and 
chloride (green), leaving only one opening to the active site.  The water molecule located at the 
predicted dioxygen binding site is shown in cyan.  The white scale bar is ~15 angstroms. C. 
αKG-SyrB2 (magenta), and Cl-Fe(II)-αKG-SyrB2 (blue).  Arrows show change in conformation 
upon binding of iron and chloride. 
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Figure III.8 Stereoviews of channel to Cl-Fe(II)-αKG-SyrB2 active site.  Phe196 is shown in 
red, iron in brown, chloride in green, and water in cyan.  αKG is shown as sticks.  A. with 
Phe196 B. with side chain of Phe196 removed. 
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Figure III.9  Proposed mechanism for the reaction catalyzed by SyrB2.  The crystallized 
form of SyrB2 is labeled A.  
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 Chapter IV.  Structural Comparisons of Fe(II)/αKG-dependent Enzymes 
 
 
IV.A Summary 
The family of Fe(II)/α-ketoglutarate(αKG)-dependent enzymes catalyze an amazing 
range of oxidative chemistry using a conserved iron scaffold and core protein fold.  These 
enzymes have evolved to react with a diverse array of substrates, from large proteins to 
small molecules.  Here, we analyze the structures of eight Fe(II)/αKG-dependent 
enzymes for which both substrate-free and substrate-bound structures are available.  The 
topologies, substrate-binding interactions, and active site structures of these proteins are 
compared and discussed.  Finally, the need for further structural investigations will be 
emphasized, especially in regards to our understanding of the active site arrangement.   
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IV.B Introduction 
Fe(II)/α-ketoglutarate(αKG)-dependent enzymes perform a diverse array of oxidative 
chemistry and play a variety of biological roles1-3.  Despite their wide-ranging origins and 
physiological functions, this enzyme family relies upon a common structural scaffold and 
what is thought to be a common basic reaction mechanism.  Specifically, the Fe(II)/αKG-
dependent family is characterized by: 1) a core cupin fold and topology, 2) a 
mononuclear iron center, 3) the requirement for αKG as a co-substrate, and 4) the 
involvement of an Fe(IV)-oxo intermediate as a hydrogen atom abstracting species.  The 
iron center is typically coordinated by two histidine ligands and 1 carboxylate ligand 
from an (HXD…H) motif, although in the case of the halogenases the carboxylate ligand 
is replaced by a halide ion.  The three iron ligands are also known as the “facial triad” 
because they coordinate to one face of the octahedral coordination geometry.  The αKG 
co-substrate coordinates the iron in a bidentate manner and provides two electrons to the 
reaction through its oxidative decarboxylation to carbon dioxide and succinate.  That an 
enzyme family with so many clear commonalities in both structure and mechanism can 
perform such an amazing variety of functions testifies to the versatility of this scaffold.  
As the structural information about the Fe(II)/αKG-dependent family has grown, 
the similarities in fold and active site structure discussed above have become more 
evident.  However, subtle differences have also emerged, especially in terms of substrate 
and αKG binding.  With the current wealth of structures, we can begin to search for 
patterns that might reveal more about function and mechanism.  In particular, we are 
interested in examining structural changes that occur upon substrate binding and 
variations in the active site structure.  To that end, we have selected the eight proteins for 
 100
which both substrate-free and substrate-bound structures are currently available and 
subjected them to a detailed analysis.  A list of the selected enzymes and the relevant 
PDBIDs can be found in Table IV.1.   
Topology of the cupin fold 
In order to clearly compare the structural features of the mononuclear iron enzyme 
family, we must first describe the overall fold and define several terms.  The Fe(II)/αKG-
dependent enzymes contain a conserved cupin fold, also known as a “jellyroll” motif 
because of its spiral topology (Figure IV.1.A).  The cupin fold describes the core eight-
stranded antiparallel β-sandwich (numbered from the N-terminus), which may be 
augmented by additional strands and insertions (Figure IV.1.B).  Typically, the β-sheet 
comprised of strands 1, 3, 6, and 8 is longer than the opposing sheet of the sandwich 
(strands 2, 4, 5, 7).  The two sheets are farther apart towards the side containing strands 1 
and 2, resulting in a β-sandwich that is wider at this end.  The iron coordination motif 
(HXD…H) is located on the 2nd and 7th strands, thus placing the active site at the top of 
the more open end of the β-sandwich (Figure IV.1.C).   The typical additions to this core 
structure include an N-terminal extension near strand six (here termed region N1), a 
second N-terminal region (region N2) at the opposite side of this sheet, an insert between 
strands 4 and 5 (region 4-5), and a C-terminal extension (region C).  The locations of 
these extensions in relation to the conserved cupin fold are shown in Figure IV.1.B, and 
each region has been color coded for clarity.  Additionally, the Fe(II)/αKG-dependent 
family can be divided into two groups based on the location of the residue that 
coordinates the C5 carboxylate of the αKG, which is either an Arg from strand 8 or a Lys 
from strand 4.   
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Substrate binding motions and the protection of reactive intermediates 
One motivation for this structural analysis is the desire to better understand the methods 
by which Fe(II)/αKG-dependent enzymes shield their active sites and prevent undesirable 
chemistry.  The radical chemistry performed by these enzymes results in the formation of 
highly reactive intermediates, which if unprotected could lead to unwanted side reactions.  
One hypothesis for how these enzymes prevent uncoupled αKG turnover is that oxygen 
binding is discouraged until substrate binds.  Thus, substrate binding triggers dissociation 
of water from the sixth coordination site on iron, creating an open site for dioxygen to 
bind.  The active site in the substrate bound structure is thought to be closed and largely 
shielded from solvent, ensuring that only the desired chemistry occurs.  However, 
uncoupled and self-destructive chemistry of Fe(II)/αKG-dependent enzymes is 
commonly observed in vitro, raising the question of how well these enzymes actually 
succeed in suppressing side reactions. Here we will examine the structural changes that 
occur upon substrate binding in relation to the hypotheses about protection of the active 
site.  Further, since the selected Fe(II)/αKG-dependent enzymes react with substrates 
from small molecules to large proteins, we will examine the effect of substrate size on the 
observed structural motions required for substrate binding. 
“In-line” versus “off-line” αKG coordination 
One important unanswered question about the mechanism of Fe(II)/αKG-dependent 
enzymes is the site of dioxygen binding.  Two modes of αKG binding have been 
observed crystallographically, termed “in-line” or “off-line” because of the orientation of 
the remaining open coordination site with respect to the major substrate (Figure IV.2) 2.  
Here the major substrate refers to the molecule from which a hydrogen atom is 
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abstracted.  In the “in-line” coordination, the sixth coordination site is located in close 
proximity to the major substrate, while in the “off-line” coordination, the αKG C1 
carboxylate is closer to the major substrate and the sixth coordination site is too far from 
the substrate for hydrogen atom abstraction by an Fe(IV)-oxo.  The seemingly obvious 
mechanism would involve oxygen binding in the sixth coordination site while αKG is 
bound in the “in-line” mode, allowing formation of the Fe(IV)-oxo in close proximity to 
the major substrate.  However, another possibility is that oxygen binds while αKG is 
bound in the “off-line” mode, and then a rearrangement or “ferryl-flip” occurs following 
decarboxylation of the αKG to bring the Fe(IV)-oxo in range of the substrate.  The best 
evidence for this second possibility are structures in which the αKG coordination 
switches from “in-line” to “off-line” upon iron binding4 or upon binding of the dioxygen 
mimic nitric oxide (NO)5.  Nevertheless, in other structures, the off-line mode appears 
quite unfavorable for oxygen binding.  Because this remains an open structural and 
mechanistic question, our structural analysis will also include an assessment of the 
current evidence for the site of dioxygen coordination. 
 
IV.C Structural analysis of eight Fe(II)/αKG-dependent enzymes 
AlkB, a DNA/RNA repair enzyme 
The E. coli DNA/RNA repair enzyme AlkB repairs bases damaged by alkylation6.  The 
AlkB mechanism involves hydroxylation of the lesion which then spontaneously 
decomposes to yield the undamaged base (Scheme IV.1.A).  The selected substrate-
bound structure (PDBID 2FD8, 2.3 Å resolution) was co-crystallized with a trinucleotide 
AlkB substrate containing a methylated adenine (dT-(1-me-dA)-dT).  This substrate was 
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shown to turn over in the crystal, but at a much slower rate than in solution.  In the 
substrate-free structure (PDBID 2FDJ, 2.1 Å resolution), succinate is bound instead of 
αKG.  
AlkB binds the trinucleotide substrate sandwiched between the N2 region (called 
the AlkB “nucleotide recognition lid”) and the core strands 2 and 8 (Figure IV.3 and 
Table IV.2).  Several structural changes occur upon substrate binding to AlkB (Figure 
IV.4.A).  First, residues 50-56 move away from the substrate, and residues 71-76 move 
towards the substrate to allow Tyr76 to coordinate a phosphate group.  Residues 214-219 
at the C-terminus also become disordered in the substrate bound structure.  The side 
chain of Arg161 moves in to approach a negatively charged phosphate, and the side chain 
of Ser149 rotates away to accommodate the substrate.  The B-factors of residues in the 
regions of 50-56 and 71-76 decrease upon substrate binding, while those in the region of 
Arg 161 increase (Figure IV.4.B).  The regions of 50-56 and 71-76 (the “nucleotide 
recognition lid” from the N2 region of the topology) undergo the largest changes with 
substrate binding. 
The AlkB active site is arranged in the “off-line” conformation, with a planar 
αKG molecule.  The free oxygen of the αKG C1 carboxylate is coordinated by the side 
chain of Asn120 (Figure IV.4.C).  Arg210 sits above the iron and interacts with the free 
oxygen of Asp133 from the facial triad. The sixth iron coordination site is occupied by a 
water molecule that interacts with a network of waters above the αKG.  Dioxygen 
binding at this site would be unfavorable because of the number of waters in close 
proximity.  The methylated adenine base of the substrate packs between His131 from the 
facial triad and Trp69 (not pictured), and the orientation and distance of the substrate 
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from the iron are typical (Table IV.3).  Therefore, although the trinucleotide used in 
crystallization is a substrate for AlkB and although it appears correctly bound in the 
active site, the iron does not seem activated for dioxygen binding.  The remaining 
coordination site is far from the substrate, occupied by a water molecule, and surrounded 
by other bound waters.  What the authors of the structure have described as an “oxygen 
diffusion tunnel” to the active site is actually occupied by these bound waters.  All of 
these factors seem to point towards rearrangement of the αKG before dioxygen binding; 
however, the αKG is stabilized in its observed “off-line” conformation by the close 
interaction with Asn120.  Structures with a bound dioxygen mimic, such as NO, could 
help to distinguish between the possible dioxygen binding sites. 
Anthocyanidin synthase (ANS) 
ANS is a plant enzyme involved in flavonoid biosynthesis7.  ANS catalyzes oxidation of 
leucoanthocyanidins (and similar molecules) to the corresponding anthocyanidins 
(Scheme IV.1.B).  The proposed mechanism involves ring hydroxylation followed by 
spontaneous dehydration.  The “substrate-bound” structure (PDBID 1GP5, 2.2 Å 
resolution) contains the substrate analogue trans-dihydroquercetin (DHQ), which can also 
be a substrate for ANS.  Interestingly, two molecules of the DHQ substrate are bound in 
the crystal structure, one at the expected position above the iron and the second directly 
above the first.  The second substrate molecule is thought to be a crystallization artifact, 
due to the high concentration (10 mM) of DHQ added to the crystallization condition.  
This second binding site could however indicate a mechanism for substrate inhibition by 
preventing product release.  Inhibition of ANS activity has been observed with in vitro 
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assays using high concentrations of substrates8.  The available substrate-free ANS 
structure (PDBID 1GP4, 2.1 Å resolution) contains αKG but no metal. 
 The DHQ substrate binds against the core cupin fold and between the N2 and C-
terminal topology regions (Figure IV.3 and Table IV.2).  Almost no structural changes 
are observed upon DHQ binding to ANS (Figure IV.5.A).  The side chains of Glu306 and 
Y142 move very slightly to optimize their interactions with the substrate.   Additionally, 
no large changes in B-factor are observed between the substrate-free and substrate-bound 
structures (Figure IV.5.B).  Overall, the binding of two DHQ substrate analogues barely 
perturbs the ANS structure. 
 The αKG binds to ANS in an “offline” conformation in both the substrate-free 
and substrate-bound structures (Figure IV.5.C).  The free C1 carboxyl oxygen of αKG is 
3.3 Å from the side chain nitrogen of Asn215.  The sixth coordination site is occupied by 
a water molecule in the substrate-bound structure, indicating that this conformation is not 
primed for dioxygen binding.  This water forms hydrogen bonds with the free carbonyl of 
Asp234 from the facial triad and with a network of two other waters.  Additionally, the 
expected site of hydrogen atom abstraction is 6.3 Å from the iron, longer than the average 
observed distance of 4.5 Å.  The bound DHQ substrate analogue does not seem to have 
triggered an active site conformation that is ready for dioxygen binding.  Perhaps tighter 
substrate binding would lead to dissociation of the bound water molecule, or shift the 
αKG coordination to the “in-line” conformation.   
Alkylsulfatase (AtsK) 
AtsK from Pseudomonas putida catalyzes the hydroxylation of a variety of aliphatic 
sulfate esters including 2-ethylhexyl-1-sulfate (Scheme IV.1.C)4.  The hydroxylated 
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products then spontaneously decompose to release sulfite, which is a source of sulfur for 
the bacteria.  The reaction is therefore very similar to that catalyzed by the enzyme TauD, 
described below.  Several crystal structures of AtsK have been solved4, 9,  including the 
substrate-free structure (PDBID 1OII, 2.2 Å resolution) and the structure with bound 
substrate 2-ethylhexyl-1-sulfate (PDBID 1OIK, 2.05 Å resolution), which was obtained 
through co-crystallization4.   
 In both selected AtsK structures, large loops over the active site (residues 98-102, 
166-190) remain too disordered to model (Figure IV.6.A).  The substrate binds against 
strand 2 of the core cupin fold and makes some interactions with the 4-5 extension (Table 
IV.2 and Figure IV.3).  Because of the large disordered regions, the backside of the 
substrate is exposed to solvent and no protein packs above it to hold it in place. Before 
substrate binding residues 80-89 are also disordered, and of these, only residues 80-81, 
and 85-89 become ordered upon substrate binding.  In addition, the side chain of Arg279 
rotates towards the sulfate of the substrate and the iron, and makes an interaction with the 
αKG C1 carboxylate.  No large changes in B-factors are observed, except in regions 
which become ordered on substrate binding (Figure IV.6.B).   
 The αKG molecule binds to the iron in the in-line conformation (Figure IV.6.C).  
The sixth coordination site is closest to the substrate and is open in the substrate-bound 
structure.  However, the free C1 carboxyl group of the αKG does not form any hydrogen 
bonding interactions, indicating that it could possibly rotate and allow dioxygen to bind 
in its current location.  Arg279 is located above the iron where it interacts with the 
substrate sulfate group, and where it could interact with the αKG C1 carboxylate in either 
possible orientation.  There are no bound waters near the iron center visible in the crystal 
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structure.  While the structure suggests that dioxygen could bind to the “in-line” 
conformation, the hydrophobic residues near the free oxygen of the αKG C1 carboxylate 
in this structure indicate that we cannot rule out “off-line” binding. 
Carbapenum synthase (CarC) 
The bacterial enzyme CarC is involved in the biosynthesis of the antibiotic carbapenum, 
by catalyzing the epimerization and desaturation of (3S,5S)-carbapenam to give (5R)-
carbapenem (Scheme IV.1.D)10.  The available “substrate”-bound structure (PDBID 
1NX8, 2.3 Å resolution) contains the inhibitor L-N-acetylproline (NAP), and was 
obtained by co-crystallization.  As discussed below, this inhibitor bound structure does 
not appear to represent a productive enzyme conformation.  The substrate free structure 
(PDBID 1NX4, 2.4 Å resolution) contains αKG and Fe(II). 
 Almost no structural changes occur upon binding of the inhibitor NAP (Figure 
IV.7.A).  The NAP binds against the core cupin fold and the 4-5 extension and makes 
only one hydrogen bonding interaction to the backbone nitrogen of Gly104 (Table IV.2 
and Figure IV.3).  The residues 69-72 and 161-171 were too disordered to model in the 
NAP-bound structure, and the substrate-free structure is missing residues 68-72 and 161-
170.  Close examination reveals only very small differences in side chain orientation 
between the two structures, and none of these motions appear significant or related to 
substrate binding.  The protein B-factors increase slightly upon NAP binding (Figure 
IV.7.B).  
 The αKG binds to CarC in the “off-line” conformation in both substrate-free and 
NAP-bound structures (Figure IV.7.C).  A water molecule coordinates the iron in the 
sixth coordination site far from the bound NAP.  The free oxygen of the αKG C1 
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carboxylate forms interactions to Arg267 above the iron.  There are no potential 
hydrogen-bonding partners for this oxygen if the αKG is rotated into the “in-line” 
conformation.  The structure is similar to that observed for ANS, where the active site 
does not appear primed for dioxygen binding.  In both cases, a non-natural substrate is 
bound in the active site.    
Clavaminate synthase (CAS) 
CAS catalyzes one of the more complicated reactions of the selected Fe(II)/αKG-
dependent enzymes, the conversion of deoxyguanidinoproclavaminic acid (DGP) to 
clavaminic acid (Scheme IV.1.E)5, 11.  The reaction proceeds in three CAS-mediated 
steps: 1) hydroxylation of DGP to give proclavaminic acid, 2) ring closure to produce 
dihydroclavaminic acid, and finally 3) dehydrogenation to give clavaminic acid.  Only 
the first hydroxylation step is thought to proceed through the typical hydrogen atom 
abstraction, which is then followed by •OH rebound12.  There are two available 
“substrate-bound” structures of CAS, which were both obtained by soaking experiments.  
The first (PDBID 1DRY, 1.4 Å resolution) contains the substrate analogue L-N-α-
acetylarginine (NAR), which differs from the initial hydroxylation substrate in that it is 
missing one carbon from the four-membered ring11.  The second substrate-bound 
structure (PDBID 1GVG, 1.5 Å resolution) contains both the actual initial substrate, 
DGP, as well as the dioxygen mimic nitric oxide (NO)5.  The substrate-free structure 
(PDBID 1DS1, 1.1 Å resolution) contains Fe(II) and αKG. 
The NAR and DGP substrates bind sandwiched between the cupin core and the 4-
5 extension (Table IV.2 and Figure IV.3).  The substrate-free and NAR-bound CAS 
structures are practically identical (Figure IV.8.A).  The only exception is that in the 
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NAR-bound structure, residues 208-214 become disordered.  There are also essentially 
no structural changes between the NAR-bound and DGP/NO-bound structures.  B-factors 
of loops near the active site increase slightly in both the NAR-bound and DGP/NO-bound 
structures (Figure IV.8.B). 
The active site of the NAR-bound structure has the αKG in the “in-line” position, 
with a water molecule in the sixth coordination site (Figure IV.9).  This water is noted to 
be at low occupancy, indicating that binding of the substrate analogue NAR may be 
activating this site for dioxygen binding.  However, the DGP/NO-bound structure 
contains αKG in the “off-line” conformation, with the NO bound in the sixth 
coordination site away from the DGP substrate.  This conformational change of the αKG 
appears to result mainly from binding of NO, as the DGP and NAR substrates are bound 
in nearly identical conformations.  In both the “in-line” and “off-line” αKG modes, the 
C1 carboxylate is coordinated by the side chain of Arg297.   No interactions are observed 
with the bound nitric oxide molecule.  The NO-bound structure is the best evidence to 
date for dioxygen binding to the “off-line” active site conformation.  However, some 
critics have argued that NO is not a perfect mimic of O2, and so there is still some 
uncertainty about the site of dioxygen binding to CAS3, 13.   
Factor inhibiting hypoxia-inducible factor-1 (FIH-1) 
FIH-1 is a human enzyme involved in sensing hypoxia.  It catalyzes a hydroxylation at 
the Cβ of an asparagine residue (Asn803) on the alpha subunit of transcription factor 
hypoxia-inducible factor (HIF-1α) (Scheme IV.1.F)14.  This hydroxylation helps lead to 
degradation of HIF, thus preventing activation of the hypoxic response.  In the substrate-
bound crystal structure (PDBID 1H2L, 2.2 Å resolution), a short HIF-1α peptide 
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(residues 786-826) was used as a substrate mimic in co-crystallization experiments, and 
only residues 795-806 and 813-822 of this peptide were visible in the electron density.  
The substrate-free structure (PDBID 1MZF, 2.4 Å resolution) contains only Fe(II) and 
αKG. 
 The substrate peptide mimic binds at two interaction sites to FIH-1, one region of 
the peptide binds above the active site, and a second, α-helical region of peptide binds in 
a groove formed by two diverging β-strands (core strand 1 and the adjacent strand from 
N2) (Table IV.2 and Figure IV.3).  The peptide near the active site is in a mostly 
extended conformation, with a bend where the Asn803 (the site of hydroxylation) sticks 
into the active site.  No large secondary structure changes or loop motions were observed 
between the substrate-free15 and substrate-bound14 structures of FIH-1  (Figure IV.10.A).  
However, residues 304-306 became too disordered to model in the substrate-bound-
structure.  Several side chain motions were also observed upon substrate binding.  The 
side chain of Trp296 rotates ~90° to stack beneath Val802 of the substrate peptide.  The 
side chain of Tyr102 rotates to pack above Asn803 of the substrate, and Gln239 loses a 
hydrogen bond with Tyr102 in order to form an interaction with the same Asn803.  
Additionally, residues Asn151 and Asp152 move away from the bound substrate and the 
side chain of Lys106 becomes ordered upon substrate binding.  Although there are 
minimal structural changes between the substrate-free and substrate-bound forms, a 
noticeable drop in the B-factors, from 60.6 Å2 to 27.9 Å2, occurs upon substrate binding 
(Figure IV.10.B and Table IV.4).  This change is unsurprising given that interactions with 
the large substrate would be expected to stabilize the substrate-binding region.   
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 Both the substrate-bound and substrate-free FIH-1 structures contain αKG bound 
in the “in-line” conformation (Figure IV.10.C).  The sixth coordination site is open in the 
substrate–bound structure, which could create a site for dioxygen binding.  The free 
oxygen of the αKG C1 carboxylate interacts with both Asn205 and Asn294 in the “in-
line” structure.  Overall, the current FIH-1 structures seem to favor dioxygen binding to 
the “in-line” coordination site.  On a side note, it is worth mentioning that the backbone 
amide of Asn803 in the substrate peptide forms a hydrogen bond to the free carboxylate 
of Asp201 residue of the facial triad.  This interaction could hinder efforts to transform 
the activity of FIH-1 from hydroxylation to halogenation through mutation of the 
Asp201. 
JmjC domain-containing histone demethylation protein 3A (JMJD2A) 
The JMJD2A enzyme is a recently discovered member of a new class of Fe(II)/αKG-
dependent histone demethylases16-18.   JMJD2A catalyzes demethylation of trimethylated 
lysines 9 and 36 in histone H3 (Scheme IV.1.G).  The mechanism is thought to be similar 
to that of AlkB demethylation; hydroxylation of the methyl group that then spontaneously 
decomposes to give formate.  The selected substrate-bound structure (PDBID 2OQ6, 2.0 
Å resolution)16 was co-crystallized with an eight residue histone H3 peptide (residues 7-
14) with a trimethylated Lys9 (H3K9).  Since the structures were solved aerobically, both 
the substrate-free (PDBID 2OQ7, 2.2 Å resolution) and substrate-bound structures 
contain Ni(II) in place of Fe(II) and the inhibitor N-oxalylglycine (NOG) in place of 
αKG.   
 The H3K9 peptide binds in an extended conformation between the N2 region and 
larger side of the cupin fold on one side, and the 4-5 and C extensions on the other (Table 
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IV.2 and Figure IV.3)  Two tyrosine residues (Tyr175 and Tyr177) pack above the 
extended side chain of the substrate trimethylated Lys9.  Only small changes occur in the 
JMJD2A structure with binding of the H3K9 peptide (Figure IV.11.A).  The backbone 
near residues 309-311 moves so that residues Arg309 and Asp311 can make contacts 
with the substrate.  The side chain of Asn86 rotates away to make room for peptide 
binding.  The B-factors of residues 309-311 actually slightly increase with substrate 
peptide binding (Figure IV.11.B).  
 The NOG (inactive αKG mimic) is bound in the “in-line” conformation (Figure 
IV.11.C).  A water remains in the sixth coordination site, although this may result from 
having nickel in place of iron in the active site.  The free carbonyl of the NOG interacts 
with the side chains of Ser288 and Asn198.  The trimethylated peptide appears normally 
positioned over the metal center.   The presence of nickel and NOG in place of iron and 
αKG in the available structures complicate determination of the dioxygen binding site. 
Taurine dioxygenase (TauD) 
TauD is an E. coli enzyme that catalyzes the hydroxylation of taurine (2-
aminoethanesulfonate) at the C1 position (Scheme IV.1.H)19.  The hydroxylated taurine 
then spontaneously decomposes to aminoacetaldehyde and sulfite which serves as a 
sulfur source for the organism.  TauD is one of the best studied members of the 
Fe(II)/αKG-dependent family, with numerous spectroscopic studies20-23 and several 
crystal structures19, 24.  The selected substrate-bound and substrate-free structures19 are 
actually the “C” and “D” monomers from a single PDB (PDBID 1OS7, 2.5 Å resolution), 
in which one monomer did not bind the substrate taurine contained in the crystallization 
condition.  Thus, the observed substrate motions must be taken with some skepticism as 
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the different crystal packing against this monomer may stabilize the “open” 
conformation.  
 The taurine substrate is bound against cupin strand 2 and the N2 extension, and 
largely enclosed by interactions with the 4-5 region (Table IV.2 and Figure IV.3).  One 
major conformational change is observed in the substrate-free structure that prevents it 
from binding the substrate taurine (Figure IV.12.A).  Residues 154-182 from region 4-5, 
consisting of two 3/10 helices followed by a bend and an α-helix, hinge in an ~5 Å arc 
towards taurine in the substrate bound structure.  The beginning of this alpha helix in the 
substrate-bound structure is actually a 3/10 helix in the substrate-free chain D.  Residue 
Phe159 between the remaining 3/10 helices moves down to pack above the carbon chain 
of taurine.   Additionally, the loop region of residues 68-75 moves ~3 Å towards the 
taurine in the substrate-bound structure.  Residues His70 and Tyr73 on this loop move in 
to coordinate the taurine sulfate, and Asp94 rotates to form a hydrogen bond with Tyr73.  
The side chain of Arg270 also shifts slightly to coordinate the taurine sulfate.  While 
there are small B-factor changes between the two structures (chains C and D) (Figure 
IV.12.B), there are much larger differences in the B-factors of chains A and C which both 
have taurine bound.  Although the substrate-free and substrate-bound conformations 
appear to be an artifact of crystal packing, they do at minimum indicate portions of the 
structure that are more flexible when substrate is not bound.   
 Both the substrate-bound and substrate-free TauD structures contain αKG bound 
in the “in-line” conformation (Figure IV.12.C).  The iron is penta-coordinate in the 
substrate-bound structure, leaving room for dioxygen to bind at the sixth site.  There are 
no waters bound near the iron center in the substrate bound structure.  However, the free 
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C1 carboxyl group of the αKG does not form any hydrogen bonds in the “in-line” mode.  
Overall, the active site structure of TauD is very similar to that of AtsK.  While the 
dissociation of water from the “in-line” conformation would appear to favor dioxygen 
binding at this site, there is no clear structural reason that the αKG C1 carboxylate could 
not change conformation to the “off-line” position upon dioxygen binding.   
 
IV.D Conclusions 
The topology of substrate binding 
 The substrates of the selected Fe(II)/αKG-dependent enzymes bind against strands 
2 and 8 of the cupin core (Table IV.2 and Figure IV.3).  The remaining substrate 
interactions are typically contributed by interactions with the N2 region, strand 1 of the 
cupin core, the 4-5 core extension, and occasionally the C-terminal region.  The N2 and 
4-5 core extensions in particular can be thought of as substrate “adapter” regions, which 
have evolved to bind a wide range of substrates and orient them against the conserved 
cupin core.  In almost all cases, the substrate is enclosed on at least three sides by the 
protein, although fewer interactions are observed for the inhibitor NAP binding to CarC 
and the substrate bound to AtsK.  In both of these examples there are also large regions of 
disordered protein near the active site (Figure IV.6.A and Figure IV.7.A).   
Overall changes on substrate binding 
 In order to gain a better overall picture of the degree of structural changes caused 
by substrate binding, average B-factors were calculated in MOLEMAN25 and alignments 
of substrate-free and substrate-bound structures were performed in LSQMAN26 (Table 
IV.4).  There was clearly no trend in the average structure B-factors related to substrate 
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binding.  Some regions may be stabilized by interactions with substrate, while others may 
take on new, more disordered conformations to allow substrate to bind.  Additionally, 
there can be a large degree of crystal to crystal variation in the overall order and thus 
average B-factors.  It is interesting to note that for all but one of the selected structures 
the substrate-free and substrate-bound proteins were crystallized under the same 
conditions (Table IV.4).  For the one exception, FIH-1, the protein did crystallize without 
substrate under the “substrate-bound” conditions, but that available structure was at much 
lower resolution.  Additionally, all substrate structures except for the CAS structures 
were obtained through co-crystallization with substrate rather than soaking of apo 
crystals with substrate.  Co-crystallization should help limit structural artifacts resulting 
from limited protein motions within the crystal. 
The largest difference between substrate-free and substrate-bound structures was 
observed with the enzyme TauD (r.m.s.d. of 0.90 Å for 259 superimposed Cα atoms).  As 
discussed earlier, these two structural forms were obtained from the same crystal, and the 
substrate-free structure represents an open conformation that is stabilized by the crystal 
lattice.  The differences between these structures may indicate regions that are more 
flexible in solution before substrate binds.  The smallest observed change upon substrate 
binding occurred with the enzyme CarC (r.m.s.d. of 0.12 Å for 247 superimposed Cα 
atoms), but in this case the co-crystallized “substrate” was actually an inhibitor, and the 
structure did not appear “activated” for dioxygen binding. However, there was no 
obvious trend with substrate analogues; crystallization with a substrate analogue rather 
than the natural substrate did not necessarily result in fewer structural differences.  There 
was also no clear observed trend with the size of the substrate.  Only small changes were 
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observed for AtsK (small substrate) and JMJD2A (large protein substrate), while larger 
differences were observed for TauD (small substrate) and FIH-1 (large protein substrate).  
Overall, the structural changes that occurred on substrate binding were quite modest.  The 
fortuitous “open” TauD structure however, reveals that more structural flexibility may 
exist in solution, while crystallization could tend to “purify” the low energy substrate 
binding conformation.  Other solution state techniques might better help clarify the 
flexibility of the substrate binding regions.  The lack of more structures with both a 
substrate-bound and substrate-free form could also be a testament to the difficulties of 
observing large conformational changes crystallographically. 
Active site structure and predicted dioxygen binding site 
In order to compare the relative orientations of substrates with respect to the active site, 
an alignment of the catalytic triad residues (His, His, Asp/Glu) for each enzyme was 
performed in PyMOL27.  As shown in Figure IV.13, the proposed sites of hydrogen atom 
abstraction cluster above the metal site.  The metal to substrate carbon distances range 
from 4.2 to 6.3 Å, with most clustered around 4.5 Å (Table IV.3).  There are two outliers, 
the substrates of ANS (6.3 Å from the iron) and JMJD2A (located farther from the first 
in-plane His).  As described above, the ANS substrate structure contains two molecules 
of substrate, and the active site does not appear to be activated for dioxygen binding.  
Tighter binding of the substrate closer to the metal might be required to trigger an active 
conformation.  The JMJD2A substrate does not appear to be too far from the iron to react 
with an Fe(IV)-oxo, but its different orientation above the metal relative to the other 
substrates is interesting.  An anaerobic substrate-bound structure with Fe(II) and αKG 
instead of Ni(II) and NOG could verify that this orientation is relevant.   
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 Of these selected structures, 5 have αKG bound in the “in-line” conformation and 
4, including the NO-bound CAS structure, have αKG bound in the “off-line” 
conformation (Table IV.3).  Of those in the “in-line” mode, three have an empty sixth 
coordination site (AtsK, FIH, and TauD) and two contain a water molecule at this site 
(CAS and JMJD2A).  All of the “off-line” structures contain a six-coordinate metal, with 
either a water molecule or NO molecule bound.  The presence of the natural substrate or 
close substrate mimic does seem to be required for activation of the iron as a five-
coordinate species (AtsK, TauD, FIH-1), however, the natural substrate is not always 
sufficient to trigger this change, at least within the crystallographic conditions (AlkB, 
JMJD2A).  Some of the αKG molecules are bound in a planar conformation, while others 
have a 90° twist at C3.  There is clearly no trend relating whether the αKG is coordinated 
“in-line” or “off-line” with being in a twisted or planar conformation.   
Thus far, the best structural mimic for the dioxygen-bound state is the structure of 
DGP/NO-bound CAS, which has NO bound to the “off-line” coordination site.  In the 
NO-bound CAS structure, the C1 carboxylate of αKG can be coordinated in either the 
“in-line” or “off-line” conformation by the side chain of Arg297 from above the metal 
center.  Four other structures (AlkB, AtsK, CarC, and TauD) contain an Arg in a similar 
location, but it does not always coordinate the αKG (TauD).  The Arg often also interacts 
with a negatively charged group on the substrate (AtsK, CAS, TauD).  Additionally, not 
all of these structures appear optimized for “off-line” dioxygen binding, particularly the 
active site of AlkB with the many bound waters near this site.  The FIH-1 structure looks 
especially different from CAS, in that it lacks an Arg residue above the metal, and 
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contains αKG bound “in-line” with several interactions to Asn residues.  Thus, FIH-1 
appears activated for dioxygen binding to the “in-line” conformation.   
Clearly, these comparisons with relatively few data points raise more questions 
than they answer.  Of course, it is entirely possible that different Fe(II)/αKG-dependent 
enzymes have evolved to favor dioxygen binding at different sites, and may not all follow 
a completely conserved mechanism.  More NO-bound structures could certainly 
strengthen the case for dioxygen binding to one or the other site.  However, there has 
been some speculation as to whether NO and O2 would actually prefer the same 
coordination site3, 5.  While NO is a good dioxygen mimic because of its neutral charge 
and similar size and hydrophobicity, the electronic structures of NO and O2 are different 
(dioxygen is a diradical, while NO has only one unpaired electron), and the bound 
oxygen ligand would be expected to be more polar28, 29.  For example, different binding 
modes for NO and O2 to iron in an extradiol dioxygenase have been observed 
crystallographically, with NO binding end-on to the iron center and O2 binding in a side-
on orientation13.  As crystallographic methods improve, perhaps we will one day be able 
to trap and observe the substrate dioxygen itself binding to an Fe(II)/αKG-dependent 
enzyme.  Already, many iron-oxygen intermediates in other enzyme families have been 
observed crystallographically, often leading to new mechanistic understanding30-32.   
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Table IV.1 Selected Fe(II)/αKG-dependent structures 
Enzyme Full name Organism Substrate 
Substrate 
Free 
PDBID1,2 
Substrate 
Bound 
PDBID1 
NO 
bound 
PDBID 
AlkB AlkB DNA/RNA repair enzyme Escherichia coli T-meA-T
3 2FDJ (2.1)4 
2FD8 
(2.3)  
ANS Anthocyanidin synthase 
Arabidopsis 
thaliana dihydroquercetin
3 
1GP4 
(2.1)5 
 
1GP5 
(2.2) 
 
 
AtsK Alkylsulfatase Psuedomonas putida 
2-ethylhexyl-1-
sulfate 
1OII 
(2.2) 
1OIK 
(2.05)  
CarC Carbapenum synthase 
Erwinia 
carotovora 
L-N-
acetylproline3 
1NX4 
(2.4) 
1NX8 
(2.3)  
CAS Clavaminate synthase 
Streptomyces 
clavuligerus 
N-α-acetyl-L-
arginine3, 
deoxyguanidino-
proclavaminate 
1DS1 
(1.1) 
1DRY 
(1.4) 
1GVG 
(1.5) 
FIH-1 
Factor inhibiting 
hypoxia inducible 
factor-1 
Homo sapiens HIF-1α peptide3 1MZF (2.4) 
1H2L 
(2.2)  
JMJD2A 
JmjC domain-
containing histone 
demethylation 
protein 3A 
Homo sapiens histone H3 peptide3 
2OQ7 
(2.2)6 
2OQ6 
(2.0)6  
TauD Taurine dioxygenase Escherichia coli taurine 
1OS7_D 
(2.5) 
1OS7_C 
(2.5)  
 
 
1Structure resolution in Å is given in parentheses 
2Unless otherwise noted, “substrate free” structure contains bound iron and αKG 
3Indicates that the given substrate is an analogue of the natural substrate used in crystallization  
4Structure contains succinate instead of αKG 
5Structure contains no metal 
6Structure contains nickel in place of iron and N-oxalylglycine instead of αKG 
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Table IV.3 The topology of Fe(II)/αKG substrate interactions.   
Enzyme  PDBID 
Residues involved in substrate 
binding (within 4 Å of the substrate)1 
AlkB 2FD8 
N2: T51, Y55, T56, M57, M61, W69, 
Y76; 2: L118, L128, S129, L130, 
H131, Q131, D133, D135; 8: R210; 
4-5 : R161 
ANS 1GP5 
N2: Y142, F144; 2: K213, D234, 
V235, S236; 8: F304, E306; C: 
F334  
AtsK 1OIK 2: H81, A104, H108, D110, V111; 8: R279; 4-5 : F215 
CarC 1NX8 2: V92, H101, D103, G104; 8: R267, Q269; 4-5 : Y191, W202 
CAS 1GVG 
N2: L114; 2: L132, S133, S134, 
H144, E146; 8: R297, Y299; 4-5 : 
D202, D233, E235, L236 
FIH-1 1H2L 
 
N2: Y102, T149, L150, N151, D152, 
V159, F162, L163, W167, Q181; 1: 
L182, T183, S184; 2: H199, D201, 
E202, Q203; 6-7: M275, Y276; 8: 
W296; 4-5 : R238, Q239; C: K298, 
G299, A300, T302, A317, I318, 
R320, N321, K324 
JMJD2
A 2OQ6 
 
N2: I71, Q84, Y85, N86, I87, Q88, 
A134, D135, N137, I168, E169, 
G170, V171; 1: Y175, Y177; 2: 
E190, D191; 8: S288, T289, N290; 
4-5 : H240, K241, M242; C: R309, 
D311, M312 
 
TauD 1OS7 
N2: Y73, H70; 2: N95, H99, D101, 
V102, F104; 8: 270; 4-5 : F159, 
F206  
 
1The residues are underlined in the color corresponding to their location in the protein 
topology in Figures IV.1B and IV.3 
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Table IV.3 Fe(II)/αKG-dependent substrate-bound active sites 
Enzyme  PDBID αKG mode 
αKG 
confor- 
mation 
free C1 
carboxyl of 
αKG 
coordinated 
by 
Arg 
above 
metal? 
Water 
in 
“open” 
site? 
C5 
carboxylate 
of αKG 
coordinated 
by 
Distance 
from 
metal to 
to C of 
substrate 
(Å) 
AlkB 2FD8 off-line planar N120 R210 R210 yes 
R204 
Y122 
HOH 
4.3 
ANS 1GP5 off-line twisted N215
 
 - 
yes 
 
R298 
Y217 6.3 
AtsK 1OIK in-line twisted R279 R279 no R275 T135 4.3 
CarC 1NX8 off-line twisted R267 R267 yes 
R263 
T130 
R253 
4.2 
CAS 
 1DRY in-line twisted R297 R297 yes 
R293 
T172 4.4 
CAS 1GVG off-line planar R297 R297 NO-bound 
R293 
T172 4.4 
FIH-1 1H2L in-line planar N205 N294 - no 
K214 
Y145 
T196 
4.9 
JMJD2A 2OQ6 in-line planar 
N198 
S288 
S196 
- yes K206 Y132 4.6 
TauD 1OS7 in-line twisted none R270 no R266 T126 4.4 
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Table IV.4 Comparison of substrate-free and substrate-bound structures 
Enzyme PDBID # modeled residues 
Average 
B-Factor 
# aligned 
Cα 
atoms 
r.m.s.d.1 
(Å) 
Same 
crystallization 
conditions? 
Natural 
substrate? 
2FDJ_A 207 22.5 
AlkB 
2FD8_A 199 23.6 
199 0.62 Yes Yes, truncated 
1GP4_A 346 26.0 
ANS 
1GP5_A 346 25.5 
346 
 
0.35 
 Yes No 
1OII_A 253 34.7 
AtsK 
1OIK_A 240 48.8 
238 0.20 Yes Yes 
1NX4_B 247 23.1 
CarC 
1NX8_B 248 22.08 
247 0.12 Yes No 
1DS1_A 323 12.9 
1DRY_A 316 15.9 
316 0.23 No 
CAS 
1GVG_A 315 17.2 3152 0.192 
Yes 
Yes 
1MZF_A 335 60.6 
FIH-1 
1H2L_A 332 27.9 
330 0.61 No Yes, truncated 
2OQ7_A 346 35.2 
JMJD2A 
2OQ6_A 348 41.4 
344 0.26 Yes Yes, truncated 
1OS7_D 280 34.8 
TauD 
1OS7_C 280 38.2 
259 0.90 Yes Yes 
 
 
1Root mean square deviation 
2The r.m.s.d. between 1DRY_A and 1GVG_A 
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Scheme IV.1 Reactions of selected Fe(II)/αKG-dependent enzymes.  A.  AlkB6.  B. 
ANS7.  C. AtsK4.  D. CarC10, 12.  E. CAS5, 11, 12.  F. FIH-114.  G. JMJD2A16.  H. TauD19.   
 
A.  
N
NN
N
NH2
CH3
DNA
N
NN
N
NH2
DNA
OHaKG + O2 N
NN
N
NH2
DNA
succinate+ CO2
O
C
H H
+spontaneous
1-me-Adenine
Structure contains: dT-(1-me-dA)-dT
AlkB
  
 
B. 
O
OH
R
OHOH
HO
OH
Leucoanthocyanidins
aKG + O2
succinate+ CO2
O
OH
R
OH
HO
OH
Anthocyanidins
(cis -Leucocyanidin, R = OH) (Cyanidin, R = OH)
Structure contains: trans -dihydroquercetin
O
OH
OH
OH
HO
OH
O
ANS
  
 
C.  
S
O
OO
O S
O
OO
O
aKG + O2
succinate+ CO2
OH
2-ethylhexyl-1-sulfate
(or other branched chain sulfate ester)
Structure contains: 2-ethylhexyl-1-sulfate
AtsK
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D. 
(3S,5S)-carbapenam-3-carboxylate
Structure contains: L-N-acetyl-proline (inhibitor)
CarC
N
O
H
CO2-
N
O
CO2-
(5R)-carbapenem-3carboxylate
N
O
CO2-
(3S,5R)-carbapenam-3-carboxylate
N
CO2-O   
 
E. 
Deoxyguanidinoproclavaminic acid
aKG + O2
succinate+ CO2
Guanidinoproclavaminic acid
Structures contain: (L)-N-α-acetylarginine (below) or Deoxyguanidinoproclavaminic acid (natural substrate)
CAS
N
O
-O2C NH
NH2
NH2
N
O
-O2C NH
NH2
NH2
OH
N
O
O
CO2-
H
NH3
N
O
-O2C NH3
OH
hydrolase
N
O
-O2C NH3
OH
CAS
Proclavaminic acid
Proclavaminic acid
aKG + O2
succinate+ CO2
CAS
Dihydroclavaminic acid
aKG + O2
succinate+ CO2
CAS
N
O
O
CO2-
NH3
Clavaminic acid
H
N
O CO2-
N
H
NH2
NH2
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F. 
aKG + O2
succinate+ CO2
HIF-1α Asn803
Structure contains: HIF-1α peptide 786-826
FIH-1
N
H
NH
O
NH2
O
N
H
NH
O
NH2
O OH
  
 
G. 
di- or tri-methylated Lys 9 or 36
from human histone H3
Structure contains: histone H3 peptide 7-14 with tri-methylated Lys9
JMJD2A
N
H
H
N
O
N
aKG + O2
succinate+ CO2
H3C
H3C CH3
N
H
H
N
NH3C
H3C CH2
OH
N
H
H
N
NH3C
CH3
spontaneous +
O
H H
  
 
H. 
 
TauD
S
O
OO
NH2
aKG + O2
succinate+ CO2taurine
Structure contains: taurine
2-aminoethane-sulfonate
spontaneous O
NH2S
O
OO
NH2
OH
aminoacetaldehyde
+  HSO3-
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Figure IV.1 Topology of the cupin fold.  A.  Topology diagram showing the spiral 
“jellyroll” motif.   B.  Topology diagram emphasizing relative locations of the strands 
and core extensions.  C.  Stereoview of a representative Fe(II)/αKG-dependent enzyme 
(FIH-1, PDBID 1H2L) highlighting the cupin fold.  The eight conserved strands are 
numbered and rainbow colored from blue at the N-terminus to red at the C-terminus, with 
all extensions to the core fold colored grey.  The facial triad and αKG are shown as sticks 
and the iron is shown as a brown sphere. 
A. 
 
B. 
 
C.
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Figure IV.2 “In-line” vs. “off-line” dioxygen binding    A.  αKG bound such that open 
coordination site is “in-line” with substrate. B. αKG bound such that open coordination 
site in “off-line” or away from substrate. 
 
 
A.              B. 
 
Fe
O
O
His
O
O
O
Glu/Asp
His
Fe
O
O
His
O
O
O
Glu/Asp
His
Substrate Substrate
"in-line" "off-line"
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Figure IV.3 Topology diagrams for eight Fe(II)/αKG-dependent enzymes.   The core 
cupin fold is colored in yellow, with other regions colored as in Figure IV.1.B (region N1 
in blue, region N2 in green, region 4-5 in orange, region C in red, and other insertions in 
grey).  The locations of the iron ligands (H,D/E,D) and the main ligand to the αKG C5 
carboxylate (R/K) are labeled with the single-letter amino acid code.   
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  133
 
Figure IV.4 Substrate binding in AlkB   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structures.  The carbons of the trinucleotide DNA 
substrate are shown in orange.  Residues that move upon substrate binding are shown as 
sticks. B.  Comparison of AlkB B-factors in substrate-free and substrate-bound forms.  
The protein is colored by B-factor with blue, thin ribbon representing low B-factors and 
red, wider ribbon representing higher B-factors. C.  Stereoview of AlkB active site.  
Substrate carbons are colored orange, iron is shown as a brown sphere, and water is 
shown as red spheres. 
 
A. 
 
B. 
 
 
C. 
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Figure IV.5 Substrate binding in ANS   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structure.  The carbons of the two DHQ molecules are 
shown in orange.  Residues that move upon substrate binding are shown as sticks. B.  
Comparison of ANS B-factors in substrate-free and substrate-bound forms.  The protein 
is colored by B-factor with blue, thin ribbon representing low B-factors and red, wider 
ribbon representing higher B-factors.  C.  Stereoview of ANS active site showing closest 
bound DHQ molecule.  Substrate carbons are colored orange, iron is shown as a brown 
sphere, and water is shown as red spheres. 
 
A. 
 
B. 
 
 
C. 
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Figure IV.6 Substrate binding in AtsK   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structure.  The substrate carbons are shown in orange.  
Arg279 is shown as sticks.  Disordered regions of the structure are indicated by black 
lines.  B.  Comparison of AtsK B-factors in substrate-free and substrate-bound forms.  
The protein is colored by B-factor with blue, thin ribbon representing low B-factors and 
red, wider ribbon representing higher B-factors.  C.  Stereoview of AtsK active site with 
substrate bound.  Substrate carbons are colored orange, iron is shown as a brown sphere, 
and water is shown as a red sphere. 
 
A. 
 
 
B. 
 
 
C. 
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Figure IV.7 Substrate binding in CarC   A.  Stereoview comparing substrate-free 
(green) and inhibitor (NAP) bound (cyan) structure.  The NAP carbons are shown in 
orange.  Disordered regions of the structure are indicated by black lines.  B.  Comparison 
of CarC B-factors in substrate-free and substrate-bound forms.  The protein is colored by 
B-factor with blue, thin ribbon representing low B-factors and red, wider ribbon 
representing higher B-factors.  C.  Stereoview of CarC active site with NAP bound.  NAP 
carbons are colored orange, iron is shown as a brown sphere, and water is shown as a red 
sphere. 
 
A. 
 
B. 
 
 
C. 
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Figure IV.8 Substrate binding in CAS   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structures.  The substrate carbons are shown in 
orange.  B.  Comparison of CAS B-factors in substrate-free, substrate-bound form, and 
NO-bound forms.  The protein is colored by B-factor with blue, thin ribbon representing 
low B-factors and red, wider ribbon representing higher B-factors. 
 
A. 
 
B.
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Figure IV.9 Active site of CAS A. Stereoview of CAS active site with substrate NAR 
bound. Substrate carbons are colored orange, iron is shown as a brown sphere, and water 
is shown as red spheres.  A.  Stereoview of CAS active site as in B. but with DGP and 
NO bound.   
 
A. 
 
B. 
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Figure IV.10 Substrate binding in FIH-1   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structure.  The substrate peptide is shown in orange 
cartoon and sticks.  FIH-1 residues that move upon substrate binding are shown as sticks.  
B.  Comparison of FIH-1 B-factors in substrate-free and substrate-bound forms.  The 
protein is colored by B-factor with blue, thin ribbon representing low B-factors and red, 
wider ribbon representing higher B-factors.  C.  Stereoview of FIH-1 active site with 
substrate bound.  Substrate peptide is colored orange, iron is shown as a brown sphere, 
and water is shown as a red sphere. 
 
A. 
 
 
B. 
 
 
C. 
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Figure IV.11 Substrate binding in JMJD2A A. Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structure.  H3K9 peptide is shown as sticks with 
carbons in orange.  JMJD2A residues that move upon substrate binding are shown as 
sticks.  B.  Comparison of JMJD2A B-factors in substrate-free and substrate-bound 
forms.  The protein is colored by B-factor with blue, thin ribbon representing low B-
factors and red, wider ribbon representing higher B-factors. C.  JMJD2A active site with 
H3K9 peptide bound.  H3K9 carbons are colored orange, nickel is shown as a brown 
sphere, and waters as red spheres. 
 
A. 
 
B. 
 
 
C. 
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Figure IV.12 Substrate binding in TauD   A.  Stereoview comparing substrate-free 
(green) and substrate bound (cyan) structure.  Taurine is shown as sticks with carbons in 
orange.  TauD residues that move upon substrate binding are shown as sticks.  B.  
Comparison of TauD B-factors in substrate-free and substrate-bound forms.  The protein 
is colored by B-factor with blue, thin ribbon representing low B-factors and red, wider 
ribbon representing higher B-factors.  C.  TauD active site with substrate bound.  Taurine 
carbons are colored orange, and iron is shown as a brown sphere. 
 
A. 
 
B. 
 
C. 
 
 
 
 
 142
Figure IV.13 Active site alignment.  Stereoview of a superposition of the catalytic triad 
residues from all eight proteins with those of TauD.  The carbon atom that is the 
predicted site of hydrogen atom abstraction is shown as a small sphere.  Carbon and 
metal atoms from each structure are colored as follows: AlkB – magenta, ANS – yellow, 
AtsK – pink, CarC – grey, NAR-CAS – blue, FIH-1 – cyan, JMJD2A – orange, TauD – 
green. 
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Chapter V: A Structural Perspective on Enzymatic Halogenation  
 
V.A Summary 
The catalogue of halogenating enzymes has expanded from the well-known haloperoxidases to 
include oxygen-dependent enzymes and the first example of a fluorinase.  Most recently, the 
discovery of a SAM-dependent halogenase that catalyzes chlorination through a nucleophilic 
mechanism has expanded the repertoire of biological halogenating chemistry.  Structural 
characterization has played an important role in our understanding of the specificity and 
mechanisms of these halogenases. In particular, the crystallographic visualization of active site 
architecture and halide binding sites has provided key insights into enzyme mechanism.  In this 
review, we compare the structures of five well-characterized classes of halogenases and examine 
how structure underlies their different halogenation mechanisms.  Further, we discuss the 
available halide-bound structures and how halide binding sites (or lack thereof) may influence 
the halide selectivity of the different halogenating enzymes. 
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V.B Introduction  
Halogenation is an essential step in the biosynthesis of numerous natural products, from 
antibiotics (chloramphenicol, vancomycin) to mammalian hormones (thyroxine).  The addition 
of a halogen atom to an organic scaffold can dramatically alter the molecule’s reactivity and 
selectivity for its target.  For example, vancomycin antibacterial activity decreases up to 70% 
when one chlorine is replaced by a hydrogen1, and rebeccamycin demonstrates different cell-line 
specific chemotoxicities depending on the presence or absence of two chlorine substituents2.  
The organic synthesis of halogenated compounds is often complicated by a lack of specificity 
and regioselectivity.  Therefore, understanding the biological routes towards halogenation could 
lead to development of new methods for the synthesis of compounds with new and desirable 
reactivities.  Already, the activity of the fluorinase from Streptomyces cattleya has been co-opted 
to produce 18F labeled molecules for use in positron emission topography (PET)3.  Improved 
understanding of the fluorinase mechanism and reactivity allowed optimization of the synthesis 
with radiochemical yields of up to 95%4.  Thus, discovery and characterization of enzymatic 
halogenation mechanisms has become active area of research with many potential future 
applications, including exploiting the enzymes themselves for combinatorial biosynthesis of new 
compound libraries5-7.   
There have been several recent advances in our understanding of biological halogenation 
reactions.  The classes of known halogenases have expanded from the long-studied 
haloperoxidases to include new oxygen-dependent halogenases and the first example of a 
fluorinase8-11.  These new developments, including detailed discussion of the halogenation 
mechanisms, have been featured in several comprehensive reviews7, 12-16.  In this review we 
instead focus on examining questions of halogenation reactivity and specificity from the primary 
perspective of enzyme structure.  For all five currently known classes of halogenases, structural 
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information has proved critical in developing our understanding of the halogenation 
mechanisms.  Here we discuss how the structures of each class of halogenase underlie the varied 
mechanisms of halogenation.  In particular, we compare the halide binding sites (or lack thereof) 
and examine issues of reactivity and selectivity.  What controls the ability of a halogenase to 
perform iodination, bromination, chlorination, or fluorination?   
 
V.C An Introduction to the Five Classes, Their Mechanisms, and Overall Structures 
Halogenating enzymes can be divided into the hydrogen peroxide (H2O2)-requiring 
haloperoxidases (heme-dependent or vanadium-dependent), the oxygen-dependent halogenases 
(flavin-dependent or non-heme iron-dependent), and the S-adenosyl-L-methionine (SAM)-
dependent enzymes.  The general mechanistic strategies and substrate requirements of each class 
are shown in Table V.1.  Additionally, there are other enzymes with known halogenating activity 
which are not discussed in detail here.  These include the perhydrolases, whose physiological 
function is not thought to be halogenation17, and the SAM-dependent methyl halide transferases 
for which no structural information is available18.   
Heme-dependent haloperoxidases 
The heme-dependent haloperoxidases require H2O2 and halide (X—, where X represents any 
halogen) to catalyze halogenation of aromatic or electron rich substrates.  They can be generally 
divided into two superfamilies, the plant, fungal, and (archae)bacterial peroxidases and the 
“animal” peroxidases19.  These two superfamilies differ in sequence, structure, and in the 
attachment of their heme group, which is covalently tethered to the protein in animal 
peroxidases, and unattached in the other enzymes apart from the proximal iron ligand.  The 
plant, fungal, and (archae)bacterial peroxidase superfamily includes the well-studied enzyme 
chloroperoxidase (CPO) from Caldariomyces fumago20-23.  In addition to halogenation, CPO 
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catalyzes a variety of other oxidative reactions such as hydroxylation of aromatic substrates, 
olefin epoxidations, sulfoxidations, and catalase-type disproportionation of H2O2.  The “animal” 
peroxidases include the mammalian enzymes myeloperoxidase (MPO), lactoperoxidase (LPO), 
eosinophil peroxidase (EPO), and thyroid peroxidase (TPO)19, 23, 24.  While MPO, LPO, and EPO 
have all been implicated in the immune response through production of antimicrobial oxidative 
species, TPO is involved in biosynthesis of the thyroid hormone thyroxine25, 26.  TPO is thought 
to catalyze both the diiodination of tyrosine residues on thyroglobulin (Scheme V.1.A) and the 
oxidative coupling of these residues to form thyroxine.   
 Many comprehensive reviews of the known haloperoxidases are available19, 21, 23, 24, 27, 28, 
and here we focus only on the well-characterized enzymes MPO and CPO. Structures of 
enzymes from both heme-haloperoxidase superfamilies have been solved, including CPO22, 29, 
MPO30, 31, and LPO32.  Heme-haloperoxidases from both superfamilies are often heavily 
glycosylated, and some, such as TPO, are membrane bound26. The human MPO structure, shown 
in Figure V.1.A, is a largely alpha-helical tetramer of two dimers, each composed of two 
different protein chains, a short “light” chain and a longer “heavy” chain.  There are 6 intrachain 
disulfide bonds per dimer and 1 interchain disulfide bond that connects the two heavy chains.  
Most heme haloperoxidases, including MPO, have a proximal histidine ligand to the heme iron, 
while CPO, a fungal haloperoxidase, differs in that its proximal ligand is a cysteine.   The heme 
is bound in a low-ceilinged cavity (~5-6 Å), with a small channel leading to the distal side of the 
heme in CPO and a wider channel in MPO. The MPO heme prosthetic group is covalently 
attached through two ester linkages to Asp94 and Glu242 (conserved in known animal heme-
haloperoxidases) and a sulfonium ion linkage to Met243 (unique to MPO).   The heme groups in 
plant, fungal, and (archae)bacterial heme haloperoxidases including CPO are not covalently 
attached to the enzyme except through the proximal iron ligand19.  The distal residues His95 in 
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MPO and Glu183 in CPO are thought to play important roles as proton acceptors/donors to 
H2O221.    
 The general mechanism of heme-dependent haloperoxidases involves initial reaction of 
hydrogen peroxide with heme-Fe(III) to produce a •+heme-Fe(IV)=O species, often termed 
Compound I20, 21, 23, 24.  This net two-electron oxidation of the enzyme is similar to the “peroxide 
shunt” pathway of cytochrome P450s.  The exact nature of the halogenating species continues to 
be a subject of much discussion.  Compound I is thought to reduce the halide by two electrons to 
produce either an enzyme bound heme-Fe(III)-OX intermediate33, 34 or a free hypohalous acid 
(HOX)35.  The halogenating mechanism may depend on the substrates and reaction conditions.  
For example, MPO has been shown to react directly with the small molecule taurine through an 
enzyme-bound heme-Fe(III)-OX intermediate33, but is also capable of producing freely diffusible 
HOX36.  Regardless of the exact species responsible for halogenation, the consensus is that 
haloperoxidases couple reduction of H2O2 to oxidation of a halide to produce some form of 
electrophilic X+ that can then be attacked by an electron-rich substrate (Table V.1)13, 19, 23, 37.  In 
most cases, heme-haloperoxidases can catalyze oxidation of halides that have an 
electronegativity below a certain threshold (halide electronegativity follows the trend F— > Cl— 
> Br— > I— > SCN—), and none have the oxidative power to perform fluorination19, 23.  Thus, 
LPO can only catalyze oxidation of iodine and the pseudo-halide thiocynanide, while MPO can 
oxidize Cl—,  Br—, I—, and SCN—19. 
Vanadium-dependent haloperoxidases 
Vanadium haloperoxidases have been found in fungi, marine algae, and bacteria38-42.  They are 
named for the most electronegative halide which they readily oxidize in vitro, and presently 
chloro-, bromo-, and iodoperoxidases are known.  These haloperoxidases require a vanadate 
cofactor, hydrogen peroxide, and a halide to catalyze halogenation of electron rich substrates 
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(Table V.1).  The halogen is activated by a two-electron reduction to the X+ form, as HOX or the 
enzyme-bound equivalent.  The vanadium is found as V(V), and the redox state does not change 
during turnover.  The general mechanism for vanadium haloperoxidases involves hydrogen 
peroxide binding to the vanadate cofactor to produce an activated peroxo intermediate, which is 
then vulnerable to attack by a halide ion.  As with the heme-dependent enzymes, there is still 
considerable disagreement over the exact nature of the halogenating species, in particular, 
whether the substrate reacts predominantly with the free hypohalous acid or with some form of 
enzyme bound V-OX intermediate38, 39.  Experimental evidence suggests that at least some of 
these enzymes can perform certain reactions with regioselectivity or enantioselectivity that 
would support reaction with a “trapped” X+ equivalent43-46, while in other cases no selectivity is 
observed38.  Indeed, the Ascophyllum nodosum enzyme is purified with a halogen-modified 
surface tryptophan, which could result from free diffusion of an enzyme self-generated X+ 
equivalent47, 48.  The picture is further complicated by the fact that the exact physiological roles 
of these enzymes are still unclear.  They have been postulated to play roles in production of 
natural products, polymerization of algal polyphenols, and synthesis of toxic organohalogens for 
host defense38, 39, 49, 50.  Since the exact physiological substrates and pathways are unknown, the 
activities of these enzymes are often assayed with a generic monochlorodimedone (MCD) 
substrate (Scheme V.1.B).  Thus, the exact nature of the halogenating species remains an open 
question, and it may vary between enzymes and depend on the substrate.  The recent discovery 
of three vanadium haloperoxidase genes within a bacterial natural product gene cluster presents 
an exciting opportunity to characterize these enzymes with their physiological substrates42. 
 The first crystal structure of a vanadium-dependent haloperoxidase was solved of the 
chloroperoxidase (V-CPO) from the fungus Curvularia inaequalis51, 52.  The overall fold of the 
protein, shown in Figure V.1.B, is almost entirely alpha-helical.  The vanadate binding sight sits 
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at the bottom of a ~10 Å solvent accessible channel, and a β-hairpin partially covers the entrance 
to the active site.   A structure of this chloroperoxidase with a vanadium-bound peroxo 
intermediate has also been solved52.  More recently, structures of three algal bromoperoxidases 
(V-BPOs) were completed from the organisms Ascophyllum nodosum48, Corallina officinalis53, 
and Corallina pilulifera54.  These enzymes exhibit homodimeric (A. nodosum) or dodecameric 
(both Corallina enzymes) quaternary structure.  The algal bromoperoxidases are highly 
structurally homologous with each other and also superimpose with the fungal chloroperoxidase 
structure39.  The vanadium haloperoxidases generally exhibit unusually high protein stability, 
which may result from their tightly formed quaternary structure38.   
FADH2 and O2-dependent halogenases 
Many flavin-dependent halogenases have now been characterized, and they can be divided into 
two main groups:  those that catalyze chlorination on free small molecule substrates (RebH, 
PrnA)55-59, and those that react with substrates tethered to a thiolation domain in a non-ribosomal 
polypeptide synthetase (NRPS) system (PltA, SgcC3)60, 61.  To date, the structures of only two 
flavin dependent halogenases have been solved, PrnA from Pseudomonas fluorescens59 and 
RebH from Lechevalieria aerocolonigenes58, and both catalyze the chlorination of the free amino 
acid L-tryptophan on C7 (Scheme V.1.C).   
The chlorination reaction catalyzed by these halogenases requires reduced flavin 
(FADH2), which is provided by a partner protein reductase (NADH-dependent RebF in the case 
of RebH).  There does not seem to be a direct or specific interaction between the halogenase and 
reductase; the reduced FADH2 is thought to be released from the partner reductase and diffuse to 
its binding site on the halogenase55, 61.  There is clear spectroscopic evidence for reaction of the 
FADH2 with dioxygen to form a FAD-C4a-OOH intermediate57, which could then react with a 
chloride ion to produce hypochlorous acid HOCl.  In the currently favored mechanistic proposal, 
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this HOCl then covalently modifies a protein residue (Lys79 in RebH and PrnA) that in turn acts 
as the direct chlorinating agent.  This hypothesis is supported by the observed regioselectivity of 
the reaction and the identification of a long-lived, kinetically-competent chlorinating 
intermediate, as well as by structural analysis58.  In general, the flavin-dependent class of 
halogenases employs an oxidative strategy of chlorination (with formation of a Cl+ equivalent) 
similar to the haloperoxidases and requires an electron-rich substrate, although the route through 
a covalent protein intermediate adds the benefit of regioselectivity (Table V.1).   
The two structurally characterized flavin-dependent halogenases, PrnA and RebH, share 
55% sequence identity and catalyze the same overall reaction.  Unsurprisingly, their overall 
structures are very similar (RMSD of 0.99 Å for 483 aligned Cα atoms).  Both proteins 
crystallize as dimers (Figure V.1.C).  Each monomer consists of an N-terminal flavin binding 
region with homology to the flavin-dependent monooxygenases, and a C-terminal substrate 
binding region.  Both the flavin and L-Trp substrate bind above a long, 7-stranded antiparallel β-
sheet.  The first evidence that there was no direct interaction between the tryptophan and flavin 
intermediates during halogenation was the observation that more than 10 Å separate the flavin 
and tryptophan in the crystal structures58, 59.  The Lys79 (in both RebH and PrnA) is located 
between the flavin and tryptophan binding sites and ~4 Å from the site of chlorination on the 
tryptophan, which could allow a Lys79 chloramine to direct chlorination to this position.  Lys79 
is completely conserved across known and predicted flavin-dependent halogenases, and its 
mutation completely eliminates enzyme activity58, 59.  The residue Glu357 (RebH numbering, 
Glu346 in PrnA) appears ideally positioned in the structure for deprotonation of the tryptophan 
substrate following chlorination58, 59.  
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Non-heme iron and O2-dependent halogenases 
The first in vitro activity of a non-heme iron-dependent halogenase was demonstrated in 2005 by 
Vaillancourt and coworkers8.  Since then at least four other family members have been 
biochemically characterized62-65, and the structure of the halogenase SyrB2 has been solved66.  
All known members of this class act on a phosphopantetheine-tethered substrate during natural 
product biosynthesis by NRPS machinery.  The structure of SyrB2 revealed an anti-parallel β-
sandwich or cupin fold common to mononuclear iron/α-ketoglutarate(αKG)-dependent enzymes 
(Figure V.1.D).  The iron center sits at the top of the open end of the β-sandwich and is covered 
by several loops and a β-hairpin.  The iron coordination in SyrB2 is unusual, with only two 
histidine ligands coordinating the iron.  Most iron/αKG-dependent enzymes have a third 
carboxylate ligand to the iron, but in the halogenases this is replaced by a chloride ion.  The 
remaining three coordination sites are occupied by the bidentate α-ketoglutarate and a water 
molecule.   
The overall reaction catalyzed by non-heme iron-dependent halogenases is shown in 
Scheme V.1.D.  The mechanism is thought to parallel that of non-heme iron dioxygenases, and 
has been discussed in detail7, 12.  Briefly, binding of dioxygen to the iron center leads to oxidative 
decarboxylation of the αKG and formation of an Fe(IV)-oxo intermediate.  An Fe(IV)-oxo 
species abstracts a hydrogen from the substrate and the resulting substrate radical is then thought 
to combine with Cl• to give the chlorinated product.  The involvement of an Fe(IV)-oxo in 
hydrogen atom abstraction has been shown through Mössbauer spectroscopy in the SyrB2 
homologue CytC367.  The use of a radical halogenation mechanism allows the non-heme iron 
enzymes to halogenate substrates at unactivated, aliphatic carbons with good regioselectivity 
(Table V.1).   
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SAM-dependent halogenases 
Thus far, only one native fluorinase has been characterized, the 5'-fluoro-5'-deoxyadenosine 
synthase (5'-FDAS) from Streptomyces cattleya, and its structure was solved in 200468.  The 
enzyme employs a nucleophilic mechanism of fluorination and requires the co-substrate S-
adenosyl-L-methionine (SAM) (Table V.1).  In a unique reversal of the typical methylation 
reaction catalyzed by SAM-dependent enzymes, 5'-FDAS exploits L-Met as an excellent leaving 
group for an SN2-type reaction69.  The fluorinase catalyzes attack of a F— ion on SAM to 
produce 5'-fluoro-5'-deoxyadenosine (5'-FDA) with inversion of configuration at the C5' position 
(Scheme V.1.E).  The affinity of 5'-FDAS for F— is too weak to measure with isothermal 
titration calorimetry (ITC), and the steady state KM for the reaction > 5 mM.  In contrast, SAM 
binds quite tightly (Ka app = 8.0x105 M-1), which may be important for promoting desolvation of 
the fluoride ion70. Despite the high stability of C-F bonds, the fluorinase can also catalyze the 
reverse reaction, the synthesis of SAM and F— from 5'-FDA and L-Met71.  5'-FDAS can perform 
chlorination in coupled enzyme assays that push the equilibrium toward products, but 
bromination and iodination have not been observed.   
Very recently, the first SAM-dependent chlorinase, SalL from the marine bacterium 
Salinispora tropica, was discovered and characterized11. SalL has 35% sequence identity with 5'-
FDAS, but catalyzes chlorination of SAM to give 5'-chloro-5'-deoxyniosine (5'-ClDA).  SalL can 
also catalyze bromination and iodination, but fluorination has not been observed.  As with 5'-
FDAS, the reaction equilibrium for chlorination favors substrates over products by several orders 
of magnitude, indicating that a downstream enzyme may be required to remove products as they 
form.  Interestingly, the only other previously known halogenation reactions that employ a 
nucleophilic mechanism also require SAM, but involve methylation of a Cl—, Br—, or I— ion to 
produce the methyl halide18.   
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 The fold of the SAM-dependent halogenases is unique, and the structure of 5'-FDAS is 
shown in Figure V.1.E11, 68.  The structures of 5'-FDAS and SalL can be superimposed with an 
RMSD of 1.37 Å for 248 Cα atoms.  The monomer is composed of two domains, an N-terminal 
Rossmann-like domain with 6 β-strands surrounded by α-helices, and a C-terminal β-sandwich 
domain made up of 4 and 5-stranded antiparallel β-sheets.  The structure is arranged as a trimer, 
with three active sites located between the N-terminal domain and the C-terminal domain of the 
adjacent monomer.  The physiological oligomer is thought to be a hexamer, created in the crystal 
lattice by stacking the two trimers one on top of the other.   
 
V.D Halide Binding Sites 
The identification of halide binding sites in halogenase crystal structures can lead to new insight 
about the enzyme mechanism and halide specificity.  One difficulty can be definitively assigning 
the identity of an electron density peak as a halide.  Both Br— and I— are heavier atoms with an 
accessible anomalous signal, which can aid in their assignment.  Cl— can often be assigned based 
on its greater electron density than oxygen, but the smaller F— ion is very difficult to distinguish 
from water at typical structure resolutions.  Even after a halide binding site has been identified, 
its relevance to the enzyme mechanism must still be established.  Halide ions are typical 
additions to crystallographic conditions, and they are commonly found in protein structures.  In 
fact, more than 2,500 structures in the Protein Data Bank (PDB) contain a bound chloride ion, 
representing greater than 5% of the currently deposited structures.  For the majority of these 
proteins the bound halide is likely an artifact of the crystallization conditions.  The relevance of a 
halide binding site can be established in several ways, including the observation of a bound 
halogenated product (as with 5′-FDAS and SalL).  In other cases, such as for the heme 
haloperoxidase MPO, the importance of the observed halide binding sites remains unclear.   
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Heme-dependent haloperoxidases 
Structures of CPO and MPO with bound halides are currently available29-31.  When CPO crystals 
were soaked with high concentrations (>50 mM) of Br— and I—, seven partially occupied halide 
binding sites were identified in anomalous difference maps29.  However, none of the halide 
binding sites are located near the active site and are therefore not likely to be relevant to the 
reaction with heme iron intermediates.  Five of the sites are located on the surface of the protein.  
The remaining two sites sit in a small channel leading towards the heme with the closest I— site 
~9 Å from the heme iron.  Although chloride-soaked CPO structures have been solved, no 
chloride binding sites were identified29.   
 As with CPO, soaking of MPO with Br— results in multiple halide ion binding sites30, 31.  
In MPO crystals soaked with 20 mM NaBr, two partially occupied surface sites and one fully 
occupied site on the proximal side of the heme were observed31.  The proximal halide binding 
site sits at the amino terminus of an alpha-helix and contains chloride in a native structure 
obtained with 2 mM Cl—.  Additionally, one Br— site (site Br1) at 44% occupancy is observed in 
the distal-heme cavity at 5 Å from the heme iron (Figure V.2.A).  The bromide is only 3.1 Å 
from the water binding site above the distal iron and it makes an interaction at 3.6 Å with the 
side chain nitrogen of Gln91.  It also interacts with His95, although the angle does not appear 
optimal for a hydrogen bond.   This halide binding site could represent a site of competitive 
inhibition with H2O2 binding, or it may be a productive halide binding site in the presence of 
Compound I.  In order to mimic the structure of Compound I, a bromide-soaked structure with 
the inhibitor CN— was obtained (Figure V.2.B)30.  In this case, the Br—binding site (site Br2) is 
located farther away from the heme-iron than in the initial structure. The Br— binding site from 
the initial, non-CN— bound structure (site Br1) instead contains a water molecule (Figure 
V.2.A).  In the new site (Br2) identified in the inhibitor bound structure the Br— remains largely 
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solvated, with no electrostatic interactions to the protein.  It is positioned near hydrophobic 
portions of Glu242 and Arg239, and ~4 Å from the edges of two phenylalanine residues 
(Phe407, Phe366).  The difference in the bromide binding site upon CN— binding may be 
explained simply by steric effects, with the larger bromide ion unable to bind as close to the 
heme once CN— is bound.  Whether either site (Br1 or Br2) represents the site of halide binding 
for productive reaction with Compound I remains unclear.  Site Br2 is >7 Å from the iron, which 
is too far away for direct reaction with Compound I.  Since MPO can react with Cl—, Br—, and 
I—, even the larger iodide ion must be able to access the Compound I intermediate.  CN— is an 
imperfect mimic of Compound I (with two atoms coordinated to the iron versus one oxygen), so 
potentially the larger halides could bind at site Br1 after Compound I is formed.  Alternatively, a 
halide binding site may not be necessary, with the halides directly approaching and reacting with 
the Compound I intermediate.   
Vanadium-dependent haloperoxidases 
Thus far, a definitive halide binding site has not been established for vanadium haloperoxidases.  
There are no crystal structures that include a bound halide ion, although soaking experiments 
have been attempted48.  Further, no KD’s have been determined for halide binding to these 
enzymes. The halide ion may not interact strongly with the enzyme until the peroxo intermediate 
has formed, which would make crystallographic characterization challenging as adding halide to 
crystals in the V-peroxo form would result in turnover. 
Flavin-dependent halogenases 
The flavin-dependent halogenase PrnA has a chloride binding site that packs against the re-face 
of the flavin cofactor (Figure V.2.C)59.  At least three other flavin-dependent enzymes, AhpF 
(PDBID 1HYU)72, vanillyl alcohol oxidase (PDBID 1VAO)73, and L-aspartate oxidase (PDBID 
1KNR)74, contain remarkably similar chloride binding sites against the same face of the flavin.  
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None of these enzymes have been observed to have chlorinating activity.  The presence of such 
similar halide binding sites in non-halogenases could be an indication that this halide binding 
site is an artifact of crystallization conditions.  Alternatively, the flavin halogenases could have 
evolved by exploitation of this favorable halide binding motif in order to do halogenation.  Like 
the 5'-FDAS halide site, the PrnA halide binding site involves backbone amide residues (347-
349) that curve around the chloride ion.  The chloride interacts with the amide nitrogens of both 
Gly349 and Thr348, and the hydrophobic ring of Pro344 completes the binding pocket.  The 
chloride ion in PrnA is not completely desolvated, it forms interactions with two water 
molecules at 3.1 and 3.3 Å.  The Cα of Pro344 is also only 3.2 Å from the halide.   
Non-heme iron and O2-dependent halogenases 
The halide binding site of the non-heme iron halogenase SyrB2 is unique because the halide 
coordinates directly to the mononuclear iron cofactor (Figure V.2.D)66.  The halide binding site 
is largely hydrophobic and is formed by the side chains of Ala118, Ser231, and Phe121.  The 
side-on interaction with the aromatic ring of Phe121 is similar to interactions we will see at the 
halide binding site of SAM-dependent halogenases.  There are no hydrogen bonding interactions 
between the chloride and the protein. As in the flavin-dependent halogenase, the chloride in 
SyrB2 makes two interactions with water molecules (3.2 and 3.9 Å), although one or both of 
these may be displaced upon substrate binding.  Arg254 hydrogen bonds the apical water on the 
iron, and the positively charged side chain is located 3.9 Å above the chloride.  A structure of the 
halogenase has also been solved with bromide bound at the active site66.  The position of the 
bromide ion almost exactly overlays the location of the chloride, and no changes are observed in 
the surrounding protein structure. 
SAM-dependent halogenases 
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The F— binding site in FDAS can be inferred from the position of fluorine in the enzyme product 
complex (Figure V.2.E)68. The fluorine sits in a largely hydrophobic pocket composed of the 
backbones of residues 156-158.  Two hydrogen bonds are formed to the hydroxyl and amide NH 
of Ser158.  The fluorine is only 3.5 Å from the edge of the ring of Phe156.  Site-directed 
mutagenesis of this residue has shown that it is crucial for activity, likely because it helps form 
the hydrophobic site for binding and desolvation of the F— ion.  The remainder of the binding 
pocket is formed by residues Thr80 and Tyr77 as well as the rest of the 5'FDA molecule.  As 
described earlier, 5'-FDAS can catalyze chlorination as well as fluorination71.  A 5'-ClDA 
product complex structure is available for 5'-FDAS. The F— and Cl— binding sites essentially 
overlay one another, with no changes in the surrounding backbone structure.  However, the 
chlorine is shifted slightly away from Ser158, lengthening the distances to the amide backbone 
and side chain hydroxyl group, perhaps due to its larger size. 
More recently, the crystal structure of the SAM-dependent chlorinase SalL was solved with 
bound 5'-ClDA product (Figure V.2.F).  The major change in the halide binding site as compared 
to 5'-FDAS is the replacement of Ser158 (131 in SalL numbering) with a Gly.  This eliminates 
one hydrogen bonding interaction to the halide and slightly increases the size of the halide 
binding pocket.  The edge of the aromatic ring of Y70 (T75 in 5'-FDAS) fills in the space left by 
the missing Ser in the active site. Additionally, a side-on interaction with F156 in 5'-FDAS is 
replaced with a similarly positioned W129 in SalL.   
Comparison of halide binding sites 
For the classes of halogenases for which halide binding sites have been identified, there are 
several interesting trends in the composition of the sites.  In no cases do the negatively charged 
halides form close interactions with positively charged amino acids, such as Arg or Lys, in the 
enzyme active site.  Coordination by a curved, three amino acid stretch of backbone, and 
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interactions with amide NHs are observed for the flavin-dependent halogenases and the 
fluorinase.  The halide typically binds in a largely hydrophobic pocket, and interactions with the 
edge of Phe rings are commonly observed.  The edges of aromatic rings bear a partial positive 
charge and therefore are thought to favor interaction with small anions75. The amide nitrogen 
interactions, and ring edge aromatic interactions have also been noted in halide binding sites of 
dehalogenase enzymes76.  For example, interactions with aromatic rings occur at the halide 
binding sites of haloalkane dehalogenases77-79, haloacid dehalogenases80, and haloalcohol 
dehalogenases81.  The haloalcohol dehalogenase halide binding site is also partly formed by 
interactions with backbone amides in a curved stretch of polypeptide, similar to the interactions 
formed in the flavin-dependent halogenase and fluorinase binding sites. We also note that only 
the SAM-dependent halogenases bind a completely desolvated halide ion, which could allow 
fluorination by activating the usually hydrated F— ion for nucleophilic attack.    
 
V.E Halogenation Specificity  
To understand how and why halogenases are selective for particular halides, several factors must 
be considered.  The relative electronegativity, nucleophilicity, and size of the halides (Table V.2) 
can influence their suitability for different halogenation strategies.  Additionally, when a clear 
halide binding site exists, steric factors may also limit the size of the accepted halogen (ionic 
radii fluoride, 1.33, chloride, 1.81, bromide, 1.96, iodide, 2.20)82.  Here we discuss what is 
known about halide selectivity in these different enzyme classes, and describe what is currently 
understood about the basis for this specificity. 
Heme-dependent haloperoxidases 
In most cases, heme-haloperoxidases can oxidize all halides with an electronegativity below a 
given threshold19, 23.  Thus, if the enzyme can catalyze chlorination, it can also catalyze 
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bromination and iodination.  None of these enzymes have the redox power to oxidize the highly 
electronegative F—.  Of the characterized heme-dependent haloperoxidases only MPO can 
efficiently catalyze chlorination at neutral pH.  The enzyme-dependent halide specificity can be 
at least partially explained in terms of a simple redox argument19, 36, 83, 84.  MPO readily catalyzes 
chlorination, EPO can oxidize Br—, I—, and SCN—, and LPO only reacts with I— and SCN—.  
The standard reduction potentials for the conversion between HOX and X— follow the trend Cl— 
> Br— > I— > SCN—.  Likewise, the reduction potentials for conversion from Compound I to 
Fe(III) decrease from MPO > EPO > LPO, which parallels the decreasing oxidative power of 
these enzymes.  The electron withdrawing effects of the covalent sulfonium ion linkage between 
Met243 of MPO and the heme likely play an important role in tuning the redox potential of the 
two electron reduction of Compound I19.  This sulfonium linkage is not present in EPO or LPO, 
and may help explain their lower reduction potentials.  Of course, the reduction potentials for 
these reactions will depend on pH as well as the concentrations of other reactants and products.  
Additionally, further structures of enzymes with bound chloride or other halides could help 
distinguish the role, if any, of the halide binding sites on the differing enzyme reactivities.   
Vanadium-dependent haloperoxidases 
The vanadium haloperoxidases are named for the most electronegative halogen they can readily 
oxidize, and only chloro-, bromo-, and iodoperoxidases are known38.  As with heme-dependent 
haloperoxidases, the vanadium-peroxo intermediate is not powerful enough to oxidize 
electronegative F—.  However, there remains an interesting question of selectivity between Cl—, 
Br—, and I— ions.  Why do some haloperoxidases readily catalyze chlorination, while others can 
only easily oxidize iodide?  Comparison of the crystal structures of the bromoperoxidases with 
the chloroperoxidase reveals that the vanadate binding residues are largely conserved38, 39.  There 
are a few residues near the active site that differ between the V-CPO and V-BPOs; Arg395 in V-
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BPOs is a Trp in V-CPOs, and His480 in V-BPOs is a Phe in V-CPO.  In one exciting 
experiment, the BPO from C. pilulifera was endowed with chlorination activity by mutating the 
Arg395 to either a Trp or a Phe85.  The mutant enzyme still retained its bromination activity.  
Given the observation that all the haloperoxidases are capable of oxidizing the less 
electronegative and larger halides (for example, chloroperoxidases can also brominate and 
iodinate), it seems unlikely that the halide specificity is mediated by a selective halide binding 
event.  Rather, changes in hydrogen bonding capabilities and the presence of charged residues 
around the active site may tune the redox properties of the vanadium-peroxo intermediate and 
influence its ability to react with increasingly electronegative halides.  Further characterization 
and structural analysis of mutants would shed more light on the interesting question of halide 
preference in these enzymes.   
FADH2-dependent halogenases 
Several flavin-dependent halogenases have been shown to catalyze bromination reactions as well 
as chlorination, although with lower efficiency55, 60, 61.  Thus far, no flavin-dependent 
halogenases are known to catalyze fluorination or iodination.  It is generally agreed that the 
mechanism of this class of enzymes involves the halide oxidation to an X+ equivalent (as the 
HOX and eventually as a covalent lysine adduct), similar to the haloperoxidases7, 13, 15, 58.  Thus, 
it would be highly unexpected for these enzymes to have the reduction potential to oxidize 
electronegative F—.  The lack of iodination activity could be explained by the larger size of this 
ion impeding interaction at the halide binding site.   Alternatively, the relatively high instability 
of a lysine iodamine adduct could play a role.  Similarly, the reduced efficiency of bromination 
might result from decreased affinity to a halide binding site that is better optimized for chlorine, 
or from competition between productive halogenation and non-productive hydrolysis of a lysine 
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bromamine intermediate. The observed halide binding site is quite small, with several enzyme-
Cl— distances of < 3.5 Å, which would favor Cl— binding over Br— or I—. 
 
 
Non-heme iron and O2-dependent halogenases 
Non-heme iron halogenases have been shown to catalyze both chlorination and bromination, 
although the bromination reactions are less efficient63, 86.  No fluorination or iodination activity 
has been observed.  The halide binding site can accommodate a bromide ion, as evidenced by the 
structure described above66.  However, Cl— appears to compete for Br— binding based on 
crystallographic evidence, indicating that the binding site is optimized for Cl—66.  The higher 
reduction potential for the conversion of F— to the radical could again be responsible for the lack 
of fluorination activity.   Alternatively, the binding of F— to the iron at the correct site might be 
prohibited by the high cost of desolvation.  Inhibition experiments could reveal if F— competes 
with Cl— binding at the active site.  The lack of reactivity with I— likely results from a steric 
inability of this larger ion to bind at the correct coordination site.  
SAM-dependent 
The fluorinase 5'-FDAS has been shown to catalyze chlorination as well as fluorination71.  No 
evidence for bromination or iodination has been observed.  The chlorination activity was initially 
overlooked, because the reaction equilibrium greatly favors the reverse reaction.  By coupling 
the reaction with L-amino acid oxidase to remove the product L-methionine, the equilibrium was 
pushed towards products and formation of 5'-chloro-5'deoxyadenosine (5'-ClDA) was observed.  
However, the enzyme exhibits a clear preference for fluorination in coupled-enzyme competition 
experiments.  As described above, the halide binding site seems to easily accommodate the 
larger Cl— ion.  Therefore, the specificity of the fluorinase seems to depend on the larger relative 
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nucleophilicity of the desolvated fluoride versus chloride.  Although when solvated in water the 
nucleophility of the halides is reversed from their basicity, the halide binding site of 5'-FDAS 
seems designed to fully desolvate the fluoride ion.  When unencumbered by protic solvent, the 
order of nucleophilicity is expected to follow F— > Cl— > Br— > I—.  Similarly, that the 
dechlorination reaction is favored over the chlorination is unsurprising based on the superior 
ability of Cl— to act as a leaving group.  The inability of the fluorinase to catalyze bromination 
or iodination most likely results from the incompatibility of these larger ions to bind the small 
halide binding site.    
 The exciting discovery of SalL, the SAM-dependent chlorinase, has helped illuminate the 
underlying causes of halide specificity in these enzymes11.  SalL can catalyze chlorination, 
bromination, and iodination, but not fluorination.  The main factors appear to be a slightly larger 
halide binding pocket and the loss of an interaction with the side chain hydroxyl of Ser158 (5'-
FDAS numbering, Gly131 in SalL).  A  Gly131Ser SalL mutant is inactive, but a 
Tyr70Thr/Gly131Ser double mutant actually improves SalL’s chlorination and bromination 
activity while eliminating the iodination activity.  The size of the halide binding pocket in the 
SalL double mutant is smaller than in the wild type enzyme, which may explain the lack of 
iodination.  However, the double mutant SalL is still unable to perform fluorination, probably 
because the halide binding pocket is remains larger and more open than in the fluorinase.  Thus, 
comparison of SalL and 5'-FDAS have permitted evaluation of subtle active site changes that 
create a binding site that is optimized for a particular halide.   
 
V.F Conclusions 
Nature has devised a range of halogenation mechanisms that are tailored to different cofactor and 
substrate reactivities.  The haloperoxidases are optimized for electrophilic activation of the 
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halide but seem to lack clear specificity and regioselectivity.  Redox factors appear to play a 
large role in the reactivity of haloperoxidases with the different halides.  In contrast, the flavin-
dependent halogenases also employ a peroxo intermediate to form an X+ equivalent, but 
regioselectivity is achieved through trapping the halogenating species as a covalent intermediate.  
A wider range of non-aromatic substrates can be accessed through the use of a powerful non-
heme iron cofactor and radical halogenation strategy.  Thus far, the only known native fluorinase 
employs a nucleophilic mechanism that takes advantage of the excellent nucleophilicity of 
desolvated F—.  The fluorinase also exploits the properties of its substrate (SAM) to allow this 
unusual nucleophilic reaction.  It will be interesting to see if other fluorinases exist that can act 
on more diverse substrates, if they also employ a nucleophilic mechanism, and how they solve 
the problem of activating the relatively inert solvated fluoride ion.  The recent discovery of 
SAM-dependent enzymes that employ a nucleophilic mechanism with the less electronegative 
halogens (Cl—, Br—, I—) highlights the rapid pace of development in our understanding of 
biological halogenation reactions.  Further, structural characterization of the SAM-dependent 
chlorinase has illustrated how subtle changes in a halide binding site can tune enzyme selectivity 
for a particular halide. 
In all cases, crystallographic structure determination has proven essential in gaining an 
initial understanding of the mechanisms of these remarkable enzymes.  Structural analysis has 
allowed visualization of the metal centers and cofactors, led to identification of key residues 
involved in catalysis, pinpointed the location (or absence) of halide binding sites, and provided 
insight into halogenase regioselectivity and specificity.  We expect that structure will continue to 
play an important role in further characterization of the halogenases and their mechanisms.  
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Table V.1. The Five Classes of Halogenating Enzymes 
 
Proposed form 
of activated 
halogen 
Substrate requirements Cofactor and cosubstrate requirements 
Heme iron-dependent 
haloperoxidases X
+ Electron-rich, aromatic Heme, H2O2 
Vanadium-dependent 
haloperoxidases X
+ Electron-rich, aromatic Vanadate, H2O2 
Flavin-dependent 
halogenases X
+ Electron-rich, aromatic FADH2, O2 
Non-heme iron-dependent 
halogenases X
• Aliphatic, unactivated Fe(II), O2, α-ketoglutarate 
SAM-dependent 
halogenases X
— Electrophilic, good 
leaving group SAM 
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Table V.2. Trends in the Halides 
 Increasing Æ 
Ionic Radius F— < Cl— < Br— < I— 
Electronegativity I—  < Br— < Cl— < F— 
Basicity I—  < Br— < Cl— < F— 
Nucleophilicity 
(protic solvent) F
— < Cl— < Br— < I— 
Nucleophilicity (gas phase) I— < Br— < Cl— < F— 
Good leaving group F— < Cl— < Br— < I— 
Standard reduction potential of 
HOX/X— couple I
— < Br— < Cl— < F— 
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Scheme V.1 Halogenase reactions 
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Figure V.1  The five classes of halogenating enzymes.  Stereoviews of ribbon diagrams are 
shown for each halogenase structure.  Each chain is colored a different shade of blue.  A.  Heme-
dependent myeloperoxidase (MPO) from Homo sapiens (PDBID 1D2V).  The heme cofactor 
(orange sticks) is coordinated by the proximal ligand His336 (pink sticks).  Disulfides are shown 
as yellow sticks.  B.  Vanadium-dependent chloroperoxidase from Curvularia inaequalis 
(PDBID 1IDQ).  The vanadate cofactor (spheres) is coordinated by His496 (orange sticks).   C. 
Flavin-dependent halogenase PrnA from Psuedomonas fluorescens (PDBID 2AQJ).  Flavin 
cofactor and L-Trp substrate are shown as orange sticks.  Lys79 is shown as pink sticks, and 
chloride is shown as a green sphere.  D.  Non-heme iron halogenase SyrB2 from Psuedomonas 
syringae (PDBID 2FCT). The αKG cosubstrate is shown in orange sticks, and the iron 
coordinating ligands (His116 and His235) are in pink sticks.  Iron (brown) and chloride (green) 
are shown as spheres. E. The SAM-dependent fluorinase 5′-FDAS from Streptomyces cattleya 
(PDBID 1RQR).  Each chain is colored a different shade of blue and the 5′-FDA product is 
shown as orange sticks.   
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Figure V.2  Comparison of halide binding sites.  Stereoviews of halide binding sites with 
bromine in purple spheres, chlorine in green spheres, and fluorine in orange spheres representing 
the halide ionic radius.  Water is shown as small red spheres.  A. MPO with bound Br— (Br1, 
PDBID 1D2V). The heme is shown as cyan sticks with iron as a brown sphere.  B. MPO with 
bound Br— and CN— (Br2, PDBID 1D7W) in the same orientation as A.  The heme is shown as 
cyan sticks with iron as a brown sphere.  C. PrnA (PDBID 2AQJ) with bound FAD (cyan sticks) 
and Cl-.  D. SyrB2 with bound Cl— (PDBID 2FCT).  The co-substrate αKG is shown as cyan 
sticks, and iron as a brown sphere.  E. 5′-FDAS (PDBID 1RQP) with bound 5′-FDA (cyan 
sticks).  F. SalL (PDBID 2Q6I) with 5′-ClDA and L-Met shown as cyan sticks. 
 
A. 
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Appendix I: Collection of Experimental Protocols  
 
  
Index of selected protocols 
1. Mini-prep for DNA purification 
2. Site-directed mutagenesis of SyrB2 
3. Anaerobic protein purification of SyrB2 mutants 
4. Ferene S assay for iron concentration 
5. Activity assays for SyrB2 variants 
6. Amino acid OPA-derivatization 
7. Activity assay results for SyrB2 mutants A118E and A118D 
8. Purification and activity of wt SyrB2 with varied thiolation domains 
9. Purification of phosphopantetheine-loaded SyrB1 
 
 
 
AI.1 Mini-prep for DNA purification 
Adapted from Fred Vaillancourt at Harvard Medical School, based on a protocol 
developed by David Pulleybank at the University of Toronto 
 
Reagents: 
1. Cell resuspension buffer:  
1% ethylene glycol, 1 mM sodium azide, 10 mM Tris-HCl pH 8 
 
2. Cell lysis solution: 
2% sodium dodecyl sulphate, 0.15 M NaOH, 0.025 M sodium iodate, 10 mM EDTA 
 
3. Acid-iodide precipitation solution (store at 4°C): 
2.5 M cesium chloride, 0.25 M tartaric acid, 0.25 M sodium iodide 
 
4. PEG-ethanolamine plasmid precipitation solution: 
37% (w/v) PEG 2000 (Fluka), 4 M mono-ethanolamine 
 
5. 75% EtOH, 25% HOH v/v mixture (store at -20°C) 
 
6. sterile deionized water 
 
Sources:  PEG2000 from Fluka is recommended.  An inexpensive grade of Cesium 
chloride is fine, as the impurities typically do not affect the outcome of the miniprep.  
Reagent grade sodium dodecyl sulphate should be used, as cheaper grades may contain 
reducing agents. 
 
Recommended storage of reagents:  The reagents may be stored at room temperature for 
at least one year.  However, the acid-iodide precipitation solution will slowly turn yellow 
and then brown because of air oxidation, which should not significantly affect the 
properties of the solution.  It is slowed by cold storage at 4 °C.  Store solution #5 at -
 181
20°C.  The ethanolamine in the plasmid precipitation solution also undergoes slow air 
oxidation resulting in a slight yellowing of the solution over a period of months.  This 
does not affect the properties of the solution. 
 
*All centrifugations are performed in a bench top microcentrifuge (14,000 rpm) at room 
temperature.  Align eppendorf tubes with the closing loop all in the same direction, to 
allow pipetting without disturbing the pellets. 
 
 
1. Sediment the bacteria by centrifugation for 1 minute (Typically 3x1.5 mL for a 5 
mL culture).  Open the tube and remove the supernatant.  Residual supernatant 
should not exceed 25 μL.  (Can store at -20°C at this step).  Add 200 μL 
resuspension buffer (#1) and resuspend using a pipette. 
2. Add and mix 300 μL cell lysis solution (#2) with the cells by quick addition.  
Allow tubes to stand 2 minutes then: 
3. Add 400 μL acid iodide precipitation mix (#3).  Close the tubes and give them a 
vigorous shake then centrifuge for 3 minutes.  (prepare tubes for next step while 
centrifuging).  The plasmid will be in the supernatant. 
4. Pour the supernatant from step 3 into a 500 μL aliquot of the PEG-ethanolamine 
plasmid precipitation solution (#4) in an appropriately labeled tube.  Close the 
tube, shake briefly and allow to stand 5 minutes for the precipitate to form.  
(Longer is acceptable, 15 minutes for low copy plasmids).  Then centrifuge 5 
minutes.  Plasmid will be in pellet.  You can prepare the gel at this step. 
5. Remove the supernatant and rinse the usually invisible pellet 2 times with 0.3 mL 
of cold 75% EtOH (#5).  In order to ensure adequate rinsing close the tube and 
invert it several times before spinning for 30 seconds, followed by removal of the 
rinse solution.  You may wish to dry any remaining yellow solution from the 
eppendorf caps at this step, using a Kemwipe.  For the 2nd rinse, simply add the 
EtOH and remove it (no need to invert and centrifuge).  A slight yellow color will 
be present in the initial rinse because of regeneration of a small amount of iodine.  
Drying the pellets can be accelerated by placing the tubes open on a 50°C dry 
block (15-20 minutes). 
6. Redissolve the plasmid in sterile deionized water (#6) and analyze by 
electrophoresis (resuspend in 10 μL and put 0.5 μL on gel). 
 
Gel should be 0.8% agarose in TAE(Tris, acetate, EDTA), 1.6 g in 200 mL 
For standard used 1kb DNA ladder from New England Biolabs 
Load 1 μL DNA (or standard) + 1 μL DNA loading buffer (6x) + 4 μL H2O 
Cover gel with TAE and run at 100V for ~30 minutes 
 
There are three points where timing of the incubations may be important: 
1. Cell lysis must be complete for good yields to be obtained.  Lysis of E. coli in the 
lysis mixture is almost immediate and therefore should not pose a problem.  
Prolonging the lysis step beyond 5 minutes may cause partial loss of plasmid 
because some plasmid will be nicked in consequence of chemical attack by the 
NaOH. 
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2. Plasmids should not be left in the acid-iodine solution for longer than is necessary 
as its acidity is sufficient to cause slow depurination. 
3. Sufficient time should be allowed to permit the plasmid precipitate to form before 
centrifugation (step 4).  5 minutes is sufficient for typical high copy number 
plasmids, but longer times may be necessary for low copy number plasmids 
(about 15 minutes).   
 
 
 
AI.2 Site-directed mutagenesis of SyrB2 
Variation of the QuickerChange protocol based on original adaptation by Michael 
Fischbach at Harvard Medical School.  Enzymes and buffers from New England Biolabs 
(NEB) 
 
QuickerChange Protocol 
 
1. Design oligos with 10-20 bp of annealing sequence on either side of the mutation.   
 
2. Dilute oligo stock in H2O to get 84 μL of 12 μM.  Incubate at 95°C for 5 minutes, 
then cool to room temperature.  This step makes subsequent phosphorylation more 
efficient.   
 
3. To diluted oligo, add: 
       10 μL T4 DNA ligase buffer   (NEB) 
       6 μL T4 polynucleotide kinase 
       Incubate at 37°C for 30 minutes 
 
4. Set up QuickerChange reaction : 
            2.5 μL                     10x Pfu buffer    
 1    μL                     mix of dNTPs (10 mM each)  
 10  μL                     Oligo phosphorylation mix 
 2.5 μL                     10x Taq ligase buffer 
 2    μL                      plasmid DNA template 
 2    μL                      Pfu Turbo 
 1    μL                      Taq ligase 
          Complete to 50 μL    H2O 
 
5. Set up thermocycler program (use equipment with hot bonnet) 
            95°C    3 min 
            |     95°C     30 seconds 
    30x  |     47°C     30 seconds 
            |     65°C     3 minutes per kb (size of plasmid template- i.e. 10kb template=30min) 
                  4°C  hold 
 
6. Add 2 μL DpnI and incubate at 37°C for 1.5-2.5 hr  (to digest template) 
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7. Transform chemically competent cells with 3-5 μL of the thermocycler/digest mix 
5 μL DNA in Top 10 cells, incubate 15 minutes on ice 
42 °C water bath for 30 seconds 
Add 250 μL SOC media incubate at 37 °C for 1.5 hr 
Plate 5 μL and rest on 2 plates (Kan 50 LB) at 37 °C overnight 
 
8. Pick 5 different colonies for each mutant, and inoculate one 5 mL culture of each.  
Grow overnight at 37 °C with shaking. 
 
9. Make glycerol stocks (.5 mL culture + .5 mL glycerol stock solution), miniprep and 
sequence each mutant 
 
10. Use correct mutant DNA to transform BL21-DE3 cells as above, make glycerol 
stocks (.5 mL culture + .5 mL glycerol stock solution) 
 
 
AI.3 Anaerobic protein purification of SyrB2 mutants 
Based on protocol developed by Fred Vaillancourt at Harvard Medical School 
 
1. Inoculate a liquid culture of the appropriate size directly from the glycerol stock 
(plasmid in BL21 DE3) in LB + Kan 50 (for pET28b derivatives) and incubate overnight 
at 37°C (shake at 200 rpm). Typically, inoculate 75mL of culture directly from the 
glycerol stock and start the incubation at 3pm due to the large culture volume. 
 
2. The next day, around 9h-9h30am, inoculate 6 L of culture with 10 mL per L of 
overnight culture and grow the culture (shake at 200 rpm) at 35°C until about 1 pm, then 
25C until about 3-3h30 pm, then 15C until 4h-4h30 pm. At this time, the OD at 600nm 
should be around 0.5-0.7.  Add 0.5mM of IPTG final concentration when the OD has 
reached at least 0.5. Continue the incubation until the next morning at 9h-9h30 am then 
spin down the cells and freeze them in liquid nitrogen and store them at -80°C until 
purification (should be okay for several months).  Spin down in 500 mL centrifuge tubes 
at 5,000 rpm for 12 minutes (large rotor). Combine with washes of original tubes and do 
a final spin in orange-capped conical to obtain maximal amount of cells.  Keep 
centrifuges at 4°C.   
 
For large scale growth used the culture media LB and Kan 50 ug/mL.  
 
Luria-Bertani broth 
5g Yeast extract 
10g tryptone 
10g NaCl 
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Purification of His-tagged enzymes in glovebox 
 
Reagents: 
1. Buffer A 
20mM Hepps pH 8.0 
300mM NaCl 
5mM Imidazole 
 
2. Buffer B 
20mM Hepps pH 8.0 
300mM NaCl 
30mM Imidazole 
 
2. Buffer C 
20mM Hepps pH 8.0 
100mM NaCl 
200mM Imidazole 
 
3. Buffer D 
20mM Hepps pH 8.0 
100mM NaCl 
 
4. Buffer E 
20 mM Tris, pH 8.0 
 
5. Buffer F 
20 mM Tris, pH 8.0 
 
6. Buffer G 
20 mM Hepes, pH 7.5 (make with chloride-free water) 
 
HEPPS: 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid 
Not the same as HEPES, one methyl group difference that increases the pKa by about 0.5 
unit 
 
Protocol Day 1 
 
1. Resuspend the cells in <30 mL of buffer A. Typically get about 20g of cells from 6 L 
of culture. 
 
2. Add 1mM CaCl2 (stock 1 M), 1 mM MgCl2 (stock 1 M) and 0.1 mg/mL DNase I 
(stock 10mg/mL). Adding DNase I and its cofactors makes the broken cells a lot less 
viscous and easier to work with because the long chromosomal DNA fragments are 
cleaved. 
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3. Pass through French Press 2X at 1280psi (high ratio), store a sample for gel at       -
20°C 
 
4. Blow argon over solution through septum, bring into box 
 
5. Place broken cells in airtight centrifuge tubes, bring out of box and spin at 15,000rpm 
for 30minutes in SS-34 rotor 
 
6. While centrifuging, prepare Ni-NTA column resin in the box.  Typically have the resin 
in twice its volume; shake the bottle and add 10-12mL. Exchange the resin into buffer D 
by simply putting it in a Bio-Rad yellow column and changing the buffer.  Wash an 
amicon filter twice with buffer D- don’t let it dry out! 
 
7. Bring centrifuge tubes into box, carefully remove supernatant with Pasteur pipette and 
transfer to a beaker 
 
8. Add 5-6 mL of the prepared Ni-NTA agarose resin from Quiagen (about 1-1.2 mL/ L 
of culture).  
 
9. Slowly stir the resin with supernatant for 1 hr on ice (small beaker in big beaker full of 
ice) or in cold room.  While this is stirring, prepare the bio-rad column and wash with 
buffer D 
 
10. Put Ni resin in yellow column and let all liquid flow through resin (typically use 1.5 x 
20 cm yellow Bio-Rad column) 
 
11. Wash with about 5 column volumes (CV) of buffer A, remove bubbles as you add 
buffer A (save samples for gel) 
 
12. Wash with 3-4CV of buffer B   
 
13. Elute with 4-5CV of buffer C 
 
14. Concentrate the proteins down to about 10mL in Amicon stirred cells with the proper 
sized membrane cut-off. Amicon Ultra centrifugal filter devices are also good to 
concentrate these proteins in a centrifuge. 
 
15. Pass the proteins through a desalting column made up with Bio-Gel P6-DG desalting 
gel from Bio-Rad (Cat #150-0738) equilibrated in buffer D. Typically use the 2.5 x 10cm 
yellow column; 3.5-4g of gel in buffer D (it swells instantly). 
 
16. Collect 15 fractions of 2 mL and check where the protein is by taking 5 μL from each 
tubes, put in eppendorf and add 200-500 μL of Bradford reagent. 
 
17. Pool fractions containing protein and concentrate down to 5-10mL 
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18. Perform Bradford to find protein concentration (save sample before cleavage) 
 
19.  Add 2 mM CaCl2 and thrombin, and incubate for 3 h at 15-19 °C (1 U thrombin:10 
mg SyrB2 (save sample after cleavage for gel) 
 
20.  Freeze in liquid N2 in 3-4 aliquots, in glass serum vials with rubber septa 
 
Protocol Day 2 
 
1. Secure septums with copper wire before bringing protein into box to thaw 
 
2. Dilute frozen aliquots 1:1 with buffer E (only thaw one at the time).  Transfer to two 
10 mL syringes/purple needles and cap with rubber septa to remove from box.  Change 
needle to injection needle. 
 
3. Run MonoQ equilibrated in buffer E using a gradient with buffer F (load fraction 
collector with ~60 tubes) 
 
4. Wash 50 mL Amicon with buffer E 
 
5. Perform multiple runs (about 50mg per injection),  
 
6. Pool fractions containing protein and concentrate to 5-10mL 
 
7. Exchange HPLC buffers to Cl free H2O to wash columns and lines 
 
8. Inject 5-10mL on 26/60 Superdex 75 column equilibrated in buffer G.  First transfer 
contents of amicon to 10 mL glass vial using large pipette.  Add two 500 μL washes of 
amicon. Transfer to10 mL syringe as before, with rubber septum to remove from box.  
(need ~25 clean tubes) 
 
9. Wash 50 mL and 5 mL amicon with Cl free buffer twice 
 
10. Pool fractions, concentrate to ~ 1mL in amicoms, wash amicons with 200 μL then 
100 μL H2O 
 
10. Run Bradford on concentrated, pooled sample 
 
SyrB2 reconstitution with αKG and Fe(II) 
 
1. To x mL add: 
20x μL 100 mM DTT + 20x μL 100 mM αKG + 50x μL 20 mM Fe(II) 
Repeat, adding the same amount of DTT, αKG, and Fe(II) again 
 
2. Run desalting column (2-2.5 inches resin in Cl free buffer).  Empty column.  Add 
protein gently and directly to surface.  Wash with 2 small amounts buffer, then larger, 
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collect <.5mL fractions in eppendorfs.  Do qualitative Bradford (as after first desalting 
column) to determine which fractions to pool 
 
3. combine protein-containing fractions, run Bradford, and flash-freeze in liquid N2
 
The following mutants were created and grown in 6 L of culture: 
 A118D    25.7 g cells 
 A118E    21.3 g cells 
 N123A    33.4 g cells 
 T143A     34.7 g cells 
 E102A     34.2 g cells 
  
Only A118D and A118E were further purified.  The following amounts of protein were 
obtained at each stage of purification: 
 
 Before thrombin cleavage:   
  A118D  ~12mL of 13.2 mg/mL = ~158.4 mg 
  A118E   ~14mL of 3.2 mg/mL = ~44.3 mg 
 
 After superdex: 
   A118D  ~ of 13.5 mg/mL = ~131 mg 
  A118E   ~1.5mL of 21.0 mg/mL = ~31.5 mg 
 
            Final:  
A118D 
~1mL apo at 13.5 mg/mL (for crystallization) 
~1.5mL reconstituted at 4.7 mg/mL (for activity assays) 
 
A118E 
20x25 μL samples apo at 21.0 mg/mL   (for crystallization) 
Saved 32x50 μL samples reconstituted at 4.1 mg mL (for activity assays) 
 
AI.4 Ferene S assay for iron concentration 
Adapted from Fred Vaillancourt at Harvard Medical School 
 
Reagents: 
 
1. Ferene S solution (100 mL) 
 0.75 mM Ferene S (37.08 mg) / 2 = 18.54 mg 
            10 mM L-Ascorbic acid (179.1 mg)/2 = 89.55 mg 
 45% NaAc·3H2O (45 g)/2 = 22.5 g 
Takes about 2 hours to be fully soluble.  Filter with 0.45 μm syringe.  Keep in the dark on 
ice.  Always use the same day prepared.   
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2.  12 N HCl 
 
3.  80% TCA 
 
4.  45% NaAc·3H2O 
 
5.  2 mM FeCl3·6H2O (54.06 mg/100 mL) 
 
Create standard curve 
 
1. In HCl treated glass tubes mix 
Tube # Fe 2mM (μL) H2O (μL) μmoles Fe 
0 0 800 0 
1 2 798 0.004 
2 4 796 0.008 
3 6 794 0.012 
4 8 792 0.016 
5 12 788 0.024 
6 16 784 0.032 
     
2. Add 100 μL HCl Conc. 
        100 μL 80% TCA 
        200 μL NaAc 45% 
        1.8 mL Ferene S solution 
 
3. Mix and read OD at 593 nm 
  
Assay iron concentration in protein sample 
 
1. In eppendorf manage to have at least 10 nmoles of protein in sample (used 115 μL of 
~4 mg/mL protein).  Bring to 800 μL with H2O.   
 
2. Add 100 μL HCl, mixing every 2 min for 10 minutes.   
 
3. Add 100 μL 80% TCA.   
 
4. Spin for 10 minutes at room temp at 14,000 rpm.  Transfer supernatant into HCl 
treated glass tubes.   
 
5. Add 200 μL 45% Na acetate and mix.   
 
6. Add 1.8 mL Ferene S solution and read OD at 593 nm.   
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The following iron contents were determined for the reconstituted samples: 
A118D 86.02 μM Fe (74.4%) 
A118E 87.29 μM Fe (65.3%) 
The wt SyrB2 used in activity assays had an iron content of 83.0% 
 
 
AI.5 Activity assays for SyrB2 variants  
Based on protocol developed by Fred Vaillancourt at Harvard Medical School 
 
Each mutant was tested at 2 concentrations of protein (10 μM, the optimal concentration 
for formation of 4-Cl Thr by wt SyrB2, and 50 μM, the optimal concentration for 
formation of di-Cl Thr by wt SyrB2).  At each concentration, the reaction was run both 
with and without added chloride.  Positive controls with wt SyrB2 were performed under 
all of these conditions.  Sfp is the promiscuous phosphopantetheine-loading enzyme from 
B. subtilis. 
 
1.  Assay set-up: 
 Condition 20 mM 
HEPES 
pH 7.5 
(μL) 
0.5 M 
MgSO4 
(μL) 
0.5 M 
MgCl2 
(μL) 
50 mM 
CoA 
(μL) 
62 μM 
Sfp 
(μL) 
501.2 
μM 
SyrB1 
(μL) 
1 MgSO4 + 10 μM SyrB2 75.8 1 - 1 2 29.5
2 MgCl2 + 10 μM SyrB2 75.8 - 1 1 2 29.5
3 MgSO4 + 50 μM SyrB2 55.5 1 - 1 2 29.5
4 MgCl2 + 50 μM SyrB2 55.5 - 1 1 2 29.5
5 MgSO4 +10 μM A118D 66.5 1 - 1 2 29.5
6 MgCl2 + 10 μM A118D 66.5 - 1 1 2 29.5
7 MgSO4 +50 μM A118D 5.5 1 - 1 2 29.5
8 MgCl2 + 50 μM A118D 5.5 - 1 1 2 29.5
9 MgSO4 + 10 μM A118E 64.0 1 - 1 2 29.5
10 MgCl2 + 10 μM A118E 64.0 - 1 1 2 29.5
11 MgSO4 + 50 μM A118E - 1 - 1 2 29.5
12 MgCl2 + 50 μM A118E - - 1 1 2 29.5
 
2. Incubate 30 min at room temperature 
 
3. Add to each reaction mixture 
     2 μL of 100mM L-Thr  
     3 μL of 100 mM ATP  
      and incubate 60 minutes at room temperature 
 
4. Add 2 μL of 100 mM αKG to each reaction mixture, then close eppendorfs and bring 
into box.  Open tubes in box near filter. 
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5. To each mixture add: 
 wt SyrB2 (388.45 μM) A118D SyrB2 (133.61 μM) A118E SyrB2 (115.63 μM) 
1 4.7 μL - - 
2 4.7 μL - - 
3 25.0 μL - - 
4 25.0 μL - - 
5 - 14 μL - 
6 - 14 μL - 
7 - 75 μL - 
8 - 75 μL - 
9 - - 16.5 μL 
10 - - 16.5 μL 
11 - - 80.5 μL 
12 - - 80.5 μL 
 
6.  Bring reaction mixtures out of box and mix with air.  
Incubate at room temperature for 1 hr, open tubes and mix with air again after 30 
minutes.   
 
7.  Place samples in Millipore Ultrafree-0.5 centrifugal filter devices (10 kD MW cutoff).   
Fill to 500 μL with 20 mM HEPES pH 7.5, spin 10 min 12,000 x g at 4°C 
Repeat 4 times, 5 if sample size does not decrease to at least 50 μL each time.  This step 
removes any unbound L-Thr from sample. 
 
8. Refill spin filters to ~125 μL.  Cleave amino-acids off of SyrB1 by adding 5 μM TycF 
type II thioesterase and incubating 1 hour at room temperature. 
 
9. Replace tube to catch flow through.  Wash 2x with 125 μL 20mM HEPES pH 7.5. 
Freeze and store flow through 
 
10. Thaw one sample at a time and derivatize using OPA procedure (see section AI.7).  
Run on HPLC and compare to authentic standards.   
 
AI.7 Amino acid OPA-derivatization  
Protocol developed by Fred Vaillancourt at Harvard Medical School) 
 
Derivatization mixture (1 mL) 
1. Dissolve 10 mg of o-phthaldehyle (OPA) in 200 μL MeOH; store in cold room 
wrapped in aluminium)  
2. Add 19.6 μL 3-mercaptopropionic acid (MPA); (Fluka) 
3. Add 880.4 μL 0.4 M borate pH 10.4 
4. Put the mixture in a 5 mL Wheaton bottle with a septum and purge under nitrogen 
or argon on ice and in the dark for 20 minutes 
5. Store the mixture at 4 °C and use within 2 days  
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HPLC conditions 
Buffer A: 40 mM Na2HPO4 pH 7.8 (buffer with HCl) 
Buffer B: Acetonitrile:MeOH:HOH; 45:45:10 
 
Program: 
Flow 1mL/min 
Gradient 0-60% B in 20min 
Gradient at 20 min 100% B in 5 min 
At 30 min 0% B 
At 40 min stop data 
 
UV Detector channel 338nm 
Fluorescence detector excitation at 340/450nm (Ex/Em) 
 
Sample preparation (for about 120uL) 
12 uL borate pH 10.4  
110 uL amino acid mixture 
add 2 uL OPA derivatization mix 
 
The reaction is over within a few minutes 
 
Typically, achieved very good signal with injection of 100 uL of a 50 uM (final 
concentration) of amino acid 
 
Column: Phenomenex Luna 5u C18(2) 100A; 250mm x 4.6mm 
 
 
AI.8 Activity assay results for SyrB2 mutants A118E and A118D 
 
Normal activity was observed for the wt SyrB2 positive control (Figure AI.1).  The 
SyrB2 variants showed no activity under any conditions (Figure AI.2).  There was no 
formation of 4-Cl Thr, or 4-OH Thr by A118E or A118D.   
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Figure AI.1 Positive control for wt SyrB2 activity. 
10 12 14 16 18 20 22
Thr 4Cl-Thr diCl-
standard 
standard 
10μM SyrB2 
10μM SyrB2 + Cl-
50μM SyrB2 
50μM SyrB2 + Cl-
 
 
 
Figure AI.2.  Activity of SyrB2 variants.  All samples contained 50 μM protein and 
chloride. 
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AI.9 Purification and activity of wt SyrB2 with varied thiolation domains 
 
SyrB2 reacts with substrate tethered to the thiolation (T) domain of SyrB1.  SyrB1 is a 
large (~66 kD), flexible protein containing both an adenylation (A) domain and T 
domain.  The large size and expected flexibility of the SyrB1 protein would likely make 
co-crystallization with SyrB2 very difficult, and so several thiolation (T) domains and T-
domain constructs were purified and assayed for activity to determine their suitability for 
co-crystallization experiments.  CmaD, from the coronatine biosynthetic pathway, and 
CytC2, from the cytotrienin A pathway, are both single T domains that interact with 
homologues of SyrB2.  SyrB1, CmaD, and CmaC were purified as described in AI.3 (but 
aerobically) from 6 L of culture, and good yields were obtained through the thrombin 
cleavage step.  A SyrB1 construct containing only the T domain (not the attached 
adenylation (A) domain) was cloned and purified with low yields.  The activity of wt 
SyrB2 was assayed against wt SyrB1, the SyrB1-T domain, CmaD, and CytC2.  The 
procedures used for this experiment were similar to those used to test the activity of the 
SyrB2 A118D/E variants (section AI.5 and AI.6).   
 
The following conditions were assayed: 
 T domain SyrB2 
1 CmaD - 
2a CmaD + 
2b CmaD + 
3 CytC2 - 
4a CytC2 + 
4b CytC2 + 
5 SyrB1-T - 
6 SyrB1-T + 
7 SyrB1 - 
8 SyrB1 + 
 
CytC1, a promiscuous adenylation domain, was used to load the Thr on the T-domains.   
Each initial reaction mixture contained: 
1   μL    0.5 M MgCl2
1   μL    50 mM CoA 
15 μL    350 μM CytC1  
2   μL    62 μM SfP 
 
As well as: 
 CmaD  CytC2  SyrB1-T  SyrB1 
T domain  20 μL at  
1.472 mM 
120 μL at  
152.5 μM 
140 μL at 
131.4 μM 
40 μL at 
574.2 μM 
20 mM HEPES pH 7.5 120 μL 20 μL - 100 μL 
 
Incubate 30 min room temperature 
Add  
3 μL Thr (100 mM) 
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3 μL ATP (100 mM) 
Incubate 1 hr at room temperate 
Add 3 μL αKG 100 mM 
Bring reactions 2a,2b,4a,4b,6,8 into box and at 15 μL of 388.45 μM SyrB2 each. 
 
The rest of the procedure was performed as previously described.  The results are shown 
in Figure AI.3.  Surprisingly, despite the high sequence homology between the different 
T domains, CmaD was not active with SyrB2.  CytC2 converted a large percentage of 
Thr to 4-Cl-Thr, while the truncated SyrB1 T domain was only slightly active.   
 
Figure AI.3. Comparison of activity of wt SyrB2 with varying T domain substrates.  
 
10 15 20 25
Time (min)
CmaD (1)
CmaD (2)
CytC2 (1)
CytC2 (2)
SyrB1 T domain
Control no SyrB2
SyrB1
 
Thr 4Cl-Thr
 
 
AI.10 Purification of phosphopantetheine-loaded SyrB1 
 
Based on the activity results, purification of SyrB1 loaded with the 
phosphopantetheine arm was undertaken to prepare protein for co-crystallization 
experiments.   
 
1.03 mL of SyrB1 at 39.2 mg/mL  
Dilute to 200 μM, and for each 100 μL of protein solution add: 
1 μL  0.5 M MgCl2   
2 μL 50 mM CoA 
2 μL 82 μM Sfp 
Stir at room temperature 2 hours 
Run over Superdex 200 column  (obtained ~10 mL containing protein) 
Concentrate in amicon washed with 20 mM HEPES pH 7.5  
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Obtained ~1250 μL at 10.3 mg/mL by Bradford 
 
Only about a third of the original protein was recovered using this procedure.  There was 
still a trace amount of Sfp remaining even after the Superdex column (Figure AI.4).  The 
column did appear to have removed some truncation products of SyrB1.    
 
Figure AI.4.  Purification of phosphopantetheine-loaded SyrB1. 
 
Lane 1.  Standards 
Lane 2.  SyrB1/Sfp mixture (~7 μg SyrB1) 
Lane 3.  After Superdex column (~20 μg SyrB1) 
Lane 4.  Standards 
Lane 5.  SyrB1/Sfp mixture (~25 μg SyrB1) 
 
1 2 3 4 5 
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Appendix II: Xenon In and at the End of the Tunnel of Bifunctional Carbon 
Monoxide Dehydrogenase/Acetyl-CoA Synthase 
 
AII.1. Summary
A fascinating feature of some bifunctional enzymes is the presence of an internal channel or 
tunnel to connect the multiple active sites. A channel can allow for a reaction intermediate 
generated at one active site to be used as a substrate at a second active site, without the need for 
the intermediate to leave the safety of the protein matrix.  One such bifunctional enzyme is 
carbon monoxide dehydrogenase/acetyl-CoA synthase from Moorella thermoacetica 
(mtCODH/ACS). A key player in the global carbon cycle, CODH/ACS uses a Ni-Fe-S center 
called the C-cluster to reduce carbon dioxide to carbon monoxide, and uses a second Ni-Fe-S 
center, called the A-cluster, to assemble acetyl-CoA from a methyl group, coenzyme A, and C-
cluster-generated-CO. mtCODH/ACS has been proposed to contain one of the longest enzyme 
channels (138-Å-long) to allow for intermolecular CO transport. Here, we report a 2.5 Å 
resolution structure of xenon-pressurized mtCODH/ACS, and examine the nature of gaseous 
cavities within this enzyme. We find that the cavity calculation program CAVENV accurately 
predicts the channels connecting the C- and A-clusters, with seventeen of nineteen xenon binding 
sites within the predicted regions.  Using this X-ray data, we analyze the amino acid composition 
surrounding the nineteen Xe sites and consider how the protein fold is utilized to carve out such 
an impressive interior passageway. Finally, structural comparisons of Xe-pressurized 
mtCODH/ACS with related enzyme structures allow us to study channel design principles, as 
well as consider the conformational flexibility of an enzyme that contains a cavity through its 
center. 
 
 
 
This chapter has been submitted for publication as Doukov, T.I., Blasiak, L.C., Seravalli, J., 
Ragsdale, S.W., Drennan C.L. (2008) “Xenon in and at the end of the tunnel of bifunctional 
carbon monoxide dehydrogenase/acetyl-CoA synthase.”  
 
 
 
 
 
 
 
 
 
 
 197
AII.2 Introduction 
 
Carbon monoxide dehydrogenase/acetyl-CoA synthase (CODH/ACS) is a key component of 
various energy yielding pathways in microbes. In acetogens like Moorella thermoacetica, 
CODH/ACS is a bifunctional enzyme that is responsible for the reduction of CO2 to CO and 
subsequent assembly of acetyl-CoA, as part of the Wood-Ljungdahl carbon fixation pathway.  
Methanogenic archea also use a CODH/ACS variant sometimes referred to as acetyl-CoA 
decarboxylase/synthase (ACDS); but, in this case, the enzyme complex has a different subunit 
organization and is involved in the degradation of acetyl-CoA to form methane and CO2. 
Additionally, organisms such as the phototrophic anaerobe Rhodospirullum rubrum use 
monofunctional CODH to grow on CO, a chlorophyll and heme degradation product, when light 
is not available for photosynthesis. Due to their role in reducing the levels of gaseous pollutants 
CO and CO2 in our environment, CODH/ACS enzymes have been well studied (reviewed in (1-
5)). One of the best-characterized family members, the bifunctional M. thermoacetica enzyme 
(mtCODH/ACS) is a 310 kilodalton α2β2 heterotetramer that catalyzes two different reactions 
using seven metalloclusters (two A-, two B-, two C- and one D-cluster). While the B- and D-
clusters in the CODH (β) subunit are Fe4S4 centers that shuttle electrons, the C-cluster, also in β, 
generates CO from CO2 (Scheme AII.1). The CO produced at the C-cluster travels through a 
channel in the enzyme to the A-cluster of the ACS (α) subunit, where it is combined with a 
methyl group and coenzyme A (CoA) to form acetyl-CoA (Scheme AII.1). The methyl group is 
transferred to the A-cluster from the methyl-Co(III) state of a corrinoid iron-sulfur protein 
(CFeSP).  Thus, the synthesis of acetyl-CoA at the A-cluster involves a methylation reaction, a 
carbonylation reaction, and the synthesis of a high-energy thioester bond. Acetyl-CoA synthesis 
also involves substrates of three very different sizes: CO (2 atoms, 28 Da), methylated-CFeSP 
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(11,911 atoms, 84124 Da), and coenzyme A (84 atoms, 768 Da). Here we use X-ray 
crystallography and structural comparisons to consider how CO produced at the C-cluster travels 
to the A-cluster, and how the enzyme is able to perform a molecular juggling act such that the A-
cluster can react with substrates of such different sizes.   
 Several lines of evidence indicate that CO is sequestered from solvent as it travels 
through the enzyme between the C-cluster in CODH where it is produced, and the A-cluster in 
ACS where it is utilized.  Studies with labeled CO2 and unlabeled CO show that CO derived 
from CO2 is preferentially incorporated into acetyl-CoA, suggesting that the main route for CO 
to access the A-cluster is by way of the C-cluster (6). Also, the rate of acetyl-CoA synthesis is 
significantly faster with CO2 than CO as a substrate and hemoglobin, a CO “sponge”,  has little 
effect on the rate, consistent with CO2-derived CO from the C-cluster being the preferred 
substrate for ACS(7). Similarly, CO does not compete with CO2 as a substrate for an ACS-
catalyzed exchange reaction between labeled CO2 and the carbonyl group of acetyl-CoA, and 
hemoglobin does not affect the rate of this reaction(6). With this strong evidence for a channel 
between active sites, it came as a surprise when the first crystal structure showed that the C- and 
A-clusters are almost 70 Å apart(8).  How then is the enzyme designed such that CO is 
sequestered in the enzyme for its 70 Å-long journey from one active site to another?  The first 
insights into this query came from cavity calculations on the structure of mtCODH/ACS using 
the program CAVENV(9). Interior surface calculations revealed a 138-Å-long cavity that runs 
almost the entire length of the enzyme, connecting all A-clusters and C-clusters(8).  The radius 
of this cavity is at least 1.4 Å, except for a contraction at M148 in CODH (Mt numbering is used 
throughout unless otherwise noted). Mutagenesis experiments of putative channel residues 
A110C, A222L, and A265M showed decreased acetyl-CoA activity(10), and a preliminary 
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experiment with Xe gas also showed that this cavity could serve as a gas conduit but the details 
of the Xe sites were not described(11). Here we use Xe gas to further explore the nature of this 
amazing 138-Å-long channel.  We consider how this channel is created given the protein fold, 
and how differences in cavities are generated between a monofunctional CODH (where CO need 
not be directed to a second active site) and the β-subunits of a bifunctional CODH/ACS where a 
pathway is required.   
 The first enzyme channel was discovered in tryptophan synthase by the Davies 
group(12), and later in carbamoyl phosphate synthase, glutamine phosphoribosylpyrophosphate 
amidotransferase, asparagine synthetase, imidazole glycerol phosphate synthase, and 
glucosamine 6-phosphate synthase, among others(13). In many cases, channels exist to allow 
highly reactive intermediates to travel from one active site to another without encountering 
solvent that would lead to their decomposition.  In the case of CODH/ACS, however, CO is not a 
highly reactive molecule.  Instead, one might consider whether its channel protects the 
environment from this intermediate rather than the other way around.  Also, making CO from 
CO2 and then discarding it, as would occur without a channel, is energetically wasteful since 
each molecule of lost CO discards two low-potential electrons originally derived from glucose or 
H2 oxidation. Another function of a channel is to direct molecules to a particular site on an 
enzyme. For mtCODH/ACS, a channel could direct CO to a metal coordination site on the A-
cluster where it would be catalytically competent rather than potentially inhibitory. Finally, the 
activities of the C- and A-clusters become synchronized when substrates for both reactions are 
available(14), and a channel connecting the clusters could assist in this coordination.  The data 
presented here allows us to investigate these possible channel functions.    
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 One puzzle is how CO can be so completely sequestered by a channel in mtCODH/ACS 
when conformational changes must occur to allow this enzyme to react with the large substrate 
methylated-CFeSP and the medium-sized substrate CoA. It seems that at least four different 
conformations of this enzyme must exist for the A-cluster to access all substrates and perform 
the required chemistry (Scheme AII.2).  There must be a 'channel-open' conformation where CO 
generated at the C-cluster can travel uninterrupted to the A-cluster. Since biochemical data 
suggests that CO generated on the enzyme does not leave(6, 7), the A-cluster in the α-subunit 
must be sealed off from solvent when the CO channel is open ('channel-open; α-closed'). 
However, for the CFeSP to transfer a methyl group to the A-cluster, the A-cluster must be 
solvent accessible. When the A-cluster is accessible for methyl transfer, the channel must be 
closed or CO would diffuse out of the enzyme, something known not to occur.  In this state, the 
enzyme would be 'channel-closed; α-open'. When CO reacts with a methyl moiety to form an 
acetyl-metal intermediate, the A-cluster must again be sequestered from solvent ('intermediate-
bound; α-closed').  If water were allowed to access the active site at this stage, acetate rather than 
acetyl-CoA would be formed, leading to an uncoupling of CODH/ACS activity from energy 
production, as it is the thioester bond of acetyl-CoA from which the organism derives energy.  
Finally, CoA, a medium-sized substrate, must access the A-cluster in such a way as to prevent 
solvent entry. This conformation of mtCODH/ACS is expected to be 'CoA-bound; α-mostly-
closed'. Below, we explore the evidence for these different enzyme conformations.  
AII.3 Materials and methods 
Crystal growth ⎯ Moorella thermoacetica (formerly Clostridium thermoaceticum strain ATCC 
39073) was purified under strictly anaerobic conditions as described(15, 16). Crystals were 
grown using standard sitting drop vapor diffusion at room temperature in an anaerobic chamber 
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(Coy Laboratories).  The sitting drops consisted of 5 μl of protein solution (CODH/ACS at 40-60 
mg/ml in 50 mM Tris pH 7.6) mixed with 7.5 μl of reservoir solution (8-10% (w/v) polyethylene 
glycol monomethyl ether 5000, 20% glycerol, 200 mM calcium acetate, 100 mM PIPES pH 6.5, 
2 mM dithiothreitol (DTT)), with 0.25 μL of a solution of crushed microcrystals to aid in 
nucleation. For data collection, crystals were flash-cooled in liquid nitrogen using 20% glycerol 
as a cryoprotectant.  
Pressurizing mtCODH/ACS crystals with xenon ⎯ Crystals of CODH/ACS were harvested 
anaerobically and transported to The Stanford Synchrotron Radiation Laboratory (SSRL) in glass 
capillaries filled with a stabilizing solution that contained an increased PEG concentration. A Xe 
pressure cell (smb.slac.stanford.edu/facilities/hardware/pressurecell/ltpc.html), available at 
SSRL, was used to pressurize the crystals with Xe before cryocooling, according to standard 
protocols(17). Briefly, a looped crystal was lowered quickly into the pressurizing chamber, and 
the chamber was locked. The crystal was kept moist by placing ~500 μL of holding solution at 
the bottom of the pressurizing chamber. The chamber was purged three times with 50 psi Xe gas, 
followed by an increase in Xe pressure to 200 psi for 60 seconds. After quickly depressurizing 
the chamber (~20 seconds), the looped crystal was plunged into liquid nitrogen. Since the Xe 
pressurization procedure was performed outside of the anaerobic chamber, 2 mM DTT was used 
to protect the metallocenters from oxygen damage. We know from previous work that crystals 
exposed to oxygen for more then 26 hrs show complete destruction of the C- and D-clusters, 
while the A-cluster's binuclear cluster remains intact (data not shown). Following data collection 
on the Xe-CODH/ACS crystals, we examined the electron density for the metalloclusters, and 
did not observe any damage to any clusters including the most oxygen sensitive C- and D-centers 
(Figure AII.1). 
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Data collection and processing ⎯ Data on Xe pressurized CODH/ACS crystals were measured 
at the SSRL beamline 9-1 (Table AII.1).  The resulting P1 unit cell had the following 
dimensions:  a=99.54 Å, b=136.60 Å, c=141.75 Å, α=101.29°, β=109.22°, γ=103.91°. The 
mosaicity of the Xe-pressurized crystal increased to 0.7-0.9 degrees from the usual 0.3-0.4 
degrees. Xe-pressurized crystals diffracted to better than 2.5 Å allowing for a highly detailed 
view of the Xe binding sites.  Data processing was carried out using the HKL package(18). The 
published CODH/ACS structure (pdb 1MJG) stripped of water molecules was used for the initial 
rigid body refinement, followed by slow cool cartesian dynamics simulated annealing refinement 
in CNS(19). This first round of refinement alone resulted in R factors that were under 30%, 
suggesting that the structure with Xe gas was quite similar to the previous native structure. Final 
rounds of refinement were performed with REFMAC(20) with NCS restraints for each rigid part 
(2 segments in CODH; 3 in ACS). The final model includes residues 2-674 for CODH chains A-
D, residues 2-729 for ACS chains M, N, and P, and residues 2-728 for ACS chain O.  
Ramachandran analysis of the final model shows that 98.9% of residues lie in the most favoured 
or additionally allowed regions, with 0.4% in disallowed regions.   Final refinement statistics are 
given in Table AII.1. 
Identifying Xe binding sites and refinement-  Following initial rounds of refinement, 
unaccounted for electron density in the 2|Fo|-|Fc| maps was present in the hydrophobic cavities.  
|FXe|–|Fnative| difference Fourier maps (Figure AII.2) and |Fo|-|Fc| difference Fourier maps showed 
consistent high sigma electron density peaks. Into these electron density peaks, Xe atoms were 
modeled in XtalView(21).  It is important to note that no water molecules are present in these 
hydrophobic locations in native, high-resolution structures.  Electron density only appears in the 
hydrophobic channels of this enzyme structure when crystals are pressurized with Xe.  The 
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model was adjusted, and water molecules were added back to the model.  At 2.51 Å resolution, 
B-factors and occupancies cannot be considered separately, however, Xe sites may not all be 
fully occupied.  Therefore, the B-factors for Xe atoms were set to the average value for the 
structure (~30) and occupancies were refined in CNS(19).  When the occupancy of a Xe atom 
refined to a value greater than one, then the occupancy for that site was set at one and the B-
factor was allowed to refine.   CNS values for occupancy and B-factor were then transferred to 
REFMAC(20) for a final round of refinement.   
 All figures were created with PyMOL (DeLano, W.L. The PyMOL Molecular Graphics 
System (2002) DeLano Scientific, Palo Alto, CA, USA. http://www.pymol.org).  The atomic 
coordinates and structure factors (accession number 2Z8Y) have been deposited in the Protein 
Data Bank, Research Collaboratory for Structural Bioinformatics (http://www.pdb.org). 
AII.4 Results 
Prediction versus experimental data for two 70-Å-long channels ⎯ Biochemical data are 
consistent with the presence of a channel that connects the C-cluster (the site of CO generation) 
with the A-cluster (the site of CO consumption)(6, 7).  The location of this channel has been 
predicted in this CODH/ACS crystal form by the cavity calculation program CAVENV(9).   
Here we describe the use of Xe gas to further explore the nature of this predicted cavity.  Xe is 
known to bind to hydrophobic sites on proteins with high enough occupancy to serve as a heavy 
atom derivative(22). It has also been applied with good success to identify hydrophobic substrate 
channels(23), and with a van der Waals radius of 2.16 Å, Xe is a reasonable size mimic for CO, 
which has an effective van der Waals radius on the order of ~2 Å.  Using a SSRL Xe cryocell, 
we have solved a 2.5 Å resolution structure of Xe-pressurized CODH/ACS, and identified 19 Xe 
sites per α2β2 CODH/ACS complex in locations that are an excellent match with the previously 
 204
reported cavity calculations (Fig. 3).  A total of 38 Xe sites have been identified and refined 
between the two α2β2 CODH/ACS complexes present in the asymmetric unit. Each α2β2 
CODH/ACS complex shows a similar set of sites (Table AII.2). There are 4 sites distant from the 
CO channel (sites 10 and 10’ in Figure AII.3), at equivalent positions in each of the 4 CODH 
subunits.  There are 8 equivalent sites (1-7 and 9), or total of 32, in each of four CO tunnels, with 
two sets of these sites (Figure AII.4B) close enough (2.75 Å) that they are unlikely to be 
simultaneously occupied. In addition, 2 minor sites exist that are only present in 2 of 4 CO 
channels (site 8 in Figure AII.3 and AII.4F). The Xe-lined channel connects each C-cluster to an 
A-cluster and spans a distance of ~70 Å. Xe1 is closest to the Ni of the C-cluster at one end of 
the 70 Å-long channel, and Xe9 is closest to the binuclear metal site of the A-cluster at the other 
end (Figure AII.3).  Although the cavity calculations suggest a channel between the two C-
clusters of the CODH subunits, no Xe atoms are found there. Other than sites 10 and 10’, all Xe 
atoms are present in the cavities connecting C- and A-clusters, the route that CO would take 
under turnover conditions. In addition, no Xe atoms are located in any putative entranceways that 
substrate CO2 might take from the outside of the protein into the C-cluster. Presumably, the route 
into and out of the C-cluster is dynamic, allowing Xe to enter but also allowing it to leave. A 
dynamic channel would not have stable binding sites for gaseous substrates, thus preventing its 
detection by the Xe method. Since the Xe sites are similar between the two α2β2 CODH/ACS 
complexes in the asymmetric unit, in the following sections, only one α2β2 CODH/ACS will be 
discussed. 
Nature of the CO channel ⎯ Xe atoms bind in chiefly hydrophobic sites (Figure AII.4, Table 
AII.2). Within 5 Å of the Xe atoms are 70 contacting amino acids, of which 50 (71%) are 
nonpolar, 18 (26%) are polar, and only 2 (3%) are charged. Although there are polar and charged 
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amino acids near the Xe atoms, the polar or charged ends of the side chains usually point away 
from the channel, while the hydrophobic parts of the side chains are utilized in creating a channel 
lining that is mostly hydrophobic.  The exceptions to this rule are residues C468 (site 1), T593 
(site 2), and C350 (site 10), which have polar groups oriented towards the channel (Figure 
AII.4).  Additionally, there are two water molecules located in the channel near site 6 that were 
not observed in the native high-resolution structure. The issue of sequence conservation of 
channel residues is more complex. Analysis of conservation is complicated by the fact that no 
other CODH/ACS proteins have been experimentally shown to channel CO.  Also, a BLAST 
(24) search reveals only nine pairs of CODH/ACS sequences that contain the channel-forming 
domain of the α-subunit and are close enough in the genome to be colocalized in a gene cluster. 
With this limited number of sequences, the channel-lining residues do not exhibit any more 
significant conservation than the overall level of conservation in the protein.  However, the 
hydrophobic character of residues lining the channel is somewhat conserved (81% conserved for 
ACS tunnel residues, 67% conserved for CODH residues). It is perhaps not surprising that there 
is not a clear pattern of conservation, since a channel might be quite tolerant of mutations that 
conserve the fold and general hydrophobic character.  More detailed analysis of the sequence-
based requirements for tunnel formation will require experimental characterization and ideally a 
crystal structure of another bifunctional CODH/ACS. 
Binding of Xe near the A-cluster ⎯ The A-cluster (site of acetyl-CoA synthesis) is a complex 
metallocofactor, containing a Fe4S4 center bridged through a cysteine residue to a binuclear 
metal site.  One of the positions of the binuclear site, called the proximal metal because it is 
closest to the Fe4S4 cluster, is subject to substitution and can contain Cu, Ni, and Zn, resulting in 
binuclear site compositions of Cu-Ni, Ni-Ni, and Zn-Ni (3, 5, 11, 25). The Cu-Ni is the dominant 
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form of the as-isolated enzyme from native M. thermoacetica, and the Ni-Ni form appears to be 
the catalytically relevant form(11, 25-27), and reviewed in(1, 3-5).  Since substrate CO has been 
proposed to bind to the proximal metal(8, 11), one potential role of the channel is to direct CO to 
that site.  Here we find a high occupancy Xe site (Site 9 in Figures AII.3 and AII.4) ~3.9 Å from 
the proximal metal and ~3.7 Å from the distal metal.  While the Xe packs against the binuclear 
metal site on one side, protein residues F229, F512, G145, V149, C509, C595, G596, and C597 
surround the Xe and contribute to what is a largely hydrophobic binding site (Figure AII.4G).  It 
is likely that this Xe site represents the entry point to the A-cluster for CO, just prior to ligation 
of CO to the metal center.  The almost identical distance for the Xe to both metals of the 
binuclear site suggests that the channel alone is not responsible for metal binding selectivity, at 
least between these two possible sites.  The channel may protect against CO binding to the Fe4S4 
cluster or to the undersides on the binuclear cluster metal ions, preventing interactions that would 
not be catalytically relevant. The geometry of the A-cluster is modified by the Xe treatment. 
Since no oxygen-related damage to the oxygen-sensitive D- and C-clusters is observed (Figure 
AII.1), the effect must be due to the presence of Xe rather than accidental exposure to oxygen 
during Xe treatment. A metal ligand of unknown identity reported previously (8) is displaced by 
a Xe atom, changing slightly the geometry of the central metal to become more planar, and 
altering the metal-metal distance from ~2.7 Å to ~3.0 Å. These rearrangements demonstrate the 
plasticity of this metallocenter, a plasticity that is likely to be essential for catalysis.  
Protein architecture that creates a channel ⎯ Both β-CODH and α-ACS subunits are composed 
of multiple domains.  The CODH subunit has an α-helical domain at the N-terminus (CODH 
domain 1, residues 1-257), an α/β Rossmann-like domain in the middle (CODH domain 2, 
residues 262-458), and an α/β Rossmann-like domain at the C-terminus (CODH domain 3, 463-
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674) (Figure AII.5A).  The helical domain contributes ligands to the D-cluster and B-cluster, 
which are typical Fe4S4 clusters. The two Rossmann-like domains coordinate the C-cluster with 
loops following the third and fifth β-strands of the middle domain and the first three β-strands of 
the C-terminal domain.  The ACS subunit is composed of three domains (Figure AII.5A). The 
first domain consists of a helical region (residues 1-154) at the N-terminus of a Rossmann-like 
(six stranded α/β) fold (155-316). Domain 1 resembles the helical region and the C-terminal 
Rossmann domain of the CODH β- subunit and could have resulted from gene duplication (158 
of 316 residues align with an rmsd of 1.83 Å). The second and third domains of the ACS α-
subunit are α + β folds, neither of which align well with known structural motifs in the DALI 
structural database.  In both CODH and ACS subunits, the hydrophobic channel passes both 
through the middle of domains and in between domains.  In particular, the pathway starts at the 
Ni site of the C-cluster in the CODH subunit and then proceeds through the C-terminal 
Rossmann domain, between the bottom face of its six-stranded β-sheet and its α-helices. After 
passing through the center of the Rossmann domain, the channel runs alongside this domain, still 
protected from solvent by the helical domain of the β-subunit.  The middle Rossmann domain of 
the CODH subunit makes no contacts with the channel. The CODH β-subunit part of the 
pathway contains 4 Xe sites (sites 1-4), and a single ordered Xe is present at the interface 
between CODH and ACS subunits (site 5).   
Xe sites 6-9 are found in the channel that runs through the ACS subunit. As the channel enters 
the ACS subunit, it continues essentially parallel to the β-strands of the Rossmann-like domain 
from the carboxy side to the N-terminal side (Figure AII.5A).  The channel is sandwiched 
between the bottom face of this β-sheet and the helical domain, with α-helices from the 
Rossmann domain on either side.  The channel exits the Rossmann domain at the N-terminal side 
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and continues to the A-cluster in the third domain of the ACS subunit. Residues from the third 
domain and the helical subdomain form the end of the channel; the second domain of the ACS 
subunit makes no contacts with the channel.  While the helical/Rossmann regions of the ACS 
and CODH subunits are closely related structurally and in both cases are used to form the 
majority of the channel, the pathway taken by the channel through these very similar folds is 
completely different (Figure AII.5B and C).  
Channels in monofunctional versus bifunctional CODHs ⎯ In the bifunctional CODH/ACS, CO 
produced at the C-cluster must travel to the A-cluster where it is incorporated into acetyl-CoA.  
In a monofunctional CODH (28, 29) or the monomeric hybrid cluster protein (HCP) from 
Desulfovibrio vulgaris (30), only one type of active site exists.  Gas substrates and products must 
enter and exit the active site of the monomer, but the location of the exit should not matter. The 
function of HCP has not been clearly defined, but there is evidence that it may be involved in 
oxidative stress (31) or nitrogen metabolism(32-35). Structurally, HCP is highly homologous to 
CODH, with a similar helical domain followed by two Rossmann-like domains (overall 275 
alpha carbons align with an rmsd of 1.8 Å). The Rossmann domains coordinate metalloclusters 
with nine of twelve cluster ligands conserved, suggesting an evolutionary relationship between 
HCP and CODH. With this high structural homology between the CODH domain of the 
bifunctional enzyme, the monofunctional enzyme, and HCP, the protein fold must not be the 
factor that dictates the directionality of the gaseous product away from the active site 
metallocluster. Hydrophobic cavities have been identified through cavity calculations in 
monofunctional CODH from C. hydrogenoformans (28) and R. rubrum (29), and channels have 
been found through Xe-derivatization of HCP (pdb 1E9V)(30, 36). By comparing cavity 
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calculations and Xe experiments, we can identify how the bifunctional enzyme is designed to 
channel CO from the C-cluster exclusively to the A-cluster.   
 Not unexpectedly, HCP and monofunctional CODHs show additional cavities compared 
to the bifunctional enzyme, although the main cavity is duplicated (Figure AII.6).  Three Xe sites 
in HCP (1E9V) are found in a Rossmann-like domain on the same face of the  β-sheet as 
described for mtCODH/ACS (Figure AII.6). The other ten Xe sites in HCP identify three 
additional channels.  If these hydrophobic cavities were present in CODH/ACS, CO would not 
be channeled to the A-cluster as effectively.  Structural comparisons show negative design at 
work: the secondary structure allows for the cavities, but large aromatic residues in 
mtCODH/ACS block their openings. Blocking a potential channel to the left in Figure AII.6 is 
W95 and blocking the one to the right are F632 and F634.  A third large channel opens to the 
right in the HCP structure, above the plane of the CODH channel.  Blocking this potential 
channel are residues W594, W595 and F576 of the mtCODH subunit. Residues F576, W595, and 
F634 of mtCODH would also block the extra channels that are present in the two available 
structures (28, 29) of monofunctional CODH enzymes. This analysis does not provide clues as to 
the entryway for CODH substrate CO2, as several potential cavities appear to be effectively 
blocked. What is most intriguing is that the protein fold does not dictate channel number or 
direction; the latter is designed through changes in amino acid side chains. It is interesting that 
the design principles that nature uses here are similar to ones that a researcher might have tried, 
blocking potential channel exits with large aromatic residues.  
AII.5 Discussion 
One hypothesis concerning the origins of life is that nickel-iron-sulfur slurries were able to 
utilize a largely carbon dioxide environment to create an energy source in the form of acetyl 
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thioesters by reactions similar to those of the modern Wood-Ljungdahl pathway(37, 38), which 
has been proposed to be the most primitive biochemical pathway of CO2 reduction(39). These 
concepts are based in part on the activity of CODH/ACS enzymes, which use nickel-iron-sulfur 
clusters to produce acetyl-CoA from carbon dioxide and coenzyme A. This theory underscores 
the catalytic role of the metallocenters in CODH/ACS chemistry. Here, we consider the role of 
the protein. Our studies, taken together with previous work discussed above, suggest that the 
protein is in fact very important in acetyl-CoA synthesis. Perhaps one reason for the large size of 
the protein (310 kDa) is that a scaffold is required to encapsulate an interior channel that is 
hydrophobic and long enough to connect two active sites, allowing CO generated at the C-cluster 
in the CODH subunit to be used as a substrate for the A-cluster in the ACS subunit.  
Here, we describe the use of Xe gas to confirm that a 138 Å-long channel identified through 
cavity searching software can indeed house gas molecules.  With its similar size to CO, Xe 
serves as a good substrate mimic.  Ten sites have been described that can stably bind Xe atoms, 
and nine of these lie within the predicted channel. The ten sites are chiefly hydrophobic, as is the 
overall channel itself. While some polar and two charged residues are present along the channel, 
in most cases the polar or charged part of the side chain points away from the channel and the 
hydrophobic parts are involved in channel formation.  There are a few exceptions, including two 
waters near Xe site 6 that are absent in the native structure.  In this case, it seems that Xe binding 
causes a rearrangement that creates two water binding sites (Figure AII.4D). There are no water 
molecules present in the native structure that are displaced by Xe, presumably because Xe does 
not bind in hydrophilic sites that water molecules favor.  CO would also prefer a more 
hydrophobic environment than water, and it would be unfavorable from a functional perspective 
for CO to have to compete with water molecules for channel passage.  
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 As discussed in the results section above, the analysis of channel residue conservation is 
complicated by the limited biochemical data on CODH/ACS enzymes from other species, 
however, it seems unlikely from studies done thus far that residue identity will be particularly 
important.  That is, there is more than one way to line a hydrophobic channel.  We see that the 
use of hydrophobic residues is not even necessary as long as most of the polar parts of residues 
are pointing away from the channel.   The cavities that allow for channel formation are created 
by the proper juxtaposition of common protein motifs. The CODH/ACS channel runs between 
helical and Rossmann-like domains as well as through two Rossmann domains. Both helical and 
Rossmann domains are ubiquitous in nature, showing, as observed before (13), that formation of 
a channel does not require an unusual protein structure.  Interestingly, the helical region and 
Rossmann region of ACS domain 1, used to form the ACS part of the channel, may have resulted 
from gene duplication from the CODH helical domain and its C-terminal Rossmann domain, 
which forms the CODH part of the channel (158 of 316 residues align with an rmsd of 1.83 Å). 
In analyzing how Xe traveled through the helical and Rossmann motifs of both CODH and ACS 
subunits, we expected to find channel duplication related to the gene duplication.  However, 
despite the high structural homology, the pathway taken by Xe is completely different in each 
subunit.  Thus, while nature chose the same architecture for both halves of the channel, this 
architecture was not used in the same manner.  As there is more than one way to line a channel, 
there is apparently more than one way to create a channel using the same ordinary protein 
structural units.  
 It is also worth considering how nature uses the same protein structure for 
monofunctional and bifunctional CODHs, which need to enlist different routes for CO into or out 
of the C-cluster.  In the later case, the bifunctional enzyme should direct CO to the A-cluster 
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where it is assembled into acetyl-CoA, and in the former, no second active site exists, making 
substrate/product routes less important.  By comparing our CODH/ACS Xe data with cavity 
calculations of monofunctional CODHs and Xe data from the monofunctional CODH cousin 
HCP, we can describe the differences in channel compositions between these monofunctional 
and bifunctional proteins. The solution to this ‘design’ problem appears simple. Monofunctional 
CODH/HCP’s have additional cavities that are absent in the CODH subunit of a CODH/ACS; 
however, the difference in cavity composition is not due to an elaborate difference in protein 
structure. Simple placements of aromatic residues block the pathway for Xe, and presumably 
CO, in the bifunctional enzyme, serving to direct it to the A-cluster.  It is important to note that 
the positions of Xe atoms in this mtCODH/ACS structure do not indicate how CO2, the substrate 
for the C-cluster, accesses its CODH active site.  Xe does access the C-cluster since it is bound 
within 10 Å of this cluster, but it is unclear how it gets there.  We believe that the entrance routes 
to the C-cluster from the outside of the protein are dynamic and not designed for the stable 
binding of gaseous molecules, and are thus not ‘visible’ through the use of Xe.  An alternative 
hypothesis that has been suggested by Volbeda and Fontecilla-Camps (1) is that Xe or CO2 could 
enter the enzyme via the A-cluster, and travel through the internal channel to the C-cluster 
(Figure AII.3).  This hypothesis seems unlikely given that mutants of channel residues between 
the A and C clusters do not appear to affect CODH activity (10), and traveling of CO2 against the 
flow of CO would require an elaborate gating mechanism (1).  Another proposal is that CO2 
enters the C-cluster through the channels connecting the C-clusters or through a hydrophilic 
channel near the CODH dimer interface (40).  Entrance through the channel connecting the C-
clusters would again require that CO2 travel against the expected path of product CO, even 
though this distance would be shorter (Figure AII.3). The entry of CO2 must not allow escape of 
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CO from the tunnel, so separate “entrance” and “exit” pathways would make sense. At this stage 
however, all hypotheses for CO2 entrance should be considered since definitive experimental 
evidence is difficult to obtain.  
 Returning to one of the more fundamental questions: why is it necessary for CODH/ACS 
to have its C- and A-clusters connected via a channel that stretches almost the full length of the 
310 kDa protein molecule? Channels often exist to allow highly reactive intermediates to travel 
from one active site to another without encountering solvent that would lead to their 
decomposition; however, CO is very stable in aqueous solution.  Instead, a channel might protect 
the cellular environment from the toxic effects of CO. However, a number of organisms can 
grow on CO, including M. thermoacetica (41).  For example, C. hydrogenoformans, which uses 
CO as a carbon and energy source, has a doubling time of 2 hours in the presence of CO (42). 
Since these organisms can thrive on growth media containing CO gas, a role for a channel in 
their CODH/ACS to protect the cellular environment would be unnecessary. We propose that a 
major role for the channel in CODH/ACS is to ensure that each molecule of CO generated from 
CO2 is properly directed into cellular metabolism. Being approximately -200 mV more reducing 
than NAD(P)H, CO is fairly expensive to make from CO2, as it requires low-potential electrons 
originally derived from substrate (H2, glucose, etc.) oxidation.  Thus, the uncoupling of CO 
production from acetyl-CoA synthesis due to a leaky channel could be life threatening.  A similar 
situation exists for methanogens, since growth on acetate is even more energetically marginal 
than growth on H2/CO2. Given that the methanogenic ACDS lacks one of the domains that is part 
of the M. thermoacetica CODH/ACS channel, it will be very interesting to determine if these 
aceticlastic methanogens also have evolved a CO channel.    
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 Another potential function of a channel is to direct molecules to a particular site on an 
enzyme. Since many metals are capable of binding CO, a channel in CODH/ACS could direct 
CO to a metal coordination site on the A-cluster where it would be catalytically competent rather 
than potentially inhibitory. We find a Xe positioned within van der Waals distance of the 
proximal and distal metals in the binuclear site the A-cluster.  It is interesting that the channel 
does not appear to guide CO toward one site of the cluster exclusively; however, it would 
prevent CO binding to the backsides of both metals and to the Fe4S4 cluster.  
 An additional role of enzyme channels is to synchronize activities at two active sites. Our 
Xe data shows gas molecules lined up along the full extent of the C- to A-cluster channel, 
invoking an image of a factory assembly line, and suggesting one mechanism by which the 
activities of the C- and A-clusters become synchronized when substrates for both reactions are 
available(14).  The rates of CO2 reduction by the C-cluster depend on the context of the CODH 
protein.  Monofunctional CODH catalyses CO2 reduction at a rate of ~11 s-1(43), while CODH in 
complex with ACS catalyzes CO2 reduction at a rate of ~0.6 s-1 in the absence of all ACS 
substrates, and with a rate of ~3.3 to 5.8 s-1 in the presence of ACS substrates(14). Thus, 
complexation with ACS slows the CO2 reaction rate down; however, the rate of CO2 reduction is 
heavily modulated by the activity of the A-cluster, even at saturating CO2 concentrations (7). In 
the bifunctional enzyme, if the channel is ‘full,’ catalysis at the C-cluster should temporary halt 
until one CO has been removed from the channel by action of the A-cluster. Then, resumption of 
CODH activity would fill the empty CO binding site and allow continuation of acetyl-CoA 
synthesis. If the A-cluster is not functioning properly, due for example to lack of substrates, the 
wait could be even longer. For the monofunctional CODH, CO would simply diffuse into 
solution, and ‘buildup’ should never occur. It is unknown whether any CO ‘buildup’ would even 
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occur on the bifunctional enzyme under normal physiological conditions, but it has been 
suggested that the channel ‘crowding’ is responsible for CODH/ACS inhibition observed under 
high CO concentrations(10). 
 One danger of keeping a ‘full’ CO channel or in making more CO than is needed at the 
moment, is that CO could escape as the ACS α-subunit opens to the react with the methylated 
CFeSP for methyl transfer thereby wasting energy. The formidable challenge of reacting with 
three substrates of very different dimensions requires that the enzyme perform a molecular 
juggling act in which the ACS α-subunit must open and close to allow the largest substrate to 
access the A-cluster.  The fact that the A-cluster is coordinated directly by only one domain of 
ACS (the C-terminal domain) allows for a domain rearrangement to occur without damaging the 
A-cluster (8).  Our cavity calculations shown in Figure AII.7 compare and contrast the ‘channel 
open’ and ‘channel closed’ states of the ACS subunit.  As discussed previously (11), helix 7 of 
domain 1 moves to seal the channel upon subunit opening.  Thus, the channel in CODH/ACS 
comes complete with a plug.  
 While ‘channel open’ and ‘channel closed’ states are two necessary forms of the 
CODH/ACS enzyme, there are at least two others (Scheme AII.2).  After methylation and 
carbonylation, an acetyl intermediate is formed, coordinated to a metal of the A-cluster.  At this 
stage, opening of the ACS subunit could be disastrous since the access of water to the A-cluster 
would result in formation of acetate rather than the desired acetyl-CoA.  How then is the ACS 
subunit prevented from opening? We have proposed (8) that the intermediate itself might restrict 
the motion of the domains of the ACS subunit by jutting across the interface between domains 1 
and 3.  It is interesting to think about when and how often the ACS opens. Is it opening and 
closing all the time under physiological conditions or does it only open in the presence of 
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methylated CFeSP?  When methylated CFeSP interacts with ACS, CFeSP may help to slide ACS 
domain 1 from 3, creating access to the A-cluster for methyl transfer.  When the A-cluster is 
unliganded or when the small substrate CO is bound, this sliding motion should be unrestricted 
and easily prompted by the presence of CFeSP.  In contrast, if a branched acetyl intermediate is 
present, extending across the domain-domain interface of ACS, sliding may be restricted such 
that subunit opening would not occur until turnover is complete. Thus, ACS itself may have a 
turnover-dependent locking device.  To date, no one has captured a structure of CODH/ACS 
with CoA (Scheme AII.2, “CoA-bound; α-mostly closed”), although proposals have been made 
as to where it binds, including the suggestion that it binds to the cavity between the three 
domains of ACS (8). Thus, in CODH/ACS, we have a protein with a channel for a small 
substrate, a channel plug, a flexible ACS subunit that can open to interact with a large substrate, 
and an inter-domain cavity to putatively bind a medium sized substrate.  
 While Ni-S-Fe slurries could have been involved in the origins of life by producing 
acetate from CO2, current day CODH/ACS chemistry requires a protein scaffold. The enzymatic 
machine that is CODH/ACS is fueled by electrons from glucose oxidation, transforms CO2 into 
CO, and funnels CO down an assembly line as ACS opens and closes to catalyze a condensation 
of CO with a methyl moiety and finally produce acetyl-CoA.  
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Table AII.1.  Data collection and refinement statistics 
 
 
 
 
 
 
 
 
 
 
 Xenon CODH/ACSa
Data Collection  
   Space group P1 
   Cell dimensions    
   a, b, c (Å) 99.54 136.60 141.75 
   α, β, γ (°) 101.29 109.22 103.91 
   Wavelength (Å) 0.9184 
   Resolution (Å) 49.0 – 2.51 (2.60-2.51) 
   Reflections total/unique 457691/217468 
   Rsym (%) 8.3 (42.2) 
   Mean I/σI 10.3 (2.0) 
   Completeness 96.1 (92.0) 
   Redundancy 2.1 (2.0) 
Refinement  
   Resolution (Å) 49.0 – 2.51 
   Reflections in  
   working/test set 
193081/10717 
   Rwork/Rfree (%) 17.8/25.0 
   No. atoms  
      Protein 43321 
      Heteroatoms (Fe S Ni Cu) 124 
      Waters 1153 
      Xenon 42 
   Avg. B-factor, all atoms (Å2) 31.3 
       Protein 31.5 
       Heteroatoms (Fe S Ni Cu) 33.8           
       Waters 23.0 
       Xenon 28.4 
   r.m.s.b deviations  
      Bond lengths 0.026 
      Bond angles (°) 2.28 
 
 
 
 
 
 
 
 
 
a Highest resolution shell is shown in parentheses. 
b r.m.s., root mean square. 
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Table AII.2. Xe binding sites in mtCODH/ACS based on |FoXe| -|FoNative| difference Fourier 
maps and refinement 
Xe 
sites 
Channel 1,  
Mol 1 
Channel 2,  
Mol 1 
Channel 1,  
Mol 2 
Channel 2,  
Mol 2 
Neighboring residues, (atoms, and 
average distances) 
 Occ B-factor Occ 
B-
factor Occ 
B-
factor Occ 
B-
factor  
1 0.13 32.32 0.15 23.79 0.19 34.46 0.09 13.77 
CODH residues: C468(SG-3.3), A590 
(CB-3.4), T602(CG2-3.6), W595(CD1-
3.9), S579(C-4.0), G592(CA-4.0), H603 
(O-3.9), A578(C-4.5), I591(CG2-4.6) 
2 1.00 25.33 1.00 27.34 0.86 29.20 1.00 33.81 
CODH residues: P608(CG-3.8), V102 
(CG2-3.9), A589(O3.9), T593(OG1-3.9), 
F632(CZ-3.9), I106(CD1-4.7) 
CODH residues: 3A: I106(CD1-3.7), 
L620(CD2-3.9), A234(CB-4.0), T593 
(CG2-4), M148(CE-4.0), E156(OE2-
3.7), M182(SD-3.9), F184(CZ-4.7), 
Y221(CE1-3.7), A222(CA-4.0), 
I248(CG2-3.8).0), V231(CG1-4.4), 
V102(CG1-4.6).   
3A 
 
 
  B 
0.56 
 
 
0.35 
26.65 
 
 
25.68 
0.60 
 
 
0.19 
30.46 
 
 
14.04 
0.48 
 
 
0.26 
28.75 
 
 
30.93 
0.51 
 
 
0.30 
29.28 
 
 
33.15 
3B: V102(CG1-3.4), A234(CB-3.8), 
A99(O-4.0), G103(N-4.4), V231(CA-
4.4), I106(CD1-4.6), L230(O4.8) 
4 0.87 29.88 0.84 30.13 0.69 28.85 0.67 30.30 
CODH residues: L620(CD2-3.6), I235 
(CD1-3.8), V231(CG1-3.9), V596 
(CG1-4.0), T593(CG2-4.4), F632(CE2-
4.2), A624(CB-4.5) 
5 1.00 21.32 1.00 24.50 1.00 27.49 0.87 31.68 
CODH residues: V228(CG1-4.0), F232 
(CE1-4.2), I619(CG1-4.4), I623(CG2-
3.8), V627(CG2-4.2)     ACS residues: 
T31(CG1-4.0), Y35(CG1-4.6) 
6 0.31 27.13 0.30 29.16 0.24 29.10 0.18 30.25 
ACS residues:  T106(CG2-4.9), A110 
(CB-4.7), F212(O, 4.2), T213(CG2-4.1), 
I215(CG2-3.9), V261(CG1-3.4), A265 
(CB, 4.1), HOH877-3.6, HOH837-4.7 
7 1.00 21.87 1.00 24.50 1.00 27.49 0.73 33.0 
ACS residues:W107(NE1-4.4), I158 
(CG2-4.5), L160(CD2-4.8), I215(CG1-
4.0), V252(CG2-4.0), A265(O-3.8), 
A266(CA-4.3), A269(CB-4.3) 
8 0.19 25.25   0.14 19.28   
ACS residues:  M148(CE-4.0), E156 
(OE2-3.7), M182(SD-3.9), F184(CZ-
4.7), Y221(CE1-3.7), A222(CA-4.0), 
I248(CG2-3.8) 
9 0.73 34.79 0.75 30.98 0.45 31.90 0.37 42.27 
ACS residues:  Cu-3.7, Ni-3.9, G145(C-
4.4), I146(N-4.8), V149(CG1-3.8), 
F229(CD1-3.2), C509(SG-4.2), 
F512(CB-4.9), C595(CB-4.2), G596(N-
4.4), C597(CB-4.1) 
10 0.28 24.55 0.41 31.99 0.20 25.94 0.36 35.46 
ACS residues: S396(O-3.3), L287 
(CD1-3.73), A400(CB-3.8), T374(CG2-
3.8), Y388(CD1-3.9), A397(N-4.0), 
I386(CD1-4.1), C350(SG-4.3), 
I291(CD1-4.45) 
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Scheme AII.1 Reactions of CODH/ACS 
CODH (β-subunits) 
ACS (α-subunits) 
C-cluster: CO2 +2H+ + 2e- CO + H2O 
CO + CFeSP-CH3 + CoA acetyl-CoA + CFeSP  A-cluster: 
B-cluster: electron transfer 
D-cluster: electron transfer 
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Scheme AII.2 Cartoon of required CODH/ACS conformations 
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Figure AII.1 Electron density for the C and D clusters.   Maps show 2Fo-Fc density contoured 
to 1.5 σ. 
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Figure AII.2 |FXe|–|Fnative| map contoured to +4 σ (blue) and -4 σ (red) indicating the 
locations of Xe atoms.   
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Figure AII.3 Overall structure of α2β2 CODH/ACS complex.  CODH β-subunits are shown in 
green and yellow, and ACS α-subunits are in pink and magenta.  Xe sites are shown as blue 
spheres, and the predicted channel pathway is highlighted in blue.  Length of scale bar from A 
cluster to opposite A cluster is ~138 Å.   
 
 
 
 228
Figure AII.4 Detailed views of Xe binding sites.  CODH β-subunit is shown in green, ACS α-
subunit in magenta.  Residues within 5 Å of xenons are shown as sticks. Interior protein surfaces 
are lightly shaded.  A. Xe site 1 B. Xe sites 2,3,4  C. Xe site 5 D. Xe site 6 E. Xe site 7 F. Xe site 
8 G. Xe site 9 H. Xe site 10. 
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Figure AII.5 CODH/ACS domain architecture.  Metal clusters are shown as spheres, 
calculated channel is highlighted in grey. A. Domain structure of one α/β CODH/ACS complex.  
CODH domain 1 (helical) shown in cyan, CODH domain 2 in purple, CODH domain 3 
(Rossmann-like) in green.  ACS domain 1 helical region is shown in pink, domain 1 Rossmann-
like region is in magenta, ACS domain 2 colored yellow, and domain 3 colored orange.  B. 
CODH helical domain 1 (cyan) and Rossmann domain 3 (green) shown in same orientation as 
ACS domain 1 helical/Rossmann region in C.  The Rossmann β-sheet and two α-helices are 
shown in orange to highlight the similarities to ACS domain 1.  C. ACS domain 1 helical region 
shown in pink and Rossmann region shown in magenta.  The Rossmann β-sheet and two α-
helices are highlighted in orange. 
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 Figure AII.6  Stereoview comparing Xe sites in M. thermoacetica CODH and HCP.  Xenons 
in the CODH structure are shown as blue spheres, and the CODH/ACS channel is highlighted in 
blue.  The HCP xenons are colored magenta.  Aromatic residues in CODH that block channels 
observed in HCP are shown as green sticks. Metal clusters from HCP (atoms of cluster shown as 
magenta spheres) align with those from mtCODH (colored by atom with iron brown, sulfur 
yellow, and nickel green). 
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Figure AII.7 Comparison of ‘open’ and ‘closed’ α-subunit structures.  ACS α-subunit 
domains are labeled and colored pink (domain 2), hotpink (domain 1), and magenta (domain 3), 
CODH β-subunits colored yellow and green.  The A-cluster is shown as spheres, Xe sites are 
shown as blue spheres, and the predicted channel pathway is highlighted in blue. A. Xe bound 
structure with closed α-subunit and open channel. B. Structure with open α-subunit and closed 
channel (pdb 1OAO). 
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